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The liver is an essential organ and carries out many essential functions. Most studies in 
the liver development are carried out in mice and chick using reverse genetics and 
explants culture method, however, the whole picture of liver organogenesis is still 
mysterious due to limitations of such approaches and the early lethality of liver defect in 
mouse. Zebrafish emerges as an ideal model for forward genetics and liver organogenesis. 
To investigate molecular mechanism of the liver development without bias, we carried 
out a forward genetic screen for liver defective mutants in zebrafish assisted with a high 
throughput whole mount in-situ hybridization method using the liver specific marker 
prox1 as a probe. After screening 524 mutagenized genomes, we obtained 71 putative 
mutants which came from 51 F2 families. Of these mutants 19 lines showed liver defects 
with relatively normal morphology and were considered as interesting mutants for further 
study. 
To initiate positional cloning to reveal molecular lesion in a liverless mutant sq181 
obtained in our screen, a total of 451 simple sequence length polymorphism (SSLP) 
markers from established panels were tested in our lines, and 226 markers that showed 
polymorphism were selected for construction of the initial mapping panel. Positional 
cloning identified a G to A substitution in the myosin phosphatase targeting subunit 1 
(mypt1) gene in sq181 mutants, which results in the V36 to M36 substitution in an RVxF 
motif in Mypt1. Genetic analyses unequivocally prove that the mypt1sq181 mutation is 
responsible for the liverless phenotype. 
Previous studies showed that mesodermal tissues produce various inductive signals 
essential for morphogenesis of endodermal organs. However, little is known about how 
 vii
the spatial relationship between the mesodermal signal-producing cells and their target 
endodermal organs is established during morphogenesis. The mypt1sq181 mutation 
attenuates the binding of Mypt1 to PP1c and leads to a compromised myosin phosphatase 
activity, and causes abnormal bundling of actin filaments and disorganization of lateral 
plate mesoderm (LPM) cells around the hepatic endoderm. As a result, the coordination 
between mesoderm and endoderm cell movements is disrupted. Consequently, the two 
stripes of Bmp2a-expressing cells in the LPM fail to align in a V-shaped pocket 
sandwiching the liver primordium. Mispositioning Bmp2a producing cells with respect to 
the liver primordium leads to a reduction of hepatoblast proliferation and final abortion of 
hepatoblasts by apoptosis that causes the liverless phenotype. Our results demonstrate 
that Mypt1 mediates coordination between mesoderm and endoderm cell movements in 
order to carefully position the liver primordium such that it receives a Bmp signal that is 
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Chapter 1 Introduction 
 
The liver, the largest internal organ in the human body, is a reddish-brown spongy mass 
of wedge-shaped lobes and is located in the upper right part of the abdominal cavity 
immediately beneath the diaphragm. The liver weighs about 1200 to 1500 g, 2 percent of 
the total adult body weight. It consists of two main lobes, left and right, separated by the 
falciform ligament, and two small lobes, the caudate lobe located on the posterior surface 
and the quadrate lobe on the inferior surface (Figure 1-1). 
1.1 The liver structure and functions 
1.1.1 The liver structure 
Understanding function of the liver depends on understanding its structure. The structure 
of liver can be discussed in such three aspects: the hepatic vascular system, the biliary 
system and the three dimensional arrangements of the liver cells. 
1.1.1.1 The hepatic vascular system 
Unlike other organs, the liver receives blood from two sources. A majority of 
(approximately 75%) the liver's blood supply is venous blood and supplied by the portal 
vein that drains the blood from the intestinal system (including the pancreas and the 
spleen), rich in nutrients and poor in oxygen. The remaining blood supply (about 25%) is 
oxygenated arterial blood from the hepatic artery (Figure 1-2). The blood flow from the 
terminal branches of the hepatic portal vein and hepatic artery coalesces into sinusoids in 
the liver and drains into the central vein in each lobule (Figure 1-3A). The hepatic vein 













Figure 1-1 Anterior and posterior views of the human liver. Adapted from 
http://www.britannica.com/eb/art-68633/Anterior-and-posterior-views-of-the-
liver?articleTypeId=1 
Figure 1-2 The vascular system and biliary system in the human liver. Adapted 
from http://www.moondragon.org/health/disorders/gallbladder.html 
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Figure 1-3 The microscopic view of the liver lobule and portal triad. Adapted from 
http://www.sacs.ucsf.edu/home/cooper/Anat118/GI-Glands/lvrpancsaliv.htm 
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1.1.1.2 The biliary system 
The biliary system is a series of channels and ducts that conveys bile from the liver into 
the small intestine. The bile canaliculus, the first channel in the biliary system, is formed 
by grooves between tight junctions on the contact surface of adjacent hepatocytes. The 
bile is secreted into canaliculi and progressively flows into ductules, interlobular bile 
ducts and then larger hepatic ducts (Figure 1-3A). The bile ducts coalesce to form the left 
and right hepatic ducts. The common hepatic duct drains the bile from the left and right 
hepatic ducts and joins with the cystic duct from the gallbladder to form the common bile 
duct. The common bile duct merges with the main pancreatic duct in the hepatopancreatic 
ampulla that enters the duodenum at the major duodenal papilla (Figure 1-2). 
1.1.1.3 The three dimensional arrangements of the liver cells 
A basic architecture of the liver is a polygonal column called liver lobule. The corners 
between polygonal lobules are portal spaces where locate portal triads. The portal triad is 
composed of a portal venule bundled with a hepatic arteriole, and a bile duct (Figure 1-
3A, B). Small lymphatics and autonomic nerves also run through this space. Radiating 
from the center to the lobule periphery are branching, anastamosing plates of hepatocytes, 
one or two cells thick, separated by capillaries, the liver sinusoids (Figure 1-3A, B).  
Sinusoids are vascular channels lined with highly fenestrated endothelial cells. Between 
the sinusoids and the hepatocytes is a subendothelial space called the space of Disse. 
Several types of cells are residents in the sinusoids or the space of Disse: Kupffer cells, 
stellate cells (Ito cells) and Pit cells. Microvilli from the hepatocytes protrude into this 
space. Blood plasma easily percolates through the sinusoidal fenestrations into the space 
of Disse and so makes intimate contact, facilitating exchange, with the hepatocyte (Figure 
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1-4). The hepatocyte is the main cell type accounting for 60% of all liver cells. It is the 
most versatile cell type in the human body and carries out all the main liver functions. A 
corresponding characteristic feature of hepatocytes is that their cytoplasm is very rich in 
mitochondria, ribosomes, endoplasmic reticulum (both smooth and rough), Golgi 
complexes, peroxisomes, and lysosomes (Figure 1-4). 
1.1.2 The liver functions 
As such an anatomically complex organ discussed above, the liver carries out many 
essential functions. Because the liver serves as an interface between blood returning from 
the digestive tract (the portal venous system) and the rest of the bloodstream (via the 
hepatic venous system), it must play a key role in processing all the products of digestion 
(and many ingested drugs) before entering the general systemic circulation.  
The metabolism of carbohydrates, lipids, proteins and cholesterol happens in the 
hepatocytes. The glucose level in the bloodstream is strictly regulated in the liver by 
glycogenesis (to synthesize glycogen from excess glucose in the blood), glycogenolysis 
(to depolymerize glycogen and export of glucose back into the blood) and 
gluconeogenesis (to synthesize glucose out of amino acids and non-hexose carbohydrates 
when hepatic glycogen reserves become exhausted). The liver is extremely active in 
oxidizing triglycerides and exports large quantities of acetoacetate into blood to produce 
energy. The liver is also the major site for converting excess carbohydrates and proteins 
into fatty acids and triglyceride. The most critical aspects of protein metabolism that 
occur in the liver are: deamination and transamination of amino acids, followed by 
conversion of the non-nitrogenous part of those molecules to glucose or lipids; synthesis 












Figure 1-4 Diagram of the ultrastructure of a hepatocyte. Adapted from Junqueira 
et al. Basic Histology, 8th edition. 
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other clotting factors for blood coagulation. The liver also manufactures about half of the 
body’s cholesterol, a vital part of every cell membrane and is needed to make certain 
hormones, including estrogen, testosterone, and the adrenal hormones. 
Accompanying with versatile metabolism functions, the liver has capabilities of storage 
and excretion. The synthesized glycogen is stored in the hepatocytes as reserved energy. 
Lipid droplets can be found in the hepatocytes and Ito cells, fat-storing cells in the 
sinusoids. The liver can also store iron and vitamins. The by-products of metabolisms 
excreted by two ways: By-products in the bile (such as bilirubin, a breakdown product of 
hemoglobin in Kupffer cells) enter the intestine, and then leave the body in the feces. By-
products in the blood (such as urea) are filtered out by the kidneys, and then leave the 
body in the urine. 
The most important secretory function of the liver is the secretion of bile, which are 
critical for digestion and absorption of fats and fat-soluble vitamins in the small intestine. 
The liver also serves as a primary organ of detoxification: drugs and poisonous 
substances are broken down in the liver and excreted as harmless by-products into the 
bile or the blood. 
Several cell types found in association with the sinusoids also serve important functions: 
The Kupffer cells are macrophages (derived from monocytes) that are permanent 
residents within the lumen of the sinusoids. They function in the filtration of the portal 
blood through phagocytosis of old red blood cells and bacteria. They also secrete growth 
factors. The Ito cells (fat-storing cells) are located in the Space of Disse. They store 
Vitamin A and synthesize hepatic growth factor. They also are involved in the production 
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of the extracellular matrix (collagen). The highly mobile Pit cells are natural killer 
lymphocytes attached to the endothelium. 
The liver in the human body has storage of 10-15% of total blood volume in its vascular 
system. When blood flows through the sinusoids, a considerable amount of plasma is 
filtered into the space of Disse, providing a major fraction of the body's lymph. 
Besides the above functions of the adult liver, the fetal liver serves as a site for 
haematopoiesis by mid-gestation.  
Though the liver has diverse functions, only a small number of cell types is found in liver, 
which makes the liver as an ideal organ for studies of organogenesis. Approximately 60% 
of cells in the adult liver are hepatocytes and the remaining cells are cholangiocytes (bile 
duct cells), Kuppfer cells, stellate cells and some endothelial cells. Since liver plays such 
critic roles, it is of great importance to study liver development, not only for basic 
research, but also for clinic application. 
1.2 Liver organogenesis  
1.2.1 Liver is an endoderm derived organ 
The endoderm is one of the three germ layers established during gastrulation. In mouse 
embryo, gastrulation starts with the formation of the primitive streak (PS) at the posterior 
of the epiblast (also known as the primitive ectoderm) at embryonic day 6 (E6). The 
endoderm precursor cells migrate through the primitive streak and displace the visceral 
endoderm which surrounds epiblasts (Wells and Melton, 1999). The visceral endoderm is 
an extraembryonic tissue to nourish the early embryo and does not give rise to embryonic 
tissue but to the yolk sac. To distinguish with the visceral endoderm, the embryonic 
endoderm is called the definitive endoderm. At the end of gastrulation (E7.5), the 
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definitive endoderm that is a single-cell thick layer of about 500 cells covering the 
bottom surface of the developing embryo (Wells and Melton, 1999). The sheet then 
forms a gut tube with invaginations at the anterior and posterior ends of the tube to 
generate the foregut and hindgut respectively by E8.5. The gut tube at E8.5 was divided 
into four regions in a fate map generated based on the single endoderm cell labeling at 
E7.5 (Lawson et al., 1986). The region I, the ventral foregut, gives rise to the thyroid, 
lung, liver and ventral pancreas. Albumin, a characteristic marker of hepatic specification, 
can be detected at the ventral foregut at the stage E8.5 (Cascio and Zaret, 1991; Gualdi et 
al., 1996). Regions II and III, the dorsal foregut and middle gut, contribute to dorsal 
pancreas, stomach, duodenum, and the part of intestine. The region IV, the hind gut, 
gives rise to the large intestine and colon.   
1.2.2 The liver morphogenesis 
Before the gut tube closes off by E9, the invagination of the foregut presents itself 
juxtaposing the cardiac mesoderm and the ventral foregut undergoes hepatic specification 
to become liver diverticulum as early as E8.5 (7-8 somites) which is directed by inductive 
signals from developing heart (Douarin, 1975; Gualdi et al., 1996). Shortly after 
specification, the first morphologically distinguishable structure of liver, an outgrowth 
named the primary liver bud, appears in the ventral floor of the foregut by E8.5 to E9.0 
(10-12 somites) as a result of the proliferation of the hepatic endoderm, referred as 
hepatoblasts (Douarin, 1975; Gualdi et al., 1996). Cell linage tracing shows that two 
distinct populations of endoderm cells, lateral and medial, arising from three spatially 
separated embryonic domains, converge to generate the epithelial cells of the liver bud 
(Tremblay and Zaret, 2005).  The primary liver bud is surrounded by a basement 
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membrane (Medlock and Haar, 1983). By E9.5, this basement membrane is progressively 
disrupted and hepatoblasts delaminate from the foregut and invade as cords into the 
surrounding septum transversum mesenchyme (Douarin, 1975; Medlock and Haar, 1983). 
The hepatoblast cords intermingle with the vitelline veins, anastomosing into a venous 
bed, to begin to form a vascular, distinct liver organ by E10.5. At about E10, 
hematopoietic cells migrate from the yolk sac and aorta-gonad-mesonephros (AGM) 
region and become residents in the liver until birth (Johnson and Moore, 1975; Zaret, 
1996; Muller et al., 1994; Medvinsky and Dzierzak, 1996). The fetal liver takes gradual 
differentiation from hepatobalsts to hepatocytes and expands dramatically in volume. 
During the liver morphogenesis, cell shapes take a series of changes. Soon after 
specification, the hepatoblasts take a morphology change from columnar epithelia to 
pseudostratified epithelia, with concomitant "interkinetic nuclear migration" (INM) 
during cell division, which makes the hepatoblasts ready for migration and differentiation 
(Bort et al., 2006). During the following differentiation period, the 
hepatoblasts/hepatocytes transit from an oblong shape at E12–14 to spherical around E18 
and finally become polygonal just prior to birth (Vassy et al., 1988). Another fact of the 
differentiation is the increasing rough endoplasmic reticulum and Golgi apparatus in the 
hepatoblasts/hepatocytes. The differentiated hepatocytes become functional by synthesis 
of secreted proteins and deposition of glycogen (Medlock and Haar, 1983) and the 
neonatal liver continues to develop and mature especially with regard to expression of 
metabolic enzymes. At E13.5, hepatoblasts in the proximity to the portal mesenchyme 
will give rise to cholangiocytes (bile duct cells) (Shiojiri, 1984; Germain et al., 1988). 
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1.2.3 Molecular mechanism involved in the liver development 
Current knowledge of the molecular mechanism underlying the liver development is 
mostly obtained by reverse genetics and tissue explantation in mouse and chick. And it 
will be discussed in a stage-wise manner according to a five-step model: endoderm cells 
to gain competency to become hepatogenic cells, specification of hepatoblast, liver bud 
formation, liver bud expansion, and hepatocyte and cholangiocyte differentiation 
(Duncan, 2003). 
1.2.3.1 Acquisition of competency  
The first hepatogenic event is the specification of ventral foregut endoderm cell to be 
hepatoblast. However, gene inactivation experiments show that many genes expressing in 
endoderm before the hepatic specification occurs are necessary to enable the ventral 
foregut to respond to inductive signals, and the innate ability of ventral foregut of taking 
hepatic cell fate is called competency. Two groups of factors, Foxas and Gatas, are 
important for foregut to gain the competency (Figure 1-5A). Foxa (forkhead box A, also 
known as Hnf3, hepatocyte nuclear factor-3) were initially cloned by biochemical 
analysis of their binding abilities to the regulatory regions of the transthyretin (TTR) and 
α1-antitrypsin genes (Costa et al., 1989; Lai et al., 1990; Lai et al., 1991). All three foxa 
member genes, foxa1, foxa2 and foxa3 (formerly as hnf3α, hnf3β and hnf3γ respectively) 
are expressed in the embryonic definitive endoderm and the adult liver. During 
gastrulation, the expression of foxa2 initially appears in the node at E6.5 and maintains 
throughout definitive endoderm, in the notochord, in ventral neural plate and 
subsequently in the floorplate at E7.5. The mRNA of foxa1 can be first detected at E7 in 



















Figure 1-5 Hepatic competence and specification (A) gaining of competence at 2-6 
somite stage: The ventral foregut endoderm gains the hepatic competence with the 
action of transcription factors Foxas and Gatas, and bone morphogenetic proteins 
(Bmps) that emanate from the adjacent cells of septum transversum mesenchyme 
(STM). (B) Hepatic specification at 7-8 somite stage: During hepatic specification, 
fibroblast growth factor (Fgf) signals from the cardiogenic mesoderm and Bmp signals 
from the STM, initiate the liver gene expression in proximal endoderm, as well as 
blocking that for pancreas. Ventral endoderm cells are distal to the cardiogenic 








the expression of foxa3 extends from hindgut to the foregut/ midgut boundary from E8.5 
onwards (Lai et al., 1991; Ang et al., 1993; Kaestner et al., 1993; Monaghan et al., 1993; 
Altaba et al., 1993; Sasaki and Hogan, 1993). The embryonic liver histology is normal in 
foxa1 or foxa3 single gene knock-out mouse, however, the inactivation of foxa2 leads to 
embryonic lethality shortly after gastrulation due to the defective development of gut tube, 
node, notochord and floorplate (Ang and Rossant, 1994; Weinstein et al., 1994; Dufort et 
al., 1998; Kaestner et al., 1998; Kaestner et al., 1999) (Shih et al., 1999). To circumvent 
the embarrassment, Lee et al. engineered a conditional foxa2 knock-out mouse foxa2Loxp/ 
Loxp; foxa3-Cre to specifically abrogate foxa2 throughout the territory of foxa3 expression 
(Lee et al., 2005a). The liver development is normal in the transgenic mouse. The 
inactivation of single Foxa factor does not affect the hepatic development because of 
functional compensation by each other, however, double mutant foxa1-/- ; foxa2Loxp/ Loxp; 
foxa3-Cre has no liver bud. Moreover, the culture of endoderm from the double mutant 
fails to initiate expression of the liver markers albumin and transthyretin in presence of 
inductive signal (Lee et al., 2005b). The above data suggest that foxa1 and foxa2 are 
required for ventral foregut to respond to the inductive signal to undergo hepatic 
specification. Another group factors Gata (GATA binding protein) are also involved in 
acquiring hepatic competency of foregut. gata4 and gata6 are expressed in the foregut 
around the time of hepatic specification (Arceci et al., 1993; Laverriere et al., 1994; 
Morrisey et al., 1996; Suzuki et al., 1996; Gao et al., 1998; Koutsourakis et al., 1999; 
Zhao et al., 2005). The gene knock-out of gata6 causes embryonic lethality before 
gastrulation and gata4 mutant shows defects in foregut morphogenesis (Kuo et al., 1997; 
Molkentin et al., 1997; Narita et al., 1997; Morrisey et al., 1998; Koutsourakis et al., 
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1999; Keijzer et al., 2001). The early development arrest in these mutants is believed due 
to defects in the extraembryonic tissues. To overcome this problem, a method called 
tetraploid embryo complementation was designed to generate chimeric embryos, gata4-/- 
or gata6-/- embryo nourished with wild-type extraembryonic endoderm, which could 
survive till a later stage. The hepatic specification is normal in both chimeric embryos but 
the liver bud fail to expand (Zhao and Duncan, 2005; Watt et al., 2007). Like Foxa1 and 
Foxa2, Gata4 and Gata6 have redundant functions during hepatic specification. Double 
knock–out both factors is a probable way to obtain the direct evidence of the 
indispensability of Gata factors in the hepatic competency establishment in the endoderm.  
To investigate the mechanisms of the gain of hepatic competency, Zaret laboratory 
applied in vivo footprinnting technique to analyze the albumin enhancer and found that 
strong binding sites for Foxas and Gatas are occupied in the foregut endoderm before 
albumin expression initiates (Gualdi et al., 1996; Bossard and Zaret, 1998). They further 
demonstrated that Foxa2 occupancy in the dorsal endoderm, usually giving rise to the 
intestine, from E8.5- E11.5 endow the dorsal endoderm the ability to express albumin 
when cultured alone in vitro, and the loss of the Foxa2 occupancy at E13.5 led to the 
inability to express albumin in the cultured dorsal endoderm (Bossard and Zaret, 2000). 
This implied that the binding of Foxas and Gatas to the silent albumin enhancer facilitates 
the endoderm to initiate the hepatic cell fate once the presence of the inductive signals in 
the ventral foregut or removal of repressive interaction in the dorsal endoderm. To further 
elucidate the function of the occupancy of Foxa2 and Gata4 on the albumin enhancer, the 
Zaret laboratory demonstrated that purified Foxa2 and Gata4 can not only recognize their 
target binding sites in highly condensed chromatin in an independent of the recruitment 
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of secondary factors manner, but also remodel the chromatin structure and expose the 
local nucleosomes to generate a receptive status (Shim et al., 1998; Chaya et al., 2001; 
Cirillo and Zaret, 1999; Cirillo et al., 2002). However, the occupancy by Foxa2 and 
Gata4 is insufficient to activate transcription of the gene (Cirillo et al., 2002). Thus, the 
transcription factors activated by inductive signals can bind to remodeled chromatin to 
initiate the expression of hepatic genes.  
1.2.3.2 Hepatic specification 
The hepatic specification is a result of competent ventral foregut endoderm responding to 
the mesodermal signals and taking hepatic cell fate (Figure 1-5B). The first evidence of 
inductive mesodemal signals for hepatic specification came from LeDouarin’s classic 
tissue transplant studies in chick embryos (Douarin, 1975). She demonstrated that the 
close contact to cardiac mesenchyme is the prerequisite for the hepatic determination of 
endoderm of the foregut pocket at 5-6 somite stages (corresponding to about E8-8.5 in 
mouse). She further showed that pre-cardiac mesenchyme, when transplanted along with 
the pre-hepatic endoderm from earlier stage embryos, is the only mesoderm to help the 
endoderm to develop into a liver lobe (Douarin, 1975). Similar results were obtained in 
mouse and quail embryoes (Houssaint, 1980; Houssaint, 1980; Fukuda-Taira, 1981). 
Gualdi et al. precisely defined the stage of such cardiac mesoderm dependent hepatic 
specification as 7-8 somite stage (E8.5) in mouse using a sensitive method RT-PCR to 
detect albumin mRNA, a characteristic marker of hepatic cell linage (Gualdi et al., 1996). 
Moreover, the hepatic genes expression in the co-cultured explants of ventral endoderm/ 
cardiac mesoderm could be inhibited in presence of dorsal tissues (Gualdi et al., 1996), 
and the inhibitory effect of dorsal tissues also was reflected in the fact that the dorsal 
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endoderm lost the ability to express albumin when cultured along with the dorsal 
mesoderm (Gualdi et al., 1996; Bossard and Zaret, 2000). Further investigation of 
molecular mechanism of inductive signals revealed that fibroblast growth factors (Fgfs) 1 
or 2, but not 8, can substitute the cardiac mesoderm to induce the onset of hepatogenesis 
in the culture of foregut explants (Jung et al., 1999), and Fgfs secreted by cardiac 
mesoderm activate the hepatic genes induction and promote post-specification hepatic 
tissue growth by RAS/MAP kinase (MAPK) and PI3 kinase/AKT pathways respectively 
(Calmont et al., 2006). In addition, Fgfs guide the cell fate choice in the ventral foregut: 
the posterior portion, close to the cardiac mesoderm, develops into the liver by inhibition 
of the innate pancreatic cell fate by high concentration of Fgfs; and the anterior lip, away 
from the developing heart, gives rise to ventral pancreatic bud (Deutsch et al., 2001). The 
close relationship between the liver and pancreases also reflects on the facts that the 
commutative transdifferentiation between two cell fates in vitro and in vivo (Zaret, 2001; 
Li et al., 2005).  
The second inductive signal, bone morphogenetic proteins (Bmps), comes from the 
septum transversum mesenchyme (STM) which is derived from the lateral plate 
mesoderm (Figure 1-5B). Rossi et al. found the expression of hepatic genes in the co-
cultured explants of the cardiac mesoderm and ventral endoderm could be inhibited by 
addition of Noggin, a Bmp antagonis. Careful examination of the explants culture 
revealed the presence of Bmp4-producing septum transversum mesenchyme in the 
explants culture, moreover, adding Bmp4 or Bmp2 into the explants culture could 
overcome the inhibition by Noggin and initiate the hepatic genes expression. The results 
suggest that Bmp signaling works in parallel to Fgf signaling from the cardiac mesoderm 
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to initiate hepatogenesis in the ventral endoderm at the expense of the ventral pancreas 
(Rossi et al., 2001).   
Thus, the combination of morphogenic and molecular events make up the hepatic 
specification: Foxa and Gata factors endow the ventral and dorsal endoderm competency 
to follow hepatic cell fate, and then a serial of morphogenesis processes produces the 
close proximity of the ventral foregut to the developing heart. The ventral foregut 
responds to the inductive signals emanating from neighboring cardiac mesoderm and 
septum transversum mesenchyme to be specified into hepatoblast, while the dorsal 
endoderm does not initiate hepatogenesis inhibited by the surrounding dorsal mesoderm 
(Figure 1-5).  
1.2.3.3 The liver bud formation and growth 
The specified hepatoblast undergoes rapid proliferation and differentiation with the action 
of many intrinsic transcriptional factors and interaction with other tissues. There are two 
phases: first the proliferative hepatoblasts invade the STM to form a distinct liver organ 
by E9.5; then hepatoblasts further proliferate to increase liver size and differentiate to 
hepatocytes and bile duct cells.  
1.2.3.3.1 The liver bud formation 
In the process of liver bud outgrowth, endothelial cells play an important role. The liver 
is a high vascular organ, as early as E8.5, shortly after the hepatic specification, 
endothelial cells are found to delimit the nascent specified hebatoblasts from the 
surrounding septum transversum mesenchyme (Matsumoto et al., 2001). Knock-out flk1, 
a gene encoding vascular endothelial growth factor receptor 2 (Vegfr2), results in the 
failure of the formation of endothelial cells and blood vessels (Shalaby et al., 1995), 
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moreover, the formation of liver bud in flk1-/-  embryo is blocked after the hepatic 
specification, indicating that endothelial cells are crucial for the early liver bud formation 
prior to vascular function, although the molecular mechanism underlying is unclear 
(Matsumoto et al., 2001). Besides the essential function in the hepatic specification, the 
Fgf and Bmp signalings also take part in the liver bud formation. The Fgf8 secreted by 
the cardiac mesoderm is necessary for the morphogenetic outgrowth of the hepatic 
endoderm and PI3 kinase/AKT pathway activated by Fgf signaling contribute to liver bud 
growth (Jung et al., 1999; Calmont et al., 2006). Bmps from septum transversum 
mesenchyme is also required for liver bud growth (Rossi et al., 2001). 
The transcriptional factors involved in the early liver bud formation are Hex (also known 
as Hhex, haematopoietically expressed homeobox), Prox1 (prospero-related homeobox 1) 
and Gata factors (Figure 1-6A). The gene hex encodes a divergent homeobox 
transcription factor. The transcripts of hex appear in the ventral endoderm at E8.0, early 
before the hepatic specification, and maintain in the liver bud (Thomas et al., 1998; 
Bogue et al., 2000). The hex knock-out mouse is defective in the formation of liver and 
thyroid bud (Keng et al., 2000; Martinez Barbera et al., 2000). However, the endoderm 
initiates the hepatic program in the hex-/- embryo indicated by taking a hepatoblast 
characteristic columnar shape and the expression of liver specific genes before E9.5 
(Martinez Barbera et al., 2000; Bort et al., 2004). The hex-/- hepatoblasts display a 
deduced proliferative rate and fail to invade STM to form a liver bud (Bort et al., 2004). 
Further investigation showed the failure of liver budding in hex-/- embryo is due to the 
disruption of Hex-dependent cell morphological change from columnar epithelia to 










Figure 1-6 The liver bud formation (A) Initiation of the liver bud at 11-13 somite 
stage. After the hepatic specification, hepatoblasts become columnar in shape. These 
transitions seem to be elicited by signals that specify the endoderm. Signaling 
molecules including Bmp and Hgf from septum transversum mesenchyme (STM) and 
Vegfr2 from primitive endothelial cells, and transcription factors (such as Hex, Prox1, 
Hlx and c-Met) are essential to promote to initiate the liver bud formation. (B) The liver 
bud formation at 18-25 somite stage. Liver budding morphogenesis is marked by the 
formation of the rostral diverticulum of the gut, remodelling of the extracellular matrix 
around the hepatoblasts and of E-cadherin-based connections between the cells, and 
proliferation and migration into the surrounding STM (beige). During this stage 
primitive endothelial cells develop into blood vessels (not shown) and haematopoietic 
cells migrate into the liver bud and become residents until birth. Bmp, bone 
morphogenetic protein; c-Met, HGF receptor; Hgf, hepatocyte growth factor; Vegfr2, 
vascular endothelial growth factor receptor 2. Adapted from Zaret, 2002. 
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differentiation. The failure of morphological change in hex-/- embryo was demonstrated as 
a result from the inhibition of interkinetic nuclear migration (INM) by the ectopic 
activation of sonic hedgehog signaling (Bort et al., 2006). Another transcription factor 
involved the liver bud formation is Prox1, a homeobox transcriptional factor homologous 
to Prospero in Drosophila (Oliver et al., 1993). The prox1-/- hepatoblasts fail to 
delaminate from the foregut to migrate into the septum transversum mesenchyme and 
cluster within a core, which results from inability of degradation of the laminin and type 
IV collagen rich basement membrane and extra deposition of E-cadherin in the 
surrounding extracellular matrix (ECM) (Sosa-Pineda et al., 2000). Besides the essential 
functions of Gata factors in the acquisition of the competency, both Gata4 and Gata6 are 
indispensable for the formation of the liver bud demonstrated by the wild-type 
extraembryonic endoderm rescued gata4-/- and gata6-/- embryo (Zhao and Duncan, 2005; 
Watt et al., 2007).  
1.2.3.3.2 Growth and apoptosis of hepatoblasts 
Diverse paracrine stimuli and intrinsic factors coordinate to regulate the hepatoblast to 
proliferate and differentiate in the liver bud (Figure 1-6A). LeDouarin first found a 
second stimulation from the lateral plate mesoderm derived mesenchyme to support the 
grafted endoderm to develop into a liver lobe (Douarin, 1975). Duncan believed that the 
STM- derived ECM was the corresponding tissue (Duncan, 2003). The ECM directs the 
liver development in two ways: either by concentrating signaling molecules or by 
mediating intracellular signal through interaction with integrins. β1-integrin is a 
component of receptor for ECM proteins laminins and collagens. The β1-integrin knock-
out embryonic stem cells fail to colonize the liver, indicating the importance of ECM to 
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the liver development (Fassler and Meyer, 1995). In Smad2+/- Smad3+/- mouse embryos, 
two Tgf-β signal transducers, the expression of β1-integrin is lost and results in 
hypoplastic liver (Weinstein et al., 2001). Similar to Smad2+/- Smad3+/- mouse, the mouse 
lacking hepatocyte growth factor (Hgf), expressed in STM and hepatocytes, or Hgf 
receptor c-Met, expressed in hepatocytes, also has severe liver hypoplasia (Bladt et al., 
1995; Schmidt et al., 1995; Uehara et al., 1995). Moreover, the addition of Hgf can 
rescue the liver growth and β1-integrin expression of the Smad2+/- Smad3+/- liver 
explants in vitro, indicating Hgf and Tgf-β converge on the regulation of β1-integrin to 
control hepatoblasts growth (Weinstein et al., 2001).  
Among the STM-producing factors which control hepatogenesis includes two 
transcription factors: Hlx (H2.0-like homeobox gene) and N-myc (Figure 1-6A). 
Inactivation of hlx does not affect the initiation of hepatic program but the mutant liver 
fails to expand and is only a small bud at E14.5 without apoptosis (Hentsch et al., 1996), 
while hepatoblasts in N-myc knock-out mouse undergo extensive apoptosis (Giroux and 
Charron, 1998). It implies that Hlx and N-myc promote hepatoblasts growth and survival, 
probably by regulation the expression of growth factors and survival factors respectively. 
Besides STM, blood cells resided in the fetal liver are also the source of regulators for 
hepatogenesis. Jumonji, an AT-rich domain transcription factor, is highly enriched in 
megakaryocytes resided in the live at mid gestation (Motoyama et al., 1997). The 
hepatocyte number in jmj-/- mouse is markedly reduced and differentiation of 
hepatocytes is compromised in the primary culture (Anzai et al., 2003). It suggest that 
Jumonji probably regulate the production of panacrine growth factors to promote 
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hepatoblasts proliferation in mid gestation and help hepatocytes differentiate in late 
gestation through the action of increased expression level in hepatocytes.  
Foxm1b is an intrinsic transcription factor to promote hepatocytes proliferation by 
regulating mitosis in the fetal liver and regenerative liver (Ye et al., 1997; Krupczak-
Hollis et al., 2004). Inactivation of another transcription factor X-box binding protein 
1(Xbp1), which is expressed in the developing liver, causes reduced growth and 
prominent apoptosis in hepatoblasts (Reimold et al., 2000).  
In addition to growth signals, hepatoblasts also receive various necrotic and apoptotic 
signals. pik3r1 encodes three components of Phosphoinositide-3- kinase (Pik3s) and the 
mouse lacking  pik3r1 gene dies perinatally and shows extensive hepatocyte necrosis 
(Fruman et al., 2000). Two signal pathways are necessary to protect the hepatoblasts from 
tumor necrosis factor (TNF) induced apoptosis: NFκB (nuclear factor κB) pathway and 
SAPK/JNK (the stress-activated protein kinase/ c-Jun N-terminal kinase). Mice lacking 
either one of Rel-A, IKK-β and IKK-γ (NEMO), components of the NF-kB signal 
pathway, have extensive apoptosis of hepatocytes in the mid-fetal liver (Beg et al., 1995; 
Li et al., 1999; Tanaka et al., 1999; Rudolph et al., 2000). In addition, c-jun knockout 
mouse dies between E11.5 and E15.5 and exhibit defective liver development (Hilberg et 
al., 1993; Johnson et al., 1993). Knock out c-jun or the mediator of SPAK pawthway, 
sek1 (MKK4, mitogen-activated kinase kinase 4) leads to hypoplastic liver with features 
of apoptosis (Hilberg et al., 1993; Johnson et al., 1993; Ganiatsas et al., 1998; Nishina et 
al., 1999). These results indicated that these genes are crucial for the survival of 
hepatocytes. 
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The Wnt/ β-Catenin pathway seems also involved in the liver development regarding to 
the abundant expression in the fetal liver during E10-12 (Micsenyi et al., 2004). 
Moreover, ectopic activation of β-Catenin causes hyperproliferation of hepatocytes and 
constitutively active β-Catenin mutations are found in about 70% of human 
hepatoblastoma (Koch et al., 1999; Wei et al., 2000). 
1.2.3.4 Hepatocyte differentiation and establishment of hepatic architecture 
Hepatoblasts undergo proliferation and gradual differentiation in the liver bud, and take 
the terminal phase of differentiation to become functional polarized hepatocyte to exert 
the metabolic and other diverse functions in the late gestation and after birth. At same 
time the complex architecture is achieved by organization of parenchymal and 
mesenchymal tissues. During the process, cytokines secreted by blood cells and 
endothelial cells play essential roles. After the blood vessel is formed in the liver, the 
resident haematopoietic cells secrete Oncostatin M (OSM), an Interleukin-6 family 
cytokine, to promote the differentiation of hepatocytes through the gp130 signal 
transducer (Kamiya et al., 1999). ECM derived from Engelbreth-Holm-Swarm sarcoma 
(EHS) facilitates OSM induced terminal differentiation, indicating ECM is important to 
hepatocytes maturation (Kamiya et al., 2002). 
Hepatocyte differentiation is regulated by several transcriptional factors, such as c/EBPα 
(CCAAT/ enhancer binding protein α), Foxas, Hnf1α and Hnf4α (hepatocyte nuclear 
factor). Homozygous inactivation of c/EBPα, Foxa1 or Foxa3 does not affect the early 
development of liver, but the energy homeostasis is impaired. Conditional Knockout 
foxa2 in the endoderm or hepatocyte results in similar phenotype (Friedman and Kaestner, 
2006). Though the liver development in hnf1α-/- is normal, the products of some 
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metabolic enzymes and hepatic proteins are lost or diminished (Pontoglio et al., 1996).   
Because multiple transcription factors exert synergistic activation of hepatocyte-specific 
genes transcription, single gene knockout may not result in defective hepatocyte 
differentiation (Costa et al., 2003). Of transcriptional factors involved in hepatocyte 
differentiation Hnf4α plays a central role. hnf4α-/- embryo die during gastrulation due to 
defects in the visceral endoderm (Chen et al., 1994; Duncan et al., 1997). Using tetraploid 
embryo complementation, Li et al. demonstrated that the rescued hnf4α-/- embryos exhibit 
impaired hepatocyte differentiation with morphologically and histologically normal liver 
(Li et al., 2000). Besides downregulation of numerous hepatic proteins and enzymes, the 
expression levels of Hnf1α and orphan receptor Pxr (pregnane-X-receptor, also known as 
Nrli2; nuclear-receptor subfamily 1, group I, member 2) are also diminished in mutant 
embryos, suggesting Hnf4α probably regulates their transcription (Li et al., 2000). The 
results from mouse with postnatal inactivation of Hnf4α in hepatocytes confirm the 
central roles of Hnf4α on the regulation of metabolic enzymes production (Hayhurst et al., 
2001). In addition, α-fetoprotein enhancer and albumin promoter driven Cre recombinase 
(Alfp-Cre) directed floxed hnf4α conditional deletion results in hypoglycemia and failure 
of expression of genes associated with hepatocyte activities. Disruption of the formation 
of bile canaliculi, a consequence of the failure of hepatocyte expression of cell junction 
molecules, and distribution of sinusoids are also found in E18.5 mutant mouse, indicating 
that Hnf4α is necessary to hepatocyte differentiation and establishment of hepatic 
architecture (Parviz et al., 2003). Using chromatin immunoprecipitation and promoter 
microarrays, Odom et al. revealed that Hnf4α binds to about 40% promoter of liver genes 
(1575 genes) while Hnf1α and Hnf6 occupy 222 and 227 promoters of genes respectively, 
 25
furthermore, most Hnf1α and Hnf6 bound promoters are also occupied by Hnf4α, 
demonstrating the central roles of Hnf4α in maintaining differentiated hepatocyte (Odom 
et al., 2004). 
1.2.3.5 Cholangiocyte differentiation 
The bile duct system is composed of intrahepatic bile ducts (IHBD) and extrahepatic bile 
ducts (EHBD), including hepatic, cystic, common bile ducts and gallbladder. The lumen 
of IHBD and EHBD is delineated by biliary epithelial cells (BEC). In human, the hepatic 
diverticulum has the cranial and caudal portion, and the former contributes to the liver 
and IHBD while the latter gives rise to EHBD (Shiojiri and Koike, 1997). Though lack 
the cell lineage tracing evidence, biliary cells are believed to be derived from bipotential 
hepatoblasts able to differentiate into hepatocytes or BEC (Lemaigre, 2003).  In the case 
of IHBD, the bile ducts development can be divided into two phases: cholangiocyte 
induction and bile duct morphogenesis: the onset of cholangiocyte differentiation initiates 
with a subset of hepatoblasts around the portal mesenchyme expressing biliary- specific 
cytokeratins at E13.5. These hepatoblasts, named biliary precursor cells, also transiently 
express albumin and α-fetoprotein, characteristic markers of hepatoblasts and hepatocytes, 
and the others express much less same biliary- specific cytokeratins (Shiojiri, 1984; 
Shiojiri and Katayama, 1987; Germain et al., 1988; Shiojiri et al., 1991). Biliary 
precursor cells form a single cell layer called the ductal plate at E15.5, and the cell layer 
duplicates at E16.5. Around E17.5 the bilayer ductal plates remodel into bile ducts and 
incorporate into the portal mesenchyme before birth (Clotman et al., 2002; Lemaigre, 
2003; Fitz, 2002).  
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The cell-matrix and cell-cell interaction are suspected to regulate the development of 
biliary tracts because of the expression of proteins essential for interactions on BEC 
(Lemaigre, 2003). Biliary precursor cells originate in the proximity of the portal 
mesenchyme, thus mesenchyme is likely involved in cholangiocyte differentiation. It is 
confirmed by the abnormal gallbladder development in foxf1+/- mouse. Foxf1 is a 
transcription factor expressed in STM, the haploinsufficiency only appears in the 
formation of gallbladder and the IHBD is normal in foxf1+/- mouse (Kalinichenko et al., 
2002). Another example is Hgf which is expressed in STM. Hgf promote albumin 
negative hepatic cells to differentiate into albumin positive bipotent hepatoblasts in vitro, 
probably by inducing of the expression of c/EBPα (Suzuki et al., 2002; Suzuki et al., 
2003).  
Several transcription factors expressed in BEC play important roles in cholangiocyte 
differentiation. Two Onecut transcription factors, Hnf6 and Onecut2 (Oc2), cooperate to 
restricts the extent of biliary-cell commitment from haptoblasts. Biliary cytokeratins 
expressing hepatoblasts clusters are found throughout liver parenchyma in hnf6-/-; oc2-/- 
mouse, unlike the pattern of the distribution of biliary precursor cells near the portal vein 
in control. Moreover, the development of EHBD is disrupted in hnf6-/- mouse (Clotman et 
al., 2002; Clotman et al., 2005). Clotman et al. further elucidated that Hnf6 and Oc2 
inhibited Activin/Tgfβ signaling in the parenchyma to promote hepatocyte differentiation, 
and allow high Activin/Tgfβ signaling around the portal vein to facilitate BEC 
differentiation (Clotman et al., 2005). The involvement of Tgfβ signaling is confirmed by 
the fact that smad2+/-smad3+/- mouse is defective in the IHBD development (Weinstein et 
al., 2001). The expression of hnf6 is under the control of many factors, for example, 
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c/EBPα. Blocking c/EBPα by a dominant negative mutant form leads to a decrease of 
hnf6 expression in vitro (Suzuki et al., 2003). As a transcription factor, Hnf6 directly 
regulates the expression of another transcription factor Hnf1β (also known as vHnf1) 
(Clotman et al., 2002; Coffinier et al., 2002). Conditional knockout of hnf1β in 
hepatoblasts causes BEC to form transient biliary cysts due to abnormal tubulogenesis 
(Coffinier et al., 2002). Hnf1β is expressed in the epithelia in the liver, pancreas and 
kidney, and is the direct regulator of cystic kidney diseases genes whose products are 
localized in primary cilia, such as fibrocystin, the product of PKHD1 gene corresponding 
for the autosomal recessive form of PKD (polycystic kidney diseases) (Gresh et al., 2004; 
Hiesberger et al., 2004). Both BEC and renal epithelia have primary cilia at the apical 
surface, thus the anomalies of BEC in hnf1β-/- are referred to the defects in cilia formation 
regulated by Hnf1β. The mutations corresponding for Meckel syndrome, an autosomal-
recessive disease with renal cysts polydactyly and ductal plate malformations, are found 
in the genes coding proteins associated with primary cilia, further demonstrating normal 
primary cilia development is necessary to cholangiocyte differentiation (Clotman et al., 
2008). 
There two transcription factors essential for both hepatoblasts and BEC development. 
Besides functions in hepatoblast proliferation, Foxm1 is crucial to promote bipotential 
hepatoblasts to take biliary cell fate. foxm1-/- hepatoblasts fail to express biliary 
cytokeratins and nuclear level of Hnf1β, resulting in vacancy of IHBD in the liver 
(Krupczak-Hollis et al., 2004). Hex is expressed in the embryonic and adult liver, IHBD 
and EHBD (Keng et al., 1998; Thomas et al., 1998; Bogue et al., 2000). Endodermal 
deletion of the floxed Hex guided by foxa3-Cre results in a small cystic liver and total 
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loss of EHBD structure and the expression of Hnf4α and Hnf6; while the liver-specific 
deletion facilitated by Alfp-Cre cause abnormal development of IHBD and failure of 
Hnf1β expression in many BEC (Hunter et al., 2007). 
One of well-known biliary tract diseases is Alagille syndrome (AGS), an autosomal 
dominant disease with defects in the development of several organs, and paucity of IHBD 
and cholestasis with respect to the hepatobiliary system (Lemaigre, 2003). A ligand of 
Notch, Jagged1 is the corresponding gene and expressed in the developing BEC in human 
(Li et al., 1997; Oda et al., 1997). Unlike in human, the expression of jagged1 is detected 
in hepatic arteries and portal vein instead of BEC and haploinsufficiency of Jagged1 does 
not appear in mouse, however, jagged1+/-notch2+/- and notch2-/- mice display similar 
phenotypes as AGS (McCright et al., 2001; McCright et al., 2002). Hes1, a basic helix-
loop-helix transcription factor, is a mediator of Notch signaling pathway and expressed in 
BEC (Kageyama and Ohtsuka, 1999; Kodama et al., 2004). Studies in the hes1 knockout 
mouse revealed two aspects of functions of Hes1 in biliary development: inhibit the 
potential pancreatic cell fate in EHBD (Sumazaki et al., 2004) and regulate tubulogenesis 
in IHBD (Kodama et al., 2004).  
Interestingly, the hepatic artery development is tightly associated with IHBD 
morphogenesis. Branches of arteries fail to form in the liver of Hnf6 or Hnf1β knockout 
mouse (Coffinier et al., 2002; Clotman et al., 2003). 
In the above sections, the liver development in mouse is discussed, and an interesting 
topic associated with the liver development is the liver regeneration responding to liver 
injuries or partial hepatectomy (PH). Because the liver development and regeneration 
share many aspects of activity such as hepatocytes proliferation and ECM remodeling, 
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and the gene expression profiles are overlapped in both processes (Yamada et al., 1997; 
Jochheim-Richter et al., 2006), therefore, the studies in the liver development will help to 
understand the liver regeneration. 
The mouse is the most common used model in studies of the liver development because 
of the close similarity of physiology and anatomy to that of humans, and a lot of 
progresses are made in the mouse model using cell culture, explants culture, 
transplantation and genes knockout technologies. However, the whole picture of liver 
development is far away to be completed, and identification of novel factors is inefficient 
in the mouse model. Zebrafish, with powerful genetics, emerges as an excellent new 
model organism for studies of the liver development.    
1.3 Zebrafish: an ideal model for studies of the liver development 
1.3.1 Advantages of zebrafish 
Advantages of zebrafish as an ideal model for the study of embryogenesis display on two 
aspects: developmental study and genetic study. The following characteristics make 
zebrafish an excellent model organism for developmental study: unlike intrauterine 
development of mouse, the fertilization and development of zebrafish embryos happens 
externally, which facilitates an easy access to the developing embryos. Rapid 
development enables examination of embryogenesis in days instead of weeks in mouse. 
Furthermore, translucency of embryos favors visual analyses of early developmental 
processes; thus, real time observation of embryogenesis is feasible (Westerfield, 1989). 
Additionally, zebrafish embryos can receive enough oxygen through diffusion to support 
embryonic development to a relatively late stage, which circumvent the embarrassment of 
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early embryo lethality encountered with mammalian model organisms in studies mutants 
lacking circulation (Stainier, 2001).  
Besides such advantages on developmental study, zebrafish has excellent feasibility of 
genetic manipulation; both forward and reverse genetics methods can be applied in 
zebrafish. The most important advantage of zebrafish is the feasibility to carry out large-
scale forward genetic screen owing to its high fecundity (100-200 embryos weekly per 
female), short generation time (3 months for maturation) and low cost to breed 
(Westerfield, 1989). Before zebrafish was taken as a model organism, no large-scale 
forward genetic screen was carried out in vertebrate animals due to prohibitively 
expensive cost and intrauterine embryogenesis in case of mouse. In mouse, most genetic 
data were obtained by the reverse genetics which were depended on the knowledge from 
biochemical experiments and homologues mutants of invertebrates such as 
Caenorhabditis elegans and Drosophila melanogaster, however, the best way to decipher 
a specific biological issue is to conduct a phenotype-based forward genetic screen for 
gene knockout mutants, other than a gene directed knockdown. Most importantly, the 
forward genetic screen can lead to identify novel genes that cannot be achieved by 
reverse genetics methods.  
Several kinds of mutagens were used for mutagenesis for forward genetic screens in 
zebrafish. The most common used mutagen in zebrafish is N-ethyl-N-nitrosourea (ENU) 
which efficiently introduces point mutations in the genome (Mullins et al., 1994; Solnica-
Krezel et al., 1994).  Two successful large-scale screens (both use ENU as mutagen), one 
done in Max Planck Institute in Tubingen, Germany (Haffter et al., 1996) and the other in 
Massachusetts General Hospital, Boston, USA (Driever et al., 1996), have harvested 
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about 1740 mutants, covering 400-600 different loci, with visible morphological defects 
in all aspects of embryogenesis (Amsterdam and Hopkins, 2006). Inspired by the 
aforementioned successful screens, many research groups designed different strategies 
and initiated more specific screens using whole mount in situ hybridization, 
immunostanining, physiological and behavior analysis (Granato et al., 1996; Alexander et 
al., 1998; Farber et al., 2001; Patton and Zon, 2001; Trede et al., 2001; Shepard et al., 
2005). The ENU-induced mutations can be identified by positional cloning or candidate 
genes cloning (Schulte-Merker et al., 1994; Talbot et al., 1995; Talbot and Schier, 1999; 
Bahary et al., 2004). Characterization of those mutants reveals that numerous novel genes 
function in the development of heart, blood, neuron and other organs; and it also shows 
that conserved molecular mechanisms of development are shared among vertebrates 
(Dooley and Zon, 2000). Another effective mutagen is murine leukemia virus (MLV) 
based pseudotyped retrovirus which can integrate to zebrfish genome to inactivate the 
targeted gene (Lin et al., 1994; Gaiano et al., 1996). Insertional mutagenesis screens 
conducted in Hopkins’ laboratory successfully achieved about 520 mutants representing 
almost 400 different genes essential for early development in zebrafish (Amsterdam et al., 
1999; Golling et al., 2002; Amsterdam and Hopkins, 2004). Recently, a commercial 
company, Znomics Inc., attempts to achieve saturation mutagenesis using this method to 
establish a permanent library of cryopreserved sperms harboring proviral insertions with 
at least one insertion in each zebrafish gene. As the strategy used by Wang et al., each 
sperm sample collected from mutants was divided into two portions, one for 
cryopreservation, and other one for preparation of genomic DNA to identify the mutated 
genes in the corresponding sample in library (Amsterdam and Hopkins, 2006; Wang et al., 
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2007). The most prominent advantage of insertional mutagenesis over chemical one is 
much less effort required for mutant gene cloning because of the proviral tag on the target 
gene. However, types of alleles induced by ENU are more versatile including hypomorph 
(partial loss of function) or amorph (null), antimorph (opposing/dominant negative 
function), hypermorph (exaggerated function), and neomorph (gain of function) while 
most retroviral insertions cause only the first category alleles (Amsterdam and Hopkins, 
2006).  
Furthermore, several powerful reverse genetic approaches have recently been well 
developed. TILLING (targeting- induced local lesion in genes) (Wienholds et al., 2002; 
Wienholds et al., 2003; Stemple, 2004) is a method to identify mutations in the target 
gene by sequencing the target gene in mutagenized fishes. Using this method, the mutants 
were isolated which carry mutations in many genes of great interest demonstrated in 
mouse or other organisms.  Morphlino (chemically modified antisense oligonucleotides) 
(Summerton and Weller, 1997; Nasevicius and Ekker, 2000; Heasman, 2002) is now 
widely used to knock down target gene by blocking protein translation or mRNA splicing. 
Microinjection mRNA or target morphlino at one cell stage is an easy way to overexpress 
or knock down target gene in zebrafish embryo. 
Besides various genetic methods, a number of technologies are developed in zebrafish to 
facilitate gene function study. The foreign DNA fragments were found to be able to 
transmit to germ-line to generate transgenic lines when injected into cytoplasm of one-
cell embryos (Stuart et al., 1988; Culp et al., 1991). Using this technology, numerous 
transgenic lines with gene-specific promoter driven reporter gene, such as green 
fluorescent protein (GFP) or red fluorescent protein (RFP), were extensively employed 
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for forward genetic screens, cell lineage tracing and gene function studies. Like 
pseudotyped retrovirus used in insertional mutagenesis, two transposons, Tol2 and 
Sleeping Beauty (SB), are capable to transmit to germ-line as well with a lower 
efficiency, and were used as the vector for gene and enhancer trap (Davidson et al., 2003; 
Kawakami et al., 2004).  Two widely used inducible systems, tetracycline (Tet)-On 
system and Cre/loxP recombination system, were recently successfully adopted in 
zebrafish to achieve specific labeling according to the expression pattern of gene of 
interest at the desired stage (Huang et al., 2001; Pan et al., 2005). The heat shock-
inducible gene expression system was also set up and applied in zebrafish (Pyati et al., 
2005; Pyati et al., 2006). 
The conserved molecular mechanisms between vertebrates plus the superb feasibility of 
genetic manipulation make zebrafish as an ideal human diseases model (Zon, 1999; 
Patton and Zon, 2001; Amsterdam and Hopkins, 2006), therefore, an exceptional 
organism for high throughput chemical and drug screens considering the small size and 
high fecundity (Zon and Peterson, 2005; Murphey and Zon, 2006).   
As zebrafish are proven to be such a fantastic model organism, Sanger institute initiated 
the zebrafish genome sequencing project in the early of 2001, and more than 75% of task 
has been finished by the end of 2007 (http://www.sanger.ac.uk/Projects/D_rerio/). The 
massive information obtained from genome sequence will definitively facilitate the 
researches in zebrafish. The website, http://zfin.org, serves as a platform for zebrafish 
community to gather and exchange all kinds of information achieved in their researches, 
including mutants, gene expression patterns, anatomy, genetic and genomic data.  
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In addition to the general advantages for developmental study and genetic study, most 
importantly, Zebrafish is particularly amenable for study of liver development. Because 
the liver is an early hematopoietic organ in mammals, mutations affecting its 
development in mouse lead to early lethality from anemia (Reimold et al., 2000). 
Hematopoiesis in zebrafish takes place in the intermediate cell mass (ICM) and 
subsequently in the kidney, not the liver (Thisse and Zon, 2002), thus liver defects do not 
lead to anemia, making it possible to extend the liver development study in mutants to a 
relatively late stage. As a vertebrate model organism, zebtafish has advantages over 
invertebrates because of the great similarity between the liver in zebrafish and in human, 
either on structure and function or histopathology (Sadler et al., 2005; Lam et al., 2006).   
1.3.2 Liver development study in zebrafish 
In zebrafish, the endoderm is derived from bipotential mesendodermal cells at mid-
blastula stages, and intermingled with mesoderm and restricted to four-cell tiers close to 
the margin of the blastula (Kimmel et al., 1990; Warga and Nusslein-Volhard, 1999). 
After undergoing a series of morphogenetic processes, endoderm cells assemble to form a 
medial solid rod by 18 to 20 hour post fertilization (hpf) (Warga and Nusslein-Volhard, 
1999; Ober et al., 2003). Observation in a gut GFP transgenic line, Tg(gutGFP)S584 , with 
gfp gene specifically expressed in all digestive organs revealed two phases of liver 
morphogenesis: budding and growth (Field et al., 2003). Authors further divided the 
budding into three stages according to morphology of the liver: stage I is a period of 
thickness of two regions appearing on the endoderm rod by 28 hpf (Figure 1-7B), the 
leftward bend anterior one gives rise to liver bud that aligns with the first somite along 















Figure 1-7 Stages of liver organogenesis in gutGFP embryos. The digestive system 
develops from a solid endoderm rod at 24 hpf (A). The liver (arrowhead) and pancreas 
(asterisk) start budding from the intestinal rod between 24 and 28 hpf (A, B). Along 
with gut looping, the liver bud grows toward the left side. The swim bladder (arrow) 
starts to bud from the intestinal bulb primordium at 34 hpf (C). These organ buds 
continues to expand as shown in 46 hpf (D) and 72 hpf (E). (A–E) ventral views with 
anterior to the top. enP, endocrine pancreas; exP, exocrine pancreas; GB, gall bladder; 
IB, intestinal bulb; L, liver. Adapted from Field et al., 2003. 
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primordium at the level of fourth somite (Field et al., 2003). A debate about initial 
morphogenesis of the liver was raised by Wallace and Pack (Wallace and Pack, 2003). 
They proposed that the liver progenitor cells arise from rostral endoderm at about 21 hpf 
and migrate to assemble to gut instead of budding out from gut tube (Wallace and Pack, 
2003). By 34 hpf the proliferative liver cells builds up a distinct bud in which called stage 
II (Figure 1-7C). In the following stage III, the liver continues to expand, and a furrow is 
gradually formed between the liver bud and the esophagus, and the hepatic duct connects 
the liver bud and the intestine bulb by 50 hpf (Figure 1-7D). In the subsequent growth 
phase, the nascent liver dramatically increases cell mass and changes its shape (Field et 
al., 2003). During stage I and II of budding, the gut rod undergoes a leftward bending that 
drives the liver bud to the left side of the body, a morphogenetic process called gut 
looping. Horne-Badovinac et al found that the gut looping is driven by a simultaneous 
autonomous asymmetric lateral plate mesoderm (LPM) migration, and this LPM 
displacement is dependent on the epithelial structure of LPM and asymmetric nodal 
signaling (Horne-Badovinac et al., 2003). Unlike in mouse, the endothelial cells do not 
invade the newly specified hepatoblasts in zebrafish. Studies in the Tie2-GFP transgenic 
line showed that the GFP labeled endothelial cells are present in the proximity of liver 
bud at 36 hpf and migrate into liver till 60 hpf and vascularize whole liver by 72 hpf 
(Field et al., 2003). This observation is in concord with the fact that the zebrafish liver 
does not serve as an early hematopoiesis site. 
With the help of the gut GFP transgenic line, the whole picture of the liver 
morphogenesis in zebrafish becomes clear. However, as a new model organism, most 
parts of the underlying molecular mechanism are still mysterious. Fox and Gata factors 
 37
are involved in the acquisition of competency for foregut to take hepatic cell fate in 
mouse. All three Fox gene, foxa1, foxa2 and foxa3, are expressed in a pan-endoderm 
manner during early hepatogenesis in zebrafish (Odenthal and Nusslein-Volhard, 1998), 
unfortunately, the functions of these genes in liver development are undocumented yet in 
the characterization of mutants and morphlino knock down embryos (Rastegar et al., 
2002; Seiliez et al., 2006; Norton et al., 2005). The zebrafish mutant faust is a null allele 
of gata5, and faust mutant displays multiple defects in the development of endodermal 
organs including the liver, intestine and islet (Reiter et al., 2001), however, faust mutant 
shows defective endoderm development with much less endoderm cells than wild-type at 
the end of gastrulation (Reiter et al., 1999; Reiter et al., 2001), therefore, the faulty liver 
development in faust/gata5 is probably a consequence of failure of endoderm formation, 
and an additional evidence is that the expression of gata5 is restricted in intestine, not in 
liver. Two other gata genes, gata4 and gata6 display pan-endoderm expression pattern 
during hepatogenesis in zebrfish (Holtzinger and Evans, 2005; Shin et al., 2007). Due to 
redundant functions, single gene knock-down results in partially impaired hepatoblast 
specification and hepatocyte differentiation. Depletion of both factors leads to severe 
disrupted hepatic specification and a complete block of differentiation (Holtzinger and 
Evans, 2005; Shin et al., 2007), demonstrating that the function of Gata4 and Gata6 are 
conserved in both mouse and zebrafish; Lacking data of Fox and Gata factors binding to 
promoters of hepatic genes in zebrafish, it is not sure if such factors engage in the gain of 
hepatic competency as they do in mouse. 
Several mesodermal inductive signals including Fgfs from cardiac mesoderm and Bmps 
from STM (Jung et al., 1999; Rossi et al., 2001) are essential to hepatic specification in 
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mouse. The above two signaling pathways have also been proven to be important for 
liver development in zebrafish, though the tissues producing these signals are unclear. 
Shin et al. presented the first genetic data showing that blocking either signaling by 
inducing the expression of heat shock promoter driven dominant negative forms of Fgfs 
or Bmps receptors at 18-somite stage results in failure of hepatic specification. Moreover, 
they also demonstrated that the forced expression of bmp2b could partially rescue the 
hepatic specification in embryos lacking Fgfs signaling (Shin et al., 2007). 
Characterization of mutant prometheus (prt), a liverless mutant obtained in a forward 
genetic screen, reveals the third mesodermal inductive signal for hepatic specification. 
The prometheus locus encodes a Wnt2b homologue Wnt2bb identified by the positional 
cloning, and the signal exerts its function through a canonical pathway (Ober et al., 2006). 
The transcripts of wnt2bb are found enriched in the lateral plate mesoderm which is in 
close contact to liver bud during hepatogenesis (Horne-Badovinac et al., 2003; Ober et al., 
2006), suggesting the LPM may serve as the source of inductive signals for hepatic 
specification. Retinoic acid (RA) signaling is also found to be necessary for liver 
specification. Complete loss hepatic and pancreatic markers expression were 
demonstrated in RA-deficient mutant neckless or embryos treated by pan-RA receptor 
antagonist BMS493 (Stafford and Prince, 2002). Exogenous RA administration causes 
the anterior expansion of the liver and pancreas, suggesting retinoic acid signaling 
contributes to anterior- posterior body plan to regulate the liver development (Stafford 
and Prince, 2002). The underdevelopment of liver and pancreatic islet is a part of 
phenotype in vhnf1/hnf1β mutant. Sun and Hopkins thought that vhnf1 regulated the 
regional specification of liver primordium (Sun and Hopkins, 2001). 
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An unknown factor secreted by endothelial cells is indispensable for early liver bud 
growth in mouse (Matsumoto et al., 2001); however, it is not the case in zebrafish. 
Examination of cloche mutant which is defective in endothelial cells differentiation 
reveals that the liver development is quite normal without endothelial cells (Field et al., 
2003). This result reflects the fact that endothelial cells begin to locate closely to the liver 
bud at relatively late stage (Field et al., 2003). Two transcription factors, Hhex and Prox1, 
are reported to be involved in the early liver bud formation in mouse (Keng et al., 2000; 
Sosa-Pineda et al., 2000; Hunter et al., 2007; Martinez Barbera et al., 2000). As in mouse, 
both genes are expressed in the developing liver and serve as the earliest hepatoblast 
markers in zebrafish (Wallace et al., 2001; Liu et al., 2003; Ober et al., 2003). In hhex 
knock down morphants, the liver size is dramatically reduced at 50 hpf indicating the 
conserved role of the gene in liver bud growth (Wallace et al., 2001). Knockdown of 
prox1 were also reported, unfortunately, the liver development were not documented in 
this study (Liu et al., 2003). Hedgehog signaling is a positive regulator of endocrine 
pancreas development in zebrafish (Roy et al., 2001; diIorio et al., 2002), the liver 
initiation is normal in sonic hedgehog signaling deficient mutant sonic you (syu) (Wallace 
and Pack, 2003); however, overexpression of shh results in a great loss of hhex 
expressing hepatoblast at 26 and 34 hpf, and the liver size can recover by 50 hpf (Wallace 
and Pack, 2003), indicating that sonic hedgehog signaling is a negative regulator in the 
early liver development. 
Besides the signal molecules and transcription factors identified in the hepatic 
specification and early liver bud formation, a number of genes were revealed to be 
involved in the liver bud growth and hepatocyte differentiation by forward genetic 
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screening and gene cloning, either by positional cloning in ENU- induced mutants or 
inverse PCR in insertional mutagenesis. As a part of Boston large-scale screen, nine 
mutations, including the two causing hepatic degeneration, were found to perturb 
gastrointestinal development from about 500 lines screened with focus on digestive 
organs at 5-6 day post fertilization (dpf) (Pack et al., 1996). In Tubingen screen, four 
mutants were identified with liver development defects, either abnormally enlarged liver 
grey granules at 3 dpf or red blood cells accumulation in the liver at 4 dpf (Chen et al., 
1996).  Allende et al. reported a mutant with a provirus insertion in a novel gene 
pescadillo (pes) which is expressed in liver bud at 2 dpf. The inactivation of pes gene 
leads to failure of liver expansion from 3 dpf, probably by disruption of cell cycle 
progression (Allende et al., 1996). A proviral insertion in a novel gene digestive-organ 
expansion factor (def) causes the loss of function of the gene which is expressed in a pan-
endoderm- specific manner from 2 dpf (Chen et al., 2005). Further investigation revealed 
that the hypoplastic digestive organs except pancreatic islet in mutants are a consequence 
of arrest of the cell cycle triggered by the cell- autonomous selective up-regulation of 
Delta113p53 from 3 dpf (Chen et al., 2005). Similar phenotypes were revealed in an 
ENU-induced mutant nil per os (npo) in the cell-autonomous manner (Mayer and 
Fishman, 2003). The gene npo encodes a conserved protein with multiple RNA 
recognition motifs which promotes organ cytodifferentiation (Mayer and Fishman, 2003). 
The small size liver was found in the homozygous proviral insertion mutation in gene 
ubiquitin-like protein containing PHD and ring finger domains-1 (uhrf1), a cell cycle 
regulator and transcriptional activator of topoisomerase IIα (Sadler et al., 2007). 
Interestingly, the liver regeneration is impaired in heterozygous mutant after partial 
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hepatectomy (Sadler et al., 2007). In addition to the documented mutants, in the forward 
genetic screen to identify liver defective mutants performed in our lab and Stainier’s lab, 
most obtained alleles turn out to affect the liver bud growth and hepatocyte 
differentiation (Huang et al., unpublished data; personal communication with Stainier). 
While numerous small size liver mutants were identified, Sadler et al. carried out a 
genetic screen for hepatomegaly mutants in zebrafish (Sadler et al., 2005). Seven proviral 
insertion mutants were identified including three resembling different liver diseases. 
Mutation in the class C vacuolar sorting protein Vps18 imitates hepatic symptoms of 
arthrogryposis- renal dysfunction- cholestasis syndrome (ARC) which is related to the 
mutation in another vacuolar sorting protein Vps33b, and both proteins play an essential 
role on protein trafficking (Gissen et al., 2004). The second mutant has an insertion in the 
tumor suppressor gene neurofibromatosis 2 (nf2) and cause hepatomegaly and 
choledochal cysts. The third one is foie gras (fgr), a mutation in the novel gene. Although 
the mechanism is unclear, the fgr mutant is the first non-mammalian fatty liver disease 
model (Sadler et al., 2005). Cumulatively, a diversity of factors play important roles in 
promoting hepatoblast proliferation and differentiation. 
The early morphogenesis of the biliary system in zebrafish is not well-documented as in 
mouse; however, the results of immunohistochemistry using bile duct cell specific 
markers reveals that, as in mouse, structures of extrahepatic bile ducts (EHBD), hepatic, 
cystic, common bile ducts and gallbladder, together with extrapancreatic duct, form a 
ductal system to link the liver and pancreas with the intestine in zebrafish at 80 hpf which 
is in the liver growth stage (Field et al., 2003; Lorent et al., 2004; Dong et al., 2007). As 
for intrahepatic bile ducts (IHBD), the nascent bile duct cells present in the embryonic 
 42
liver at 60 hpf and 70 hpf, and eventually randomly distributed in the liver, not as in 
human and mouse, a bile duct is bundled with a portal venule and a hepatic arteriole to 
form a portal triad located at the corner of the liver lobule (Lorent et al., 2004). Despite of 
histological difference between zebrafish and mammals, a number of evidences show that 
the molecular mechanisms of biliary morphogenesis are conserved. Onecut transcription 
factors, Hnf6 and Onecut2 (Oc2), cooperate to regulate the development of IHBD 
through Hnf1β (also known as vHnf1) in mouse (Coffinier et al., 2002; Clotman et al., 
2002; Clotman et al., 2005). Morphlino knockdown of hnf6 does affect development of 
IHBD in zebrafish showing paucity of bile ducts, different to ectopic formation of biliary 
cells in the liver in mouse. Injection of vhnf1 mRNA can restore the bile duct 
development in hnf6 morphants, which is the first genetic evidence of relationship 
between hnf6 and vhnf1 (Matthews et al., 2004). Recently, another Onecut transcription 
factor onecut3 (oc3) was found to regulate IHDB in the upstream of hnf6 and vhnf1, thus 
oc3 was thought to be the functional ortholog of mammalian hnf6 (Matthews et al., 2008). 
One of the downstream targets of hnf6/vhnf1 cascade is aforementioned vps33b, a gene 
encoding one class C vacuolar sorting protein responsible for the ARC syndrome 
(Matthews et al., 2005). Morphlino mediated vps33b knockdown causes paucity of the 
bile ducts which is one of characteristic defects in ARC. Further investigation showed 
that the expression level of vps33b was downregulated in hnf6 and vhnf1 morphants, and 
vHnf1 were found directly bind to the promoter of vps33b (Matthews et al., 2005). 
Compound knockdowns of jagged and notch genes phenocopy defects in jagged1 
mutation caused Alagille syndrome (AGS), including abnormal development of hepatic 
and pancreatic duct cells, moreover, the over-activated Notch signal pathway results in 
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ectopic formation of biliary cells in the liver (Lorent et al., 2004). Recently, Dong et al 
reported that a mutation in fgf10 resulted in the dysmorphic EHBD and extrapancreatic 
duct which were termed as hepatopancreatic ductal system by authors (Dong et al., 2007). 
Ffg10 signaling in the neighboring mesenchyme repressed hepatopancreatic ductal 
system to undergo hepatic and pancreatic differentiation, thus to refine the proper ductal 
morphogenesis (Dong et al., 2007).  
Besides the genetic studies of individual gene aforementioned, genomics methods 
provide massive information of the liver development. Cheng et al. identified 129 liver 
enriched genes using zebrafish affymetrix microarray technology, in which 69 genes 
were found also enriched in the embryonic liver (Cheng et al., 2006). Bioinformatics 
analysis revealed that the majority of 51 liver enriched genes had more than one putative 
binding sites of Hnf1, Hnf3, Hnf4 or Hnf6 in their promoter regions, suggesting that HNF 
factors form a network to regulate the liver enriched genes (Cheng et al., 2006). Another 
elegant application of microarray technology is to demonstrate the conservation of gene 
expression signature between zebrafish and human liver tumors and tumor progression, 
which implies zebrafish as a suitable liver tumor disease model (Lam et al., 2006). 
1.4. Rationality and aim of the project 
Despite the extensive effort made, the whole picture of liver organogenesis is still 
mysterious due to limitations of reverse genetics and early lethality of liver defect in 
mouse, and zebrafish emerges as an ideal model for forward genetics and liver 
organogenesis. To explore molecular mechanism of the liver development in zebrafish, as 
a first step, a forward genetic screen was carried out to identify specific liver defective 
mutants. The obtained mutants were then classified according to liver phenotype and 
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overall morphology. An interesting mutant was chosen for positional cloning to reveal 
responsible mutated gene. Our ultimate aim is to investigate the molecular mechanism: 






















Chapter 2 Material and method 
 
2.1 Zebrafish 
2.1.1 Fish strains and maintenance 
Zebrafish (Danio rerio) local AB strain and WIK were used as wild-type lines for daily 
outcross and mapcross respectively in this study. Liver defective mutants including sq181 
were isolated from our forward genetic screen through a high throughput whole mount in 
situ hybridization using prox1 as the probe. The retroviral insertion hi2653 line obtained 
from a large-scale insertional mutagenesis screen (Golling et al., 2002) was kindly 
provided by Professor Nancy Hopkins in Massachusetts Institute of Technology 
(Cambridge, MA). A dominant negative Bmp receptor transgenic line Tg(hsp70:dnBmpr-
GFP) (Pyati et al., 2005) and a  gut GFP transgenic line Tg(gutGFP)S584 (Field et al., 
2003) were kind gifts from Professor David Kimelman in University of Washington 
(Seattle, WA) and professor Didier Stainier in University of California, San Francisco 
(San Francisco, CA), respectively. A sq181 mutant line with a gut GFP background was 
obtained by crossing the heterozygote sq181mutant with Tg(gutGFP)S584. The mutant line 
heart and soul (hasm567) was purchased from zfin zebrafish stock centre. Zebrafish were 
raised and maintained in the central fish facility in ex-IMA and IMCB according to 
standard procedures (Sprague et al., 2001). The genotyping of sq181 and has mutant 
embryos was performed by sequencing the genomic fragment containing the mutation 
amplified by PCR. Two set PCR primers were used to identify insertion in hi2653 
(Table2-1). 
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2.1.2 zebrafish embryos 
Embryos were obtained by natural spawning and cultured in embryo medium (egg water, 
0.03% sea salt in the distilled water) at 28.5°C. The medium was supplemented with 0.03 
mM methylene blue to suppress the growth of the mold. The embryos were staged as 
previously described and recorded in hours post fertilization (hpf) or days post 
fertilization (dpf) (Kimmel et al., 1995) (Figure 2-1). Embryos used for analysis at stages 
later than 24 hpf were treated with 0.03% phenylthiourea (PTU) by the end of 
gastrulation (about 10 hpf) to inhibit the melanin pigment formation.  
2.1.3 Collection of unfertilized eggs 
Male and female fish were crossed and separated by a separator. The separator was 
removed to allow male fish to pursue female fish in the next morning. Before the female 
was laying eggs, it was anaesthetized by ethyl 3-aminobenzoate methanesulfonate salt 
(also known as tricaine, stocking concentration 4 g/L, Sigma, Cat. No. A5040) in egg 
water. The unconscious female fish was put on a sponge supporter to release unfertilized 
eggs by softly squeezing the venter of the female fish, and a small soft brush was used to 
collect unfertilized eggs. 
2.2 General DNA application  
2.2.1 DNA fragment Cloning  
2.2.1.1 Polymerase Chain Reaction (PCR)  
The PCR reaction was carried out in a 0.2 ml PCR tube in a total volume of 50 μl using 
such a recipe: 5 μl 10X PCR buffer (0.5M KCL, 0.1M pH9.0 Tris-HCl, 15mM MgCl2, 
1% Triton X-100), 1 μl 10 mM dNTPs, 1 μl 10 μM of specific primers, less than 0.5 μg 
template DNA and 0.5 μl Taq (Qiagen Cat. No.201223). The Programmable Thermal 
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Controller (Model PTC-100, MJ Research) was used for amplification reaction according 
to the following program: 94°C denaturation for 3 minutes; 35 cycles of 94°C 
denaturation for 30 seconds, annealing at the desired temperature for 30 seconds, 72°C 
elongation for the desired time(1kb per minute); 72°C for 10 minutes. The primers used 
for DNA fragment cloning in this project were listed in Table 2-2. PCR products were 
separated by electrophoresis on 1% agarose gel (Invitrogen Cat. No. 15510-027) in 1X 
TAE buffer (40 mM Tris-acetate, 1 mM EDTA, pH 8.2). 
2.2.1.2 Purification of PCR product/DNA fragments  
High pure PCR product purification kit (Roche, Cat. No.11732668001) was used to 
purify DNA according to the manufacture’s instruction. QIAEX® II Gel Extraction Kit 
(Qiagen, Cat. No.20021) was used to purify DNA from excised agarose gel as described 
by the manufacturer. 
2.2.1.3 Ligation of DNA inserts into vectors 
The ligation of purified PCR fragment into pGEM®-T/ pGEM®-T Easy vector (Promega, 
Cat. No.A3600 and A1360) was performed as described in the manufacture’s instruction. 
To clone DNA fragments into other vectors, vectors were digested by appropriate DNA 
restriction enzymes from New England Biolabs and then dephosphorylated by SAP 
(Shrimp Alkaline Phosphatase, Roche, Cat. No.11758250001). Purified linearized vector 
DNA and insert DNA fragment were ligated at the molar ratio of 3:1 (insert DNA: 
linearized vector DNA) by T4 DNA ligase (Rapid DNA Ligation Kit, Roche, Cat. 
No.11635379001 or pGEM®-T Easy vector systems, Promega, Cat. No. A1360). Detailed 
procedures were following the instructions provided by the manufacturers.  
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2.2.1.4 Heat-shock transformation 
2.2.1.4.1 Preparation of DH5α competent cells 
A single colony of DH5α from a LB agar plate [1% (W/V) Bacto-tryptone, 0.5% (W/V) 
yeast extract, 1% (W/V) NaCl, 1.5% agar, pH 7.0] was cultured in 250 ml of SOB 
medium [2% (W/V) Bacto-tryptone, 0.5% (W/V) yeast extract, 0.05% (W/V) NaCl, 
2.5mM KCl, pH 7.0, add 10mM MgCl2 after autoclaving]  in a 2-liter flask at 18°C with 
vigorous shaking (200-250 rpm). When the OD600 reached 0.6, the culture were chilled on 
ice for 10 minutes, bacteria were spun down at 2500 g in Beckman J-6B centrifuge for 10 
minutes at 4°C. The pellet was suspended in 80 ml of ice-cold TB medium (10 mM 
Hepes, 15 mM CaCl2, 55 mM MnCl2, 250 mM KCl. pH 6.7) and chilled on ice for 10 
minutes. Bacteria were spun down again and the pellet was re-suspended in 20 ml of TB 
medium with gentle stirring. DMSO was added to this cell suspension to a final 
concentration of 7% (V/V), followed by the final 10-minute incubation on ice. The cell 
suspension was dispensed in 50 ul aliquots and immediately frozen by immersing in 
liquid nitrogen. The competent cells were stored at -80°C for long term use. 
2.2.1.4.2 Heat-shock transformation     
The competent cells were thawed in fingers and immediately plugged in ice. 1 ng of 
plasmid DNA or 1-5 μl of ligation product was added into 50 μl competent cells and 
gently mixed up and incubated on ice for 30 minutes for DNA binding. The competent 
cells were heat-shocked at 42°C for 90 seconds and plugged in ice for 10 minutes for 
DNA absorption. 1 ml liquid of LB medium was added to activate transformants at 37°C 
with vigorous shaking for 20 minutes for anti-ampicillin and 1 h for anti- kanamicin 
transformants respectively. The activated bacteria were concentrated by spinning down at 
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3,000 g for 5 minutes and were re-suspended in 100ul LB medium, and plated onto LB 
agar plates containing appropriate antibiotics and incubated overnight at 37°C.  
2.2.1.5 Colony PCR 
Colony PCR is a method to use bacterial colony as PCR template to examine if the 
colony contains plasmids which have the desired DNA fragment insert. The colony PCR 
reactions were performed in the same way as that to amplify the desired DNA fragment 
except using bacteria as template. PCR were scored by electrophoresis on 1% agarose gel, 
and colonies showed the desired band were consider as positive colonies containing 
plasmids which have the desired DNA fragment insert. 
2.2.1.6 Plasmid miniprep from bacteria 
The positive bacterial colony on LB agar plate was inoculated into 3-10 ml LB medium 
containing appropriate antibiotics (ampicillin 100 μg/ml or kanamicin 50 μg/ml) and 
cultured overnight at 37°C with vigorous shaking. 200 μl of the overnight culture was 
mixed with the same volume of 50% sterile glycerol and stored at -80°C as a stock for 
future use. The remaining bacterial culture was spun down at the maximum speed for 3 
minutes in a centrifuge (Sigma laboratory centrifuges 3K30). The plasmid was extracted 
from the pellet using QIAGEN Plasmid Mini Kit (QIAGEN, Cat. No.12125) according to 
the manufacturer’s instruction. 
2.2.2 DNA sequencing 
DNA sequences were determined using ABI BigDye® Terminator Version 3.1 (Applied 
Biosystem, P/N 4337458), following the protocols from the manufacturer. The recipe of a 
10-μl sequencing reaction is 4 μl BigDye, 1 μl 3.2 mM Primer, ~200 ng plasmid DNA or 
~3 ng PCR product and H2O. The sequencing reaction was performed in a thermocycling 
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using the following program: 95°C denaturation for 3 minutes was followed by 30 cycles 
of 95°C denaturation for 30 seconds, 52.5°C annealing for 10 seconds and 60°C 
elongation for 4 minutes. The sequencing products were analyzed by the IMCB Central 
Sequencing Facility. 
2.2.3 Site directed mutagenesis  
A modified PCR method was used to perform the site-directed mutagenesis in a gene. A 
50 μl PCR reaction composed of: 5 μl 10X PCR reaction buffer, 1 μl 10 mM dNTP, 1 μl 
10 μM of specific primers containing the desired mutation listed in Table 2-1, 100 ng 
template plasmid DNA, 1 μl error-proof enzyme Pfu (2.5 units/μl, Stratagene, Cat. No. 
600250) and H2O. The following program was used for amplification: 95°C denaturation 
for 20 seconds, 50°C annealing for 30 seconds, and 68°C elongation for 12 minutes for 
18 cycles. 10 μl of PCR products were loaded in 1% agarose gel for analysis, whilst 15 μl 
of PCR products was digested by 1 μl Dpn I (NEB, Cat. No. R0176S) for 2 hours at 37°C 
to selectively remove methylated miniprep template. 1 μl of digested PCR products was 
used for transformation to obtain transformants containing the plasmids with the desired 
mutation. 
2.3 Zebrafish genomic DNA extraction 
2.3.1. Genomic DNA extraction from adult zebrafish 
The sacrificed fish was digested overnight in 10 ml lysis buffer [10 mM Tris, 50 mM KCl, 
0.3% Tween-20, 0.3% Nonidet P40, 0.5 μg/μl Proteinase K (Finnzymes, Cat. No. F-
202L), pH 8.2] at 55°C with gentle shaking. The supernatant (10,000 g for 15 minutes) of 
digested product was extracted with same volume of phenol (pH 8.0) for 10 minutes with 
gentle shaking and water phase were transferred to a clean tube after a spin at 10,000g for 
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15 minutes. The water phase was further extracted with 1:1 phenol (pH 8.0) /chloroform 
and chloroform. The genomic DNA in the upper phase was precipitated by adding an 
equal volume of isopropanol and washed twice with 1.5 ml 70% ethanol. The genomic 
DNA was dissolved in 1X TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) at 4°C.  
2.3.2 Isolation of genomic DNA from embryos or scales of adult zebrafish  
To extract genomic DNA from embryos, each embryo was digested in 30 μl lysis buffer 
at 55°C for 14 hours, followed by inactivation of proteinase K at 94°C for 20 minutes, 
and the lysate can be used for PCR template. 10 μl lysis buffer was used to extract 
genomic DNA from scales taken from an adult fish. 
2.4 General RNA application 
2.4.1 Total RNA extraction from embryos or adult zebrafish 
100 mg samples were homogenized in 1 ml TRI Reagent (Molecular Research Center, 
Inc. Cat. No. TR118). The homogenized sample was extracted with 0.2 ml chloroform 
with vigorous shaking for 15 seconds and left at room temperature for 2-15 minutes. The 
aqueous phase was transferred to a new tube after spinning for 15 minutes at 12,000 g at 
4°C. An additional chloroform extraction was recommended to obtain RNA sample of 
high quality. Half volume of isopropanol was added into the aqueous phase to precipitate 
RNA with gentle shaking at room temperature for 5-10 minutes, and the RNA pellet was 
obtained by centrifugation at 12,000 g for 8 minutes at 4°C and washed with 75% ethanol 
(V/V). The pellet was air-dried for 3-5 minutes, and dissolved in nuclease-free water or 
stored in 70% ethanol at -80°C.   
The RNA precipitation can be alternatively carried out in 0.25 ml of isopropanol and 0.25 
ml of high-salt precipitation solution (1.2 M NaCl, 0.8 M sodium citrate, no pH 
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adjustment needed) per 1ml TRI reagent used, by which the RNA quality is improved 
with a loss of low molecular weight RNA.  
The RNA concentration was determined using spectrophotometer (NanoDrop, ND-1000) 
and the RNA quality was evaluated by electrophoresis. 
2.4.2 Removal of genomic DNA from total RNA   
To remove the remnant genomic DNA in total RNA, 20 μg total RNA and 1-2 units of 
RNase-free DNase I (Roche, Cat. No. 10 776 785 001) was added in 200 μl of 1X in vitro 
transcription reaction buffer (Roche, Cat. No. 11 465 384 001). After incubating the 
solution at 37°C for 20 minutes, total RNA was purified with the RNeasy® Mini Kit as 
described in the manufacturer’s instruction (QIAGEN, Cat. No. 74106), and used as 
samples for RT-PCR and other experiments. 
2.4.3 mRNA isolation 
Oligotex® mRNA Midi Kit (QIAGEN, Cat. No. 70042) was used to isolate mRNA from 
total RNA following the protocol provided by the manufacturer.   
2.4.4 Reverse Transcription PCR (RT-PCR) 
2.4.4.1 One-step RT-PCR 
The first strand cDNA synthesis and sequent PCR were carried out in one tube using The 
Titan One Tube RT-PCR system (Roche, Cat. No. 11 855 476 001). The recipe of a  
standard 50 μl RT-PCR reaction was composed of 10 μl 5X RT-PCR buffer, 1 μl 10 mM 
dNTPs, 2 μl 10 μM of specific primers (Table 2-1), 2.5 μl 100 mM DTT, 0.25 μl 
rRNasin® RNase inhibitor (20U/μl, Promega, Cat. No. N251A), 1 μg total RNA, 1 μl 
enzyme mix and sterile distilled water. The sample was incubated at 50°C for 30 minutes, 
followed by a thermocycling program as described in Section 2.2.1.1.  
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2.4.4.2 Two-step RT-PCR 
Two-step RT-PCR is composed of two reactions: synthesis of the first strand cDNAs and 
PCR with specific primers. The first strand cDNAs was synthesized from total RNA 
using SuperScriptTMII RNase H- Reverse Transcriptase (Invitrogen, Cat. No. 18064-22). 
The synthesized cDNAs (2 μl for a 50-μl PCR reaction) were ready to be used as PCR 
template within one year if stored at -20°C. To amplify the fragment bigger than 1 kb, the 
first strand cDNAs can be used as PCR template after digestion by RNase H (Invitrogen, 
Cat. No.18021-014) to remove the RNA template.   
2.4.5 Capped mRNA synthesis by in vitro transcription  
The gene of interest was cloned into the pCS2+ vector with a proper direction to utilize 
the SP6 promoter and a SV40 polyA signal in the in vitro transcription. The linearized 
construct was used as a template for capped mRNA synthesis followed the 
manufacturer’s instruction of the mMESSAGE mMACHINE® SP6 Kit (Ambion, Cat. 
No.1340). The quality and quantification of mRNA were determined by electrophoresis 
and spectrophotometer respectively, and small aliquots (1–2 μl) with high concentration 
(> 1 ug/ul) were stored at -80°C for long term use. 
2.4.6 Northern Blot analysis 
2.4.6.1 Probe preparation 
DIG-labeled DNA probes for Northern Blot or Southern Blot were synthesized by PCR 
using 10X PCR DNA DIG Labeling mix (Roche, Cat. No. 1636090) to substitute 10 μM 
dNTPs in normal PCR reaction. However, for a probe longer than 1 Kb, DIG labeling 
mix was supplemented with dNTPs at a ratio of 1:1 to perform PCR. Amplified probes 
were purified using the High Pure PCR product purification kit (Roche, Cat. No. 
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11732668001) and quantified by comparing to the fluorescence intensity of 1 Kb ladder 
after electrophoresis (New England Biolabs, Cat. No. N3232L). Usually, a same normal 
PCR using dNTPs was performed as control, and the DIG labeled probe was bigger in 
size than unlabeled control scored by electrophoresis. The denatured DIG labeled DNA 
probe (100°C for 10 minutes and chilled on ice) was diluted in pre-warmed DIG Easy 
Hyb (Roche Cat. No. 1 603 558) to reach a final concentration of 25 ng/ml. 
2.4.6.2 RNA sample preparation 
4.5 ul (containing 10-30 μg total RNA) of each sample were added in 20 μl RNA 
formaldehyde loading buffer (1X MOPS, 50% deionised formamide, 6.5% formaldehyde, 
50 ng/μl EtBr), and denatured at 65°C for 20 minutes then chilled on ice for 5 minutes.  
2.4.6.3 RNA denaturing gel electrophoresis 
The denaturing gel was prepared as described in the Table 2-3. RNA samples were run on 
the denaturing gel at 10-12 V/cm in 1X MOPS running buffer (5 mM NaOAC, 0.02 M 
MOPS, 1 mM EDTA, pH 7.0). The RNA size was referred to an RNA molecular weight 
ladder (Invitrogen, Cat. No. 15620-016). After electrophoresis, the gel was briefly rinsed 
with sterile water and then washed in 20X SSC (3M sodium chloride, 0.3M sodium 
citrate, pH 7.0) for 15 minutes twice. RNA was transferred overnight onto Hybond N+ 
membrane (GE Health care, Cat. No. RPN303B) in 20X SSC buffer. Transferred RNA 
was fixed on the membrane by a UV crosslinker (Stratalinker, Stratagene). The RNA 
quantity and quality on the membrane was evaluated by staining with methylene blue 
staining buffer (0.3 M NaOAc pH 5.2, 0.03% Methylene Blue, MRC Cat. No. MB119). 
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2.4.6.4 Hybridization and autoradiography 
The RNA membrane was pre-hybridized in DIGTM Easy Hybridization buffer (Roche Cat. 
No. 1 603 558) at 50°C for 2 hours, and then hybridized overnight with DIG-labeled 
DNA probe at 50°C. After hybridization, a series of washes were carried out, including 
two times 5-minute in 0.1% SDS / 2X SSC (W/V) at 68°C, two times 15-minute in 0.1% 
SDS / 0.5X SSC (W/V) at 68°C, one time 15-minute in 0.1% SDS / 0.1X SSC (W/V) at 
68°C. The membrane was then blocked in Roche Blocking Reagent (Roche, Cat. No. 
1585762) for 30-60 minutes at room temperature and then incubated with anti-
digoxigenin-AP (Roche, Cat. No. 1 093 274) (1:20,000 dilution in Roche Blocking 
Reagent) for 30 minutes. After six times 15 minutes washes in Roche washing buffer 
(Roche, Cat. No. 1585762), the membrane was equilibrated in Roche detection buffer 
(Roche, Cat. No. 1585762) for 3 minutes. CDP-star solution (Roche, Cat. No. 12 042 677 
001) was applied to the membrane and incubated for 5 minutes. Finally, the hybridization 
signals were photographed on an autoradiography film (HyperfilmTM MP, GE Healthcare, 
Cat. No. RPN3114K) developed on a KODAK X-Omat 2000 film processor.  
2.5 Western Blot 
2.5.1 Protein sample preparation 
To prepare protein samples from zebrafish embryos, dechorined embryos were rinsed 
briefly in cold PBS and were homogenized in 1 ml cold PBS containing protease 
inhibitor (Roche Cat. No. 10752800) using syringe (1 ml) and needle (size 26G). The 
mixture was spun down at 200 g in a 4°C centrifuge for 5 minutes. After carefully 
removing the supernatant, the pellet was added with SDS sample buffer [63 mM Tris-
HCl pH6.8, 10% Glycerol, 5% β-mercaptoethanol, 3.5% (W/V) SDS] at 1-2 μl per 
 56
embryo and 5X Laemmli buffer [50% glycerol, 25% β-mercaptoethanol, 10% (W/V) 
SDS, 0.01% (W/V) bromphenol blue, and 0.3125 M Tris-HCl pH 6.8]  to a final 
concentration of 1X. The sample was boiled at 100°C for 10 minutes on a heating block. 
The lysate was spun at the maximum speed in a desktop centrifuge for 5 minutes, and the 
resulting supernatant was used as for western analysis or stored in a -20°C freezer for 
future use. The protein expressed in bacteria can be prepared by boiling bacterial pellet in 
1X Laemmli buffer. 
2.5.2 SDS-PAGE and blot  
The SDS-PAGE gel was cast using Mini-PROTEAN® Cell (Bio-Rad, Cat. No. 165-3301) 
following the manufacturer’s instructions. The composition of SDS-PAGE gel was 
described in Table 2-4. The SDS-PAGE gel electrophoresis was performed with 100 V 
for stacking gel (10-20 minutes) and 140 V for resolution gel (1 hour or longer) with a 
dual color protein ladder (Bio-Rad, Cat. No. 161-0374EDU) as a protein size reference. 
The PVDF membrane (Millipore, Cat. No. IPVH00010) was rinsed with 100% methanol 
followed by washing with water for 2 minutes. The membrane and protein gel were 
balanced in 1X transfer buffer for 5 minutes. The protein sample was transferred from gel 
to PVDF membrane by the Mini Trans-Blot® Electrophoretic Transfer Cell (Bio-Rad, 
Cat. No. 170-3930) following the description in the manufacturer’s instructions. The 
transferred membrane was rinsed in 100% methanol followed by incubating at 37°C for 
15 minutes. Protein samples on the transferred membrane could be visualized by staining 
with Ponceau S Solution (Sigma, Cat. No. P7170) in a reversible manner. The stained 
membrane was washed in distilled water until the red dye disappeared. The membrane 
was blocked in 1.5% BSA (dissolved in PBST) (Sigma, Cat. No. A7030) for 1 hour, 
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followed by incubating with the primary antibody (dilution in 1.5% BSA) for 1 hour at 
room temperature or overnight at 4°C. The membrane was washed six times 5- minute in 
PBST, and then incubated with the secondary antibody (dilution in 1.5% BSA) (HRP-
conjugates, Pierce, Cat. No. 31460 and 31430) for 30 minutes. The excess antibodies was 
removed by six washes in PBST, each for 5 minutes. The signal was detected 
SuperSignal ELISA Femto Maximum Sensitivity Substrate (Pierce, Cat. No. 37075) and 
autoradiography. 
2.6 Cryosectioning of zebrafish embryo 
After fixing in 4% PFA (1 to 2 hour at room temperature for immunostaining and 
overnight at 4°C for other experiments), zebrafish embryos were washed twice in PBST 
(1X PBS with 0.1% Tween 20), each for 10 minutes, and orientated in small chamber 
with 1.5% agarose in 30% sucrose PBST. The blocks were trimmed to a pyramid shape 
with a surgical blade, and equilibrated in 30% sucrose PBST solution overnight at 4°C. 
After equilibration, these blocks were mounted on the bottom of plastic molds with 
O.C.T. compound (Sakura Cat. No. 4583), and then frozen in dry ice cooled ethanol. The 
frozen blocks were used immediately or stored in -80°C for several months. 
For cryosectioning, the frozen blocks were mounted on the supporter (Leica, Cat. No. 
0.370.08587) with O.C.T. compound and equilibrated at -30°C in a pre-chilled 
microtome (Leica, HM505) for 2 hours prior to sectioning. Sections were cut serially at a 
14 μm thickness and then collected on polylysine coated glass slides (Menzel, Cat. No. 
J2800AMNZ). The section slices placed on a hot plate and de-hydrated at 42°C for 2 
hours or overnight. The slides were ready for immediate use or stored in -20°C. 
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2.7 Immunochemistry 
2.7.1 Whole mount antibody staining 
All steps were carried out at room temperature unless specified. The dehydrated embryos 
were re-hydrated as described in Section 2.9.2. These re-hydrated embryos were washed 
four times in PBS, each for 2 minutes, and then permeabilized in cold acetone at -20°C 
for 7 minutes. To remove acetone, the embryos were washed four times in PBS, each for 
2-3 minutes. To reduce the non-specific binding of antibodies, the embryos were blocked 
for 1 hour with gentle agitation in blocking buffer [2% normal goat/sheep serum (Sigma, 
Cat. No. G9023) in PBDT (1X PBS, 1% BSA, 1% Dimethyl Sulfoxide (DMSO), 0.5% 
Triton X-100)]. The embryos were incubated in the primary antibody at 4°C overnight 
with gentle agitation. The embryos were washed four times in PBDT, each for 30 
minutes, followed by incubation in the secondary antibody (fluorescence or HRP 
conjugates) solution overnight at 4°C with gentle agitation. After washed four times in 
PBDT, the embryos were mounted in a mounting medium with DAPI (Vectorlabs, Cat. 
No. H-1200) for image capturing fluorescence imaging under confocal microscopes 
(Zeiss LSM 510 or Olympus FluoView 1000) or detected by DAB substrate (Sigma, Cat. 
No. D-4168). When embryos after WISH were used as the sample, the procedure started 
from blocking. The monoclonal mouse antibody F59, which marks slow muscle (1:20 
dilution, Developmental Studies Hybridoma Bank, Iowa), was used to visualize somite in 
zebrafish embryos. 
2.7.2 Antibody staining on sectioned samples 
Sectioned samples were fixed in 2% PFA for 20min and washed three times 10-minute in 
PBST. Samples were blocked in 4% BSA for 30 minutes and incubated with the primary 
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antibody for 1 hour or overnight at 4°C. Five times 20-minute washes were used to 
remove the excess antibody. The fluorescence conjugates second antibody was applied to 
sample for 1 hour or overnight at 4°C. After removal of excess antibody, the samples 
were mounted for imaging.  
2.8 Microinjection 
2.8.1 Preparation of injected materials  
Morpholino, dextran tracer or in vitro synthesized mRNA was diluted with distilled water 
and phenol red (Sigma, Cat. No. P02900, 5% in PBS) to reach a desired concentration. 
Phenol red was used to monitor the injection process. Gene-specific morpholinos were 
synthesized by Gene-Tools (www.Gene-tools.com), shown in Table 2-5. Mopholinos 
were dissolved in 1X Danieau buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 
mM Ca(NO3)2, 5.0 mM HEPES pH 7.6) or distilled water as a 5 mM stock, aliquoted into 
10 μl and stored at -20°C. 
2.8.2 Preparation of accessory items, needles and supporter dishes 
The needles were made from borosilicate glass capillaries with an internal filament 
(10cm length, O.D. 1.0nm, I.D. 0.58mm) (Sutter Instrument, Cat. No. BF100-58-10). The 
capillaries were made by the micropipette puller (Sutter Instrument, P97 flaming/brown 
micropipette puller). A sharp tip with an outer diameter of about 20 μm was cut on the 
pulled shank of the needle by fine forceps or a surgical blade under a dissection 
microscope.  
The 3% agarose in egg water was melted and cooled to 60°C. This 60°C agarose medium 
was poured on a petri dish, and a special plastic model was put on the surface. After 
 60
removing this model from the solidified gel, small wedge-shaped holes or long furrows 
can bed the embryos for injection. 
2.8.3 Microinjection 
A gas microinjection system (PLI-100, Harvard Apparatus, with a manipulator MB-B, 
Kanetec) was used for our experiments. The balance pressure was adjusted to 0.2-0.4 psi 
to prevent medium from flowing back into the needle. The injected material was filled in 
the needle by a microloader (Eppendorf Cat. No. 5242 956 003). The 1-cell stage 
zebrafish embryos were sorted in small wedge-shaped holes or furrows on supporter 
dishes. The needle was carefully extended through the chorine and quickly pierced into 
the yolk, followed by pressing the pedal. The injection volume was less than 2 nl, which 
can be measured by a calibration ruler. The injected embryos were incubated at 28.5°C. 
2.9 Whole Mount in situ Hybridization (WISH) 
2.9.1 Preparation of labeled RNA probe 
Plasmid DNAs were linearized by the appropriate restriction enzyme (Table 2-6), and 
purified by High Pure PCR product purification kit (Roche, Cat. No. 11732668001). A 20 
μl RNA probe synthesis reaction contained 1.5 μl RNA polymerase (Stratagene, Cat. No. 
600111, 600123, 600152), 0.25 μl rRNasin® RNase inhibitor (Promega, Cat. No. N251A), 
2 μl 10X DIG RNA or Fluorescein RNA labeling mix (Roche, Cat. No. 11 277 073 910 
and 11 685 619 910), 4 μl 5X reaction buffer, 1 μg linearized plasmid DNA or 100-200 
ng PCR product and nuclease free water. The reaction mixture was incubated at 37°C for 
2 hours. The DNA template was removed by incubation with 1 μl RNase-free DNase I 
(Roche, Cat. No. 10 776 785 001) at 37°C for 15 minutes. The synthesized probes were 
purified via a LiCl-ethanol precipitation method as described in the manufacturer’s 
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instructions. Alternatively, probes could be purified using M-30 microcon (Millipore, 
Cat. No. 42410). To obtain probes with high purity, purification was performed with an 
M-30 microcon filtration following a LiCl-ethanol precipitation. The quality and quantity 
of RNA probes were determined by gel electrophoresis and comparing intensity with a 
RNA Ladder (Invitrogen, Cat. No. 15623-200). The remaining was denatured at 80°C for 
10 minutes followed by instant plugging in ice for 10 minutes, diluted to a final 
concentration of 0.5-4 μg per ml in Hyb+ buffer [50% Formamide, 5X SSC, 9.2 mM 
citric acid (pH 6.0), 0.1 % Tween 20, 50 μg/ml Heparin (SIGMA Cat. No.H-3400), 500 
μg/ml tRNA (SIGMA, Cat. No. R-6750)], and stored at -20°C. 
2.9.2 High-resolution WISH  
Embryos were fixed in 4% PFA at 4°C overnight and washed three times in PBST, each 
for 10 minutes. The embryos were then dehydrated in 100% methanol for 10 minutes and 
stored in 100% methanol at -20°C for at least 20 minutes or for later use. The dehydrated 
embryos were re-hydrated in a series of methanol/PBST solutions (75%, 50% and 25% 
methanol/PBST solution), each for 5 minutes, and subsequently washed twice 10-minute 
in PBST. Embryos were permeated by digestion with proteinase K (20 ug/ml, 
FINNZYMES, Cat. No. F-202L) for an appropriate time (Table 2-7). After a brief wash 
in PBST, the embryos were re-fixed in 4% PFA for 20 minutes. The re-fixed embryos 
were washed two times 10- minute in PBST and pre-hybridized in Hyb+ buffer at 68°C 
for 2 hours and then hybridized overnight at 68°C. A serials of washes were applied to 
remove the remnant probes in embryos at 68°C as followed: twice in 50% formamide/2X 
SSCT, twice in 25%formamide/2X SSCT, twice in 2X SSCT and three times in 0.2X 
SSCT, each for 20 minutes. After two 10- minute washes in PBST at room temperature 
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the embryos were incubated in blocking solution [10% Bovine Calf Serum (Hyclone, Cat. 
No. SH30073.03) in PBST] for 2 hours, and then incubated in the anti-DIG-AP (1:5,000 
dilution, Roche, Cat. No. 11093274910) or anti-Fluorescein-AP antibody (1:2,000 
dilution, Roche, Cat. No. 11426338910) in blocking solution overnight at 4°C. Three 30-
minute washes in PBST were applied to remove non-specific binding antibody. Before 
detection, the embryos were equilibrated two times with detection buffer, each for 10 
minutes and then stained with substrate in the dark either at room temperature or at 4°C. 
The color reaction can be stopped by washing the embryos with PBST and fixing the 
embryos with 4% PFA. The stained embryos were mounted in 50% glycerol for imaging 
or stored at 4°C. 
2.9.3 Two-color WISH  
Two-color WISH was used to simultaneously examine expression patterns of two genes 
by two different colors. Usually, probes that produced stronger signals were labeled with 
Fluorescein while those giving weaker signals with DIG. Both Fluorecein and DIG 
labeled probes were used for hybridization at the same time. Post-hybridization washes 
were the same as described in Section 2.9.2. After blocking, the signals of Fluorescein-
labeled probes and DIG -labeled probes were detected one by one. 
To detect Fluorescein-labeling, the embryos were incubated in 1:2000 diluted anti-
Fluorescein-AP antibody at 4°C overnight. After post-antibody washes according to 
Section 2.9.2, the embryos were equilibrated in the FastRed detection buffer (0.1% 
Tween 20, 100 mM Tris pH 8.2) and then stained in the dark with the FastRed substrate 
[1 FastRed tablet (Roche, Cat. No. 11 496 549 001) dissolved in 2 ml FastRed detection 
buffer]. This staining process was monitored until satisfactory signal was achieved. This 
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reaction was stopped by 10-minute incubation in 0.1 mM Glycine (pH 2.2). Embryos 
were washed with PBST for 3 times, each for 10 minutes, and blocked for 2 hours. 
To detect DIG-labeling, anti-DIG-AP antibody was applied in a 1:5000 dilution for 
overnight at 4°C. Post-antibody washes were the same as described in Section 2.9.2. 
After the embryos were equilibrated in the NBT/BCIP detection buffer (50 mM MgCl2, 
100 mM NaCl, 0.1% Tween 20, 100 mM Tris pH 9.5), the NBT/BCIP substrate  [1 
NBT/BCIP tablet (Sigma, Cat. No.B5655-25TAB) dissolved in 10 ml H2O and 0.1% 
Tween 20] was used for staining. Once the second signal was satisfactory, the reaction 
was stopped as described in Section 2.9.2.  
2.9.4 High throughput WISH protocol 
This WISH method was developed for quick identification of mutant embryos. It was a 
simplified version of High-resolution WISH protocol. Before hybridization, the 
dehydration and re-hydration treatment of fixed embryos were skipped, and other steps 
were the same as described in Section 2.9.2. Post-hybridization washes were simplified 
as the follow: two 15-minute washes in 2X SSCT at 68°C, two 15-minute washes in 0.2X 
SSCT at 68°C and one 10-minute wash in PBST at room temperature. Then, the embryos 
were incubated in the blocking buffer at room temperature for 1 hour, followed by the 
antibody incubation with a high antibody concentration (1:2000 dilution in blocking 
solution) for 2 hours. After two 20-minute washes in PBST and one 10-minutes 
equilibration in the detection buffer, the embryos were stained until the signal reached 
satisfactory.  
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2.10 SSLP and SNP marker detection 
SSLP markers were amplified by PCR. The PCR reaction was carried out in a 0.2 ml 
PCR tube or 96-well plate in a total volume of 20 μl using such a recipe: 2 μl 10X PCR 
buffer, 0.2 μl 20 mM dNTPs, 0.4 μl 10 μM of specific primers, 0.5-2 μl genomic DNA 
template, 0.5 μl Taq and distilled water. The Programmable Thermal Controller (Model 
PTC-100, MJ Research) was used for amplification reaction according to the following 
program: 94°C denaturation for 3 minutes; 40 cycles of 94°C denaturation for 30 seconds, 
annealing at 55°C or 58°C for 30 seconds, 72°C elongation for 1 minute; 72°C for 10 
minutes. The primers used for the initial and fine mapping were listed in appendix 1 and 
Table 2-2 respectively. PCR products were scored by electrophoresis on 3.5% MS 
agarose gel (MS-8, Pronadisa Cat. No. 8064) in 0.5X TBE buffer (44.5mM Tris, 44.5mM 
boric acid and 1mM EDTA, pH 8.3). 
SNP markers were amplified by flanking primers (Table 2-2), and the PCR products were 
sequenced by either primer used in PCR to identify the SNPs.. 
2.11 Assay of the Mypt1-PP1c Complex  
2.11.1 Constructs  
The full-length and the N-terminal 305 amino acid fragment of Zebrafish and mouse 
MYPT1 (zMYPT1 and mMYPT1) was cloned into the pXJ41-FLAG vector such that the 
recombinant proteins would be expressed as C-terminally FLAG-tagged proteins. An N-
terminally HA-tagged mouse Phosphatase 1cδ (PP1c) construct was a kind gift from Dr 
Thomas Leong (IMCB, Singapore). 
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2.11.2 Co-immunoprecipitation (Co-IP) and Immunoblotting  
COS-7 cells were transiently co-transfected individual Mypt1 constructs mixed with the 
PP1c construct using Lipofectamine 2000 reagent (Invitrogen Cat. No.11668-027). 
Transected cells were harvested after about 40 hours of incubation. Total protein was 
extracted from each tranfection and the same amount of total protein was applied to co-
immunoprecipitation (Co-IP) using anti-FLAG antibody conjugated agarose resins. The 
immunoprecipitate was eluted in 100 ul of 2x Laemmli buffer after boiling for five 
minutes. An aliquot of 30-μl eluate was applied to two separate SDS-PAGE separations 
and immunoblotting was performed using anti-HA (to detect PP1c) and polyclonal anti-
MYPT1 (Santa Cruz Biotechnologies, Cat. No. sc17433) antibodies. 
2.12 Stress Fiber Assay 
HeLa cells grown overnight to 25-30% density on cover-slips in 6-well dishes were 
transfected with the FLAG-tagged zebrafish N-terminal Mypt11-305 or M36-Mypt11-305 
constructs. At 24 hour post-transfection, cells were fixed with 4% paraformaldehyde 
(PFA) in PBS at 4oC overnight. Fixed cells were washed with PBS to remove the traces 
of FPA and permeabilized with 0.5% Triton X-100 in PBS for 20 min. Then anti-FLAG 
antibody was added in PBS at 1:200 dilution and incubated for 2 hours at room 
temperature. Excess antibody was washed away by 5-6 washes with PBS about 30 min. 
Next Alexa Fluor 488 conjugated anti-mouse IgG (for transfected cells) and TRITC-
conjugated phalloidin (for actin stress fibres) (Sigma, Cat. No. P1951) were added at 1: 
400 dilution each. Incubation was conducted for 1 hour in the dark at room temperature. 
Cells were washed 5-6 times (10 min each) with the washing buffer. Dark condition was 
 66
maintained during the washes. The cover-slips were mounted on glass-slides and the 
stained cells visualized under fluorescence microscope for imaging. 
2.13 Mosaic Analysis via Cell Transplantation 
2.13.1 Mutant donor cells to WT embryos for endoderm replacement  
Donor cells were labeled by injection with fluorescein-dextran (Molecular probes, Cat. 
No. D1820) at one cell stage. At the 1000-cell stage, about 20 donor cells were taken and 
transplanted into the marginal region of a WT embryo at the same stage. Mosaic embryos 
were fixed at 3 dpf for WISH using DIG-labeled lfabp RNA antisense probe. TSATM-Plus 
Cyanine3 / Fluorescein system (PerkinElmer, Cat. No. NEL753) were used for detection 
after sequential incubation with anti-DIG-POD (Roche Cat. No. 11 207 733 910) and 
anti-fluorescein-POD (Roche Cat. No. 1 426 346). Images were acquired by Olympus 
Fluoview FV1000 confocal microscope. 
2.13.2 Wild-type mesoderm donor cells to mypt1 morphants for mesoderm 
replacement 
mypt1 morphants mimicked the mypt1sq181 phenotype and were used as the recipients in 
this cell transplantation experiment. Wild-type mesoderm donor cells were obtained from 
embryos injected with a casanova specific morpholino (Stafford et al., 2006) together 
with labeling compounds tetramethylrhodamine and biotin-dextran (Molecular probes, 
Cat. No. D3312) at one cell stage. At the 1000-cell stage, about 40 donor cells were taken 
and transplanted into the region close to the margin of the mypt1 morphant embryos at 
the same stage. Mosaic embryos were fixed at 3 dpf for WISH using DIG-labeled lfabp 
RNA antisense probe. Liver was stained by NBT-BCIP and donor cells by Alexa Fluor® 
488 tyramide (Molecular probes, Cat. No. T30955) after the incubation with streptavidin-
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POD (Molecular probes, Cat. No. T30955). Images were acquired by Leica fluorescence 
dissection microscope with Nikon digital camera DXM1200F. 
2.14 Mutant Rescue 
For mutant phenotype rescue, 0.5 ng of in vitro transcribed WT mypt1 mRNA (NM-
001003870) or the mutant mypt1 mRNA were injected into the one-cell stage embryos, 
respectively. For fgf8 (NM_131281), wnt2bb (NM_001044344), bmp2b (NM_131360) 
and bmp2a (NM_131359) rescue, full length cDNA corresponding to these genes were 
obtained via RT-PCR (Table 2-1). For mRNA injection, all mRNAs were synthesized 
from pCS2 plasmids using mMESSAGE mMACHINE® SP6 Kit (Ambion, Cat. 
No.1340). For plasmid DNA injection, each target gene was cloned down stream of a 
functional sox17 promoter (Wen CM and Peng JR, unpublished) and then cloned into the 
pEGFP vector (Clontech) by replacing the gfp gene at the Sac II and Not I cloning sites. 
One-cell stage embryos were used in injection. For retinoic acid (RA, Sigma, Cat. No. 
R2625) rescue, embryos at 9-10 hpf were incubated in egg water containing 10-8-10-7 M 
RA (Stafford and Prince, 2002). Embryos 3 days post-treatment were subjected to WISH 
using the DIG-labeled lfabp probe. 
2.15 Heatshock Treatment 
Transgenic fish line Tg(hsp70:dnBmpr-GFP) was previously described (Pyati et al., 
2005). Heterozygote outcross embryos between 18-21 hpf were heatshocked at 40oC for 
30 min and then transferred to 28.5oC. GFP positive embryos were selected using a 
florescence microscope 2 hrs after heatshock. For detecting the BmpR1a-GFP fusion 
protein, an anti-GFP antibody (1:1000, Clontech, Cat. No. 632381) was used in 
immunoblotting. 
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2.16 p-Histone H3 Immunostaining and TUNEL Assay 
p-Histone H3 immunostaining and TUNEL assay are performed according to the protocol 
described previously (Stafford et al., 2006). Sectioned samples were used to perform p-
Histone H3 (1:200, Santa cruz, Cat. No. sc-8656R) immunostaining as discribled in 
Section 2.7.2. For TUNEL assay, sectioned samples were refixed in 2% PFA and 
permeabilizd in ice-cooled 0.1% sodium citrate, 0.1% Triton-100 for 20 minutes. The In 
Situ Cell Death Detection Kit (TMR red, Roche, Cat. No. 12 156 792 001) was used for 



















Figure 2-1 Stages of the zebrafish embryo during development. (Adapted from 
Kimmel et al., 1995) 
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Table 2-1 List of methods used for genotyping 
mypt1sq181 
PCR primers to amplify genomic DNA sequence by the lower primer 
upper: 5’gccaagcagaagcggaacgagcagt3’ wt mut 
lower: 5’aacggcccgacgaagatggtgatga3’ GTG for V36 ATG for M36 
mypt1hi2653 
PCR primers to amplify wt genomic DNA score on 1% agarose gel 
upper: 5’agccgcccctcctgaaga3’ wt mut 
lower: 5’ccgtgctaactggttgctatgc3’ 
PCR primers to amplify viral genomic DNA 
upper: 5’gataggctcggagacggacc3’ 
lower: 5’gctagcttgccaaacctacaggt3’ 
Only wt band Only viral band 
hasm567 
PCR primers to amplify genomic DNA sequence by the lower primer 
upper: 5’gaaggaacggctgggatgtca3’ wt mut 
lower: 5’aacgctaatgctgtctaaactaatgctc3’ TGG for W519 TAG for stop 
codon 
Tg(hsp70:dnBmpr-GFP) 
PCR primers to amplify transgene genomic DNA score on 1% agarose gel 
upper: 5’gagatctaaaatgagaaaacgacttttcattgc3’ heterozygote wt control 










































Primer for PCR and RT-PCR 
Gene Upper Primer (5’-3’) Lower Primer (5’-3’) 
ifabp gaccttcaacgggacctg atcataaatatcaaaactcaca 
foxA3 gtcgtcagtcactatccgtttct agggtctgtgtaattgtctgataa 
hhex cgcacccgacgcccttctat catctttgccagcctcttcctctcg 
F-actin accaccggtattgtgctggatgc acagatccttacggatgtcaatgtc 
mypt1 full-length caggctcgaggggatgaagatgg aaggggaaagctgggaaacgcaatgg 
bmp2a atggtctcgtccaccgccgcgc tcagcggcacccgcatccctcc 
bmp2b cgctcgcgcacttcatta cttcattggggagattgttc 
fgf8 gtgcatgtacttgtcagcggtgtca agtctctggctttcggtcctctccttttc 
wnt2bb cacacgctaattcccgggcagataca tcaggtctggtccagccattccgcacg 
casanova tggacgcaaaacagcatgtatc aaaaacaaaatcagcagcaatct 












Primers for generating new SSLP and SNP markers for positional cloning of mypt1    
SSLP68 atcattgcaacagtcatctt tgccgcattcagtaaaa 
SNP24 attaggccccgcaccattc tatccctttttattttcactttccatt 
SSLP50 atagggcccttagtgtcttctgtgt aaatatggcttcggttgtgt 
SNP33 gttgttgcacgtccgccgattact aacatttgcccattgccttgat 
SNP41 ttgggaagggtgtatcgttaggac aaagggggaaagcaagcaagtga 
SSLP81 ttcctttgctgctgctgctgcttgatt tctgtttggttagggatggtcgtgtgg 
SSLP79 tagtattaatgccatgcctgaca ttccgtacggttctgcgagttcta 
SNP: Single Nucleotide Polymorphism 
SSLP: Simple Sequence Length Polymorphism 
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Table 2-5 The sequences of gene specific morpholinos 
name Morpholino sequence (5’-3’) Concentration* 
mypt1-E1I1 CGTAACGCAACGCTCTTCTTACCTG 1.2 nmol/ul 
pp1c-E2I2 AAGGAGAGAATCTAACCTACCACAG 0.4-0.5 nmol/ul 
casanova GCATCCGGTCGAGATACATGCTGTT 0.6 nmol/ul 















Total Volume (ml) 30 60 150 200 250 
Agarose (g) 0.39 0.78 1.95 2.6 3.25 
10X MOPS (ml) 3 6 15 20 25 
dd H2O (ml) 25.4 50.8 127 169.3 211.6 
Melt agarose, cool to 50°C, then add 
Formaldelhyde (37%) (ml) 1.6 3.2 8 10.7 13.4 
Resolution Gel (10 ml) Stacking Gel (2 ml) 
Components Concentration Components Concentration
 12% 10% 9%  4% 
30% polyacrylamide (ml) 4 3.4 3 30% polyacrylamide (ml) 0.34 
dd H2O (ml) 3.4 4 4.4 dd H2O (ml) 1.36 
1.5 M Tris (pH 8.8) (ml) 2.5 2.5 2.5 1M Tris (pH 6.8) (ml) 0.26 
10% SDS (μl ) 100 100 100 10% SDS (μl ) 20 
10% APS (μl) 100 100 100 10% APS (μl) 20 
TEMED (μl) 10 10 10 TEMED (μl) 3.5 
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Table 2-6 List of constructs for WISH RNA probes 
Gene Vector Restriction enzyme RNA polymerase 
prox1 pGEM® T-Easy Sma I Sp6 
lfabp pBluescipt II KS+/- Sac II T3 
insulin pGEM® T-Easy Nco I Sp6 
trypsin pBluescipt II KS+/- Sac II T3 
ifabp pGEM® T-Easy Nco I Sp6 
foxA1 pBluescipt II KS+/- EcoR I T3 
foxA3 pGEM® T-Easy Nde I T7 
gata6 pT7T3 18U Sal I T7 
hhex pGEM® T-Easy Nco I Sp6 
mypt1 pGEM® T-Easy Sac II Sp6 





















Chapter 3 Forward genetic screen for zebrafish liver defective mutants 
3.1 Introduction 
As discussed in chapter 1, the most important advantage of the zebrafish model organism 
is its feasibility to carry out large scale forward genetic screen, and zebrafish is 
particularly suitable for liver organogenesis study. To explore molecular mechanism of 
the liver development in zebrafish, we initiated our project with a forward genetic screen 
to identify specific liver defective mutants. 
3.2 Results 
3.2.1 Mutagenesis and generation of families for screen 
Forty male fish (local AB wild-type strain) were mutagenized with the standard 
ethylnitrosourea (ENU, 3 mM)) method by placing them into an aqueous for three 1-hour 
periods within a week. Seven surviving mutagenized males (founder) were crossed 
weekly with wild-type female to generate F1 progenies (F1 families). Less than 150 F1 
fish from each founder were collected to breed to avoid spermatogonial clones, and about 
700 F1 fish were generated. The efficiency of mutagenesis was calculated by the 
frequency of induced mutations at one pigmentation loci, albino, by crossing founder fish 
with albino mutant, and was found to be about 0.2%, which was within the normal 
mutagenesis rates of 0.09-0.33% (van Eeden et al., 1999). In order to save space and 
reduce workload, male and female F1 fish from different founders were paired randomly 
to generate F2 families instead of crossing F1 fish with wild-type. The siblings of each F2 
families were randomly inter-crossed to generate F3 embryos for mutant screening. Once 
the paired fish were heterozygous carriers, one fourth of their progenies would show 





Figure 3-1 Crossing scheme. ENU mutagenized males were mated to wild-type 
females to generate F1 progeny which is heterozygous for one mutagenized genome. 
F2 families were raised from cross F1 with wild-type (with another F1 fish in our 
screen). A mutation m present in one of the F1 parents was shared by 50% of the fish 
in the F2 family. Eggs were collected from random matings between F2 sibling fish. If 
both parents were heterozygous for m, expected in 1/4 of the crosses, 1/4 of the eggs 
would be homozygous and show the mutant phenotype (Adapted from Haffter et al., 
1996). 
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3.2.2 Forward genetic screen 
3.2.2.1 Setup of a high-throughput whole mount in situ hybridization (WISH) 
method for screen 
As an internal organ, the liver is only obscurely visible under a dissection microscope at 
late stages, for example 4 dpf (Chen et al., 1996; Pack et al., 1996). However, it is much 
easy to visualize the embryonic liver after RNA whole mount in situ hybridization 
(WISH) using a liver specific marker. For the purpose of screening liver defective 
mutants, we developed a high-throughput RNA WISH method using prox1, a liver 
specific marker, in our screening.  As discussed in the Chapter one, prox1 is strongly 
expressed in the embryonic liver. The results of whole mount in situ hybridization 
showed that transcripts of this gene were found in the liver from 1 dpf to 4 dpf in 
zebrafish, and were highly enriched from 1.5 dpf to 4 dpf (Figure 3-2). Because it is easy 
to dechorinate embryos at 3 dpf, we decided to use 3 dpf embryos as samples to do whole 
mount in situ hybridization. To handle large number of samples, we designed a 96-well 
box for high-throughput whole mount in situ hybridization (Figure 3-3). The protocol for 
whole mount in situ hybridization was simplified to save time, labor and reagents which 
is described in Chapter two. We found that the simplified method yielded strong prox1 
signal that was very easy to read under a dissection microscope. 
3.3.2.2 The scheme of screen 
Figure 3-4 summarized the scheme of our screen. Generation of founder fish and F2 
families were described as the above. The first round screen was classic F3 genetic screen 
(screen in F2 families), and the principle was showed in figure 3-1. Parents of putative 











Figure 3-2 prox1 is highly enriched in the embryonic liver from 1.5 dpf to 4 dpf. 
(A) dorsal view; (B) lateral view; black arrow: liver. 

















Founder x WT 
F1 x F1 
screening  F2 carriers
outcross F3 families
F3 carriersoutcross F4 familiesscreening F4 carriers 
Further outcross 







F2 sibling cross 
F3 sibling cross 
F4 sibling cross 
with wt 
with wt 
Figure 3-4 Scheme of screen. Mutangenized founders were crossed with wild-type to 
generate F1. F1 fish from different founder were mated to give rise to the F2 families. 
F2 carriers were obtained by genetic screen. Two round outcross were applied to clean 
up the genetic background in mutants and eliminate false mutants. F4 carriers were 
used for mapcross with WIK to raise mapping families for positional cloning.  
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outcrossed with wild-type to generate F3 families, by which the non- specific mutations 
(i.e. liver phenotype non-relevant) in F2 carriers would be segregated away and the 
genetic background became purer than the previous generation. The obtained F3 families 
were used for the second round screen to confirm the heritance of the phenotypes; parents 
of mutants identified were referred as F3 carriers. During this round screen, false mutants 
which could not inherit the liver phenotype identified in the first round screen were 
excluded. The F3 carriers obtained were used for another round outcross to generate F4 
families to further purify their genetic background and verify facticity of the mutants. F4 
carriers obtained in the third round screen were considered as genuine mutantion carriers 
with relatively pure genetic background and were ready for phenotype characterization 
and mapcross with a polymorphic line WIK to generate families for positional cloning 
that will be discussed in the next chapter.   
3.2.2.3 First round screen (screen in F2 families) 
Total 1481 successful sibling crosses from 262 F2 families had been screened and the 
average successful cross number achieved for each F2 family was 5.7. The coverage, the 
probability of obtaining a pair of heterozygous carriers from a heterozygote carrier 
outcross family, can be calculated using the formula 1- 0.75n, where n is the number of 
successful cross. Thus, the average coverage in our screen was 80.45%, which indicates 
most mutations responsible for the liver defects appeared in F2 families would be 
identified. After screening 262 F2 families (F2 families were generated by F1 crossing F1, 
so 262 F2 families represent 524 F1 starting fishes, in other words, 524 mutangenized 
genomes), F3 progenies of more than 100 F2 pairs were found to segregate embryos with 
defects in prox1 expression on the liver site at a ratio of 1:3 and the liver defect 
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phenotype were reconfirmed in 77 pairs which were considered as F2 carriers. Because 
F2 families were generated by inter-cross of different F1 fish, and each F1 fish carry 
multiple mutations, we probably could obtain mutants caused by different mutations in 
the same F2 family, thus, we kept all pairs as different putative mutation carriers 
including those from the same F2 families. These F2 carriers were outcrossed with wild-
type to purify mutant background.  In order to avoid missing any mutants obtained, 39 
pairs which failed to lay eggs to reconfirm the initially observed phenotype were also 
chosen for outcross. Totally, 116 F2 carriers (derived from 82 F2 families) were chosen 
for outcross with wild-type to purify mutant background. Among mutants identified in 
the first round screen, three kinds of phenotypes were observed (Table 3-1A): First group 
of mutants displayed no liver or smaller liver than that in wild-type (80 F2 carriers from 
59 F2 families), second group had a liver on its right side of the body rather than on the 
left side as in wild-type fish (27 F2 carriers from 25 families). We also observed 9 F2 
carriers (from 8 F2 families), referred as the third group, showing both phenotypes (i.e. 
having a small liver on the right side of the body, referred as mixture phenotype). We 
noticed that the above three groups of mutants could be observed in progenies of different 
F2 carriers from the same F2 family (Table 3-1B). Meanwhile, we also found that similar 
liver phenotype but with different severity of morphological defects could be observed in 
progenies of different F2 carriers from the same F2 family (for example, 74.2 and 74.3 
from F2 family 74). These facts demonstrate that a parental F2 fish can carry more than 
one mutation to cause the liver defective phenotype. Because we were more interested in 
the liverless and small liver phenotype, which are probably resulted from the defects in 
the liver specification and growth, than the left- right patterning of the liver, we gave up 
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11 F2 carriers showing liver on their right sides of body axis (derived from 11 F2 
families). Three F2 carriers giving rise to mutants with no liver or small liver (derived 
from 3 F2 families) failed to outcross with wild-type due to fish death and were thus lost, 
and remaining 102 F2 carriers (derived from 72 F2 families) successfully produced 
progenies (F3 families) which were used in our second round screen (Table 3-1C and D). 
3.2.2.4 Second round screen (screen in F3 families) 
The liver defect phenotypes were reconfirmed to be inheritable in 76 (representing 51 F2 
families) out of 102 F2 carriers in a Mendelian manner in the second round screen. We 
found that only 4 (from 4 F2 families) out of 16 F2 carriers (from 15 F2 families) were 
confirmed to have their livers on the right side of body, suggesting this liver phenotype 
was unstable and could be caused by non-specific genetic background. The liver defect 
was not confirmed in additional 14 F2 carriers (from 10 F2 families) and they were 
discarded. Interestingly, the mixture phenotype observed in the first round screen was not 
observed in this round, embryos from inter-crosss of these F3 family fish exhibited either 
a small liver phenotype (4 mutants from 3 F2 families) in a Mendelian manner or a 
normal liver (5 mutants from 5 F2 families), which probably could be explained by 
segregation of multiple mutations which joined to cause the mixture phenotype in F2 
carriers. A total of 76 F2 carriers were confirmed in the second round screen and these 
mutants were referred as F3 carriers. Another 26 pairs of F2 carriers were found to be 
false that could be caused by the following three reasons: 1) liver defects induced by non-
specific genetic background; 2) liver defects caused by multiple mutations; and 3) liver 




Table 3-1 Summary of the first round screen (screen in F2 families) 
A: F2 carriers obtained from the screen in F2 families 
mutant phenotype carrier number original F2 family number 
Group I 80 59   
Group II 27 25 
Group III 9 8 
total 116 82 
Group I: no liver or smaller liver compared with the wild-type 
Group II: the liver on the right side of the body 
Group III: showing combined phenotypes of group I and II 
 
B                                                                   D 
         
 
C: Successfully outcrossed F2 carriers  
mutant phenotype carrier number original F2 family number 
Group I 77 56   
Group II 16 15 
Group III 9 8 
total 102 72 
Group I: no liver or smaller liver compared with the wild-type 
Group II: the liver on the right side of the body 





























We noticed that while the F3 mutants inherited the liver defect phenotype, the overall 
morphology of these mutants was much less severe than F2 mutants, suggesting that 
outcross can effectively clean up the mutant genetic background (Figure 3-5). Worth to 
mention was that some F3 carriers were originated from the same F2 family and in this 
situation these F3 mutants often displayed almost identical liver and other morphological 
phenotype, suggesting that these F3 mutants are likely derived from the same mutation. 
To check if this is the case, F3 carriers with similar liver and morphology phenotypes 
from the same F2 families were subjected to allelism test. Six F3 carriers were each 
found to be allelic to other 6 F3 carriers, respectively. Thus, the number of putative 
mutants was reduced from 76 to 70. We also found some non-allelic mutants from the 
same F2 family. For example, 74.2.3 (Figure 3-7) and 74.3.1(Figure 3-8), two F3 carriers 
from the F2 family 74, produced mutant embryos with different morphology phenotype. 
Moreover, F2 mutant 50.1 segregated into two different phenotypes in F3 mutants: 
50.1M1F (Figure 3-7), 50.1F2B (Figure 3-8), suggesting the original F2 carrier 50.1 
contains two distinct mutations that cause a liver phenotype. Therefore, the total number 
of our F3 carriers became 71. These 71 F3 carriers were outcrossed with wild-type to 
generate F4 families. According to the liver and morphological phenotype the above 71 
F3 mutants (derived from 51 F2 families) could be roughly classified into four groups: A) 
2 mutants (from 2 F2 families) appear normal but are liverless (Figure 3-6); B) 22 
mutants (from 17 F2 families) appear normal but have smaller livers (Figure 3-7); C) 43 
mutants (from 31 F2 families) appear morphologically abnormal meanwhile are liverless 
or have smaller livers (Figure 3-8); and D) 4 mutants (from 4 F2 families) have the liver 
on the right side of the body axis (Figure 3-9).  
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3.2.2.5 Allelism test 
The allelism test is a method to check if different mutants are due to impairment in the 
same gene by examining the phenotype in progenies of inter-cross of parent carriers. If 
mutants are allelic, progenies of inter-cross can phenocopy each of the individual mutants, 
otherwise, no phenotype will appear. To verify if the mutants we obtained were different 
alleles, we carried out allelism test among some of the mutants in group A and B, which 
we were interested in due to their relatively specific liver phenotypes. Firstly we 
performed allelism test between mutants from the same F2 families. Total 14 F2 families 
had at least two pairs of F3 carriers. Carriers from the same F2 families were inter-
crossed to lay eggs, and progenies were collected at 3 dpf for whole mount in-situ 
hybridization using prox1 as a probe to check the liver. Results showed that in all cases 
F3 mutants belonging to A and B groups from same F2 family are allelic. After this we 
chose 19 F3 mutants in groups A or B as our focus. We also performed allelism test for 
these 19 mutant lines. In the completed tests, as shown in Table 3-2 no same allelic 
mutation was found, suggesting we might have obtained 19 different mutant lines (Table 
3-2). 
3.2.2.6 Third round screen (screen in F4 families) 
In the third round of screen, the liver defect phenotypes were confirmed to be inheritable 
in 66 out of 71 F3 mutants (51 F2 families) including the above mentioned 19 lines from 
groups A and B. Five F3 carriers failed to lay eggs and were excluded in the end. Due to 







Figure 3-5 Outcross can effectively clean up the genetic background in mutants. 
A and C show F2 mutants from F2 families, and B and D show F3 mutants from F3 
families. The overall morphologies were more normal in F3 mutants than in F2 
mutants while the liver phenotypes were inheritable. The liver in 3dpf embryos was 
visualized by WISH using prox1 as probe (black arrow).  
Figure 3-6 Two liverless mutants showed relatively normal morphology. The liver 
































Figure 3-7 Seventeen mutant lines showed small liver with relatively normal 
morphology. The liver in 3dpf embryos was visualized by WISH using prox1 as the 





















Figure 3-8 Representatives of mutants with liverless or small liver and abnormal 
morphology. The liver in 3dpf embryos was visualized by WISH using prox1 as 
probe (black arrow). 
Figure 3-9 One representative of mutants with the liver on the right side of the 
body axis. The liver in 3dpf embryos was visualized by WISH using prox1 as probe 
(black arrow). 
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Table 3-2 Allelism test among mutants 
 
181 group        
10/10 recombinations tested 
 181 187 74 85 121
181 / / / / / 
187 n / / / / 
74 n n / / / 
85 n n n / / 
121 n n n n / 
 
 
202 group  
6/10 recombinations tested 
 202 34 50 147 262
202 / / / / / 
34 n / / / / 
50 n.d. n.d. / / / 
147 n n.d. n / / 
























264 group  
6/10 recombinations tested 
 264 163 152 244 90 
264 / / / / / 
163 n.d. / / / / 
152 n.d. n.d. / / / 
244 n n.d. n / / 
90 n n n n / 
198 group  
13/15 recombinations tested 
 198 118 50 76 87 262 
198 / / / / / / 
118 n / / / / / 
50 n n / / / / 
76 n n n / / / 
87 n n n n.d. / / 
262 n n n n n.d. / 
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relatively specific liver phenotype. After two rounds of outcrosses, we believe most non- 
liver phenotype causing mutations in mutants would be segregated away and the genetic 
background should be fairly purer because no further phenotype segregation other than 
the liver phenotype were observed in the third round of screen, and phenotypes displayed 
in progenies from these F4 carriers were genuine results of responsive mutations rather 
than those caused by non-specific genetic background. F4 carriers were used for outcross 
to keep lines and mapcross with WIK to generate families for mapping and positional 
cloning.  
3.3 Discussions 
Forward genetic screen is a powerful way to identify undocumented genes involved in a 
specific biological process. In our screen for liver defective zebrafish mutants, we 
developed a high throughput whole mount in situ hybridization method to specifically 
investigate the liver development in mutagenized fish. Our screen was summarized in the 
table 3-3. After screening 524 mutagenized genomes, we obtained 71 putative mutation 
carriers. We focused on 19 lines which showed liver defects with relatively normal 
morphology, these 19 mutant lines were used for outcross to keep the lines and mapcross 
to generate mapping families for positional cloning. Till now, four mutant genes were 
successfully cloned in our lab. 
Forward genetic screen is always a balance of all kinds of issues. High mutagenesis 
efficiency means high frequency of obtaining mutants; on the other hand, high genetic 
background is also produced. In other words, much works have to be done to segregate 
away undesired mutations in the obtained mutants. Even worse, the phenotypes in some 
putative mutants are consequences of multiple mutations and not inheritable in the  
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Table 3-3 Summary of genetic screening 
screen in F2 families 
total family screened 524 F2 families 
putative mutation carrier 116 F2 carriers from 82 F2 families 
outcross 1 (F3 families) 102 F2 carriers from 72 F2 families 
screen in F3 families  
total family screened 102 F3 families 
phenotype inheritable 76 F3 families 
outcross 2(F4 families) 71 F3 carriers from 51 F2 families 
Mutant classification: A:2(2) B:22(17) C:43(31)  D:4(4) 
screen in F4 families 
total family screened 102 F4 families from 71 F3 carriers 
phenotype inheritable 66 F3 carriers 
outcross & mapcross 19 lines from 19 F2 families 
 
A: 2 mutants (from 2 F2 families) appeared normal but were liverless 
B: 22 mutants (from 17 F2 families) appeared normal but had smaller liver 
C: 43 mutants (from 31 F2 families) appeared morphologically abnormal meanwhile 
were liverless or had smaller liver 














outcross families. In our screen, F2 families were generated by inter-cross of different F1 
fish, and we did find different phenotypes from the same F2 families (F2 families 74 and 
50), and we also observed phenotype segregation in outcross families from same F2 
carriers (50.1). Thus, we kept all mutant pairs from the same F2 family in the first round 
screen, and regarded them as individual putative mutation carriers; however, it turned out 
to be unnecessary because we found that F3 mutants originated from the same F2 family 
usually displayed almost identical phenotype. Such mutation carriers were often proven 
to be allelic according to results of complementation tests. The extra work arising from 
maintaining additional pairs of mutants from the same F2 family and subsequent allelism 
tests among these mutants really increased not only workload but also difficulty of 
management of the whole screen. The mutagenesis efficiency in our screen was about 
0.2%, which was within the normal mutagenesis rates of 0.09-0.33% (van Eeden et al., 
1999). According to the experience from our screen, such mutagenesis efficiency is quite 
suitable for genetic screen. 
Other contradictory issues we met were the number of carriers to keep and the workload 
to maintain these lines and re-screen the mutants in outcross families. Every single carrier 
was kept in the first round screen; however, we found we could not afford enough 
manpower and space to handle so many lines, and decided to pick out interesting ones 
according to the specificity of mutant phenotypes. It seems to be practical to set criteria 
for mutants at the beginning of the screen.     
In genetic screen, the number of cross per family is also a conflict of efficiency with yield. 
In our screen, 5.7 crosses per family can identify about 80% liver phenotype causing 
mutation appeared in F2 families. When we determine the scale of screen, we should 
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consider about the lifespan of fish. At the end of the first round screen, the parental fish 
became quite old and the majority of paired fish were unable to lay eggs. 
After finishing really huge amount of work (set about 10,000 crosses, collect and check 
the liver development in embryos from about 5,000 crosses by whole mount in situ 
hybridization, breed more than 200 outcross families about 500 tanks of fish), we finally 
obtain 19 mutant lines with specific defects in the liver development. Two liverless 
mutant carriers, m181 and m264 were mapcrossed with polymorphic line WIK to 
generate mapping families for positional cloning. We renamed m181 after the initials of 
flights of Singapore airlines with the number of F2 family, as sq181. In the following 















Chapter 4 Positional cloning reveals that a mutation alters a conserved 
motif in Mypt1 in sq181 
4.1 Introduction 
ENU mutagenesis efficiently introduces point mutations into zebrafish genome which can 
be revealed by positional cloning. Positional cloning is a map-based approach to identify 
different loci on the chromosome to define the critical region containing the mutation. 
The genetic distance of two different loci can be calculated by the frequency of 
homologous recombination arising in meioses according to the following principle: the 
close the distance between two loci is, the less DNA break occurs in this region on the 
chromosome during meioses, and less DNA breaks- mediated homologous recombination 
happens between these two loci. Thus, the task of positional cloning is to search for the 
close loci to the mutation and for recombination event number between these loci and the 
mutation. One of results of homologous recombination is the replacement of a 
chromosome fragment from homologous chromosome, which can be used to detect 
recombination happened between two polymorphic homologous chromosomes (Figure 4-
1C). In zebrafish, to create polymorphisms between homologous chromosomes, a copy of 
the genome from polymorphic line WIK is introduced into the mutant in AB background 
by mapcrossing heterozygous carrier with wild-type WIK line to generate families for 
positional cloning (Figure 4-1B). Of several kinds of markers to detect polymorphisms 
between homologous chromosomes, simple sequence length polymorphism marker 
(SSLP marker) is most widely used. SSLP markers are designed to amplify microsatellite 
repeats (CA or other low complexity sequences, the most common repeat is CA repeat) in 
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Figure 4-1 SSLP markers are used to detect recombination occurred during 
meiosis. (A) Simple sequence length polymorphisms (SSLP) based on different 
number copy of CA repeat is easy to score on agarose gel. (B) mapcross to introduce 
WIK background into mutant. (C) Recombination induced during meiosis results in 
three kind of mutant according to the pattern of SSLP marker M. A and a, wild-type 




no recombination       single recombination   double recombination   
for marker M              for marker M               for marker M                   
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 repeats between polymorphic homologous chromosomes which is easy to score on an  
agarose gel due to difference in length (Figure 4-1A). 
Since positional cloning is a map-based approach, high density genetic maps are highly 
desirable. Postlethwait et al. first reported a genetic linkage map for zebrafish consisting 
of 401 random amplified polymorphic DNAs (RAPDs) and 13 SSLP markers spaced at 
an average interval of 5.8 Centimorgans (Centimorgan is the unit of genetic distance, and 
one centimorgan is defined as one recombination among 100 meioses. Because one 
mutant has two meioses, one centimorgan is also calculated as one recombination among 
50 mutants) (Postlethwait et al., 1994). Two high density genetic maps are established in 
the Fishman’s lab and Zon’s lab (Shimoda et al., 1999)(http://zfrhmaps.tch.harvard.edu 
/ZonRHmapper/Maps.htm, respectively). The website, http://zfin.org, collects all kinds of 
genetic mapping panels constructed in different labs and also provides a merged panel 
that integrates information from all genetic maps.   
Zebrafish Genome Fingerprinting Project (http://www.sanger.ac.uk/Projects/D_rerio/ 
WebFPC/zebrafish) provides massive information of alignment of chunk chromosome 
fragments in BAC (bacterial artificial chromosome) and PAC (P1-derived artificial 
chromosome) to facilitate chromosomal walking. The sequence released from Sanger 
Institute Zebrafish Genome Sequencing Project (http://www.sanger.ac.uk/Projects 
/D_rerio/) is of great help to identify the mutant gene at the final stage of cloning. Since 
the first mutant gene was identified in zebrafish in 1998 by positional cloning (Zhang et 
al., 1998), a number of mutant genes have been successfully isolated by this method 






















Figure 4-2 SSLP marker test. Eight SSLP markers from LG2 from Fishman’s panel 
were tested in local AB (mutant background, lane 1-6), WIK (mapping line 
background, lane 7-10) and local wild-type (lane 11 and 12). Markers displayed 
polymorphisms were selected to construct our own initial mapping panel. Note the 
high heterogeneity of different local AB and WIK fish.  
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Fingerprinting Project and Zebrafish Genome Sequencing Project, the mutant gene 
cloning becomes easier. 
Technically, positional cloning includes following steps: firstly, the heterozygous carrier 
in AB background is used to mapcross with wild-type polymorphic line WIK to generate 
families for mapping; secondly, heterozygous mutant pairs (AB/WIK) are identified from 
the mapping families; thirdly, initial mapping (also known as rough mapping, low 
resolution mapping) is performed using a small amount of homozygous mutant embryos 
to determined which chromosome the mutation locates on; fourthly, fine mapping and 
chromosomal walking (also known as intermediate and high resolution mapping) is 
performed to define a small critical region harboring the mutation; finally, DNA 
sequencing is performed to identify the mutation in the mutated gene. For initial mapping, 
a reliable mapping panel is crucial for finding out on which chromosome the mutation 
locates. Since no isogenic line is available in zebrafish, mapping panels established in 
other labs can’t directly be applied to our mapping. Thus, before starting to initiate the 
mapping work, a genetic panel for initial mapping has to be set up according to 
polymorphisms appeared in our own AB and WIK genetic background. 
4.2 Results 
4.2.1 Construction of the initial mapping panel 
Total 451 SSLP markers from two mapping panels, one generated by the Fishman’s lab 
(http://zebrafish.mgh.harvard.edu/zebrafish/bulseglist.htm) and the other by the Zon’s 
(personal communication) lab, were tested on genomic DNA templates from local AB 
(mutant strain), WIK (mapping strain) and local wild-type (Figure 4-2). Two independent 
PCR reactions were performed for each marker, with annealing temperature 55°C and 
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58°C, respectively. 226 markers were confirmed to show polymorphism in our test. 
These markers were distributed on 25 chromosomes at an average 20 centimorgan 
interval and these markers were selected for our initial mapping (Figure 4-3). There is an 
about 80-centimorgan gap in the LG 21 (LG, linkage group, standing for chromosome) 
because no suitable markers were available in this region in both established panels 
(Figure 4-3). The primer sequences of SSLP markers in our panel were shown in 
appendix 1 and the location of these primers in 96-well plates was in appendix 2. 
4.2.2 Positional cloning of sq181 
4.2.2.1 Initial mapping of sq181 
BSA (Bulked Segregant Analysis) is a method routinely used for initial mapping in 
zebrafish (Shimoda et al., 1999). Figure 4-4 shows the working principle of BSA. DNA 
pools of homozygous mutant embryos and their wild-type/ heterozygous siblings are 
respectively tested with each marker in the initial mapping panel to determine to which 
marker the mutation is closely linked. In mutant DNA pool, the chromosomes harboring 
the mutation are in AB background except small portion of them which are from 
recombined WIK fragments; while siblings DNA pool is a mixture of AB and WIK 
chromosomes (Figure 4-4). Thus, markers close to the mutation produce AB and faint or 
no WIK bands when using pooled mutant DNA as PCR template and the weak WIK band 
is due to small portion of WIK DNA agaist large portion of AB DNA in the mutant DNA 
pool (Figure 4-4 and 4-5A). However, both AB and WIK bands are expected to be 
similar in their intensities when using pooled sibling DNA as PCR template because of 
comparable AB and WIK DNA ratio in the pool (Figure 4-4 and 4-5A). Markers unlinked 














Figure 4-3 Construction of initial mapping panel. The initial mapping panel was 
composed of 226 markers showing polymorphism between home AB and WIK fish. 
These markers were distributed on 25 chromosomes at an average 20-centimorgan 
interval. 
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 templates due to Mendelian random segregation of unlinked loci. In addition, similar 
pattern will be displayed for markers which are far away from mutation in the same 
chromosome because of frequent recombination happened between the mutation and 
these markers (Figure 4-4 and 4-5A). Comparing PCR patterns between mutant pool and 
sibling pool, only markers closely linked to the mutation will show difference. Total 226 
markers on our initial mapping panel cover all 25 chromosomes at an average 20-
centimorgan interval which is sufficient to show difference between the mutant pool and 
sibling pool in BSA if the marker is closely linked to the mutation. Therefore, at least one 
marker close to the mutation will be picked out after scanning whole genome in the 
mutant using markers from our initial mapping panel. Examining individual homozygous 
mutant using the identified markers can further confirm the proximity of these markers 
and the mutation.  
To identify markers closely linked to sq181 by BSA, DNA from 28 homozygous mutant 
embryos from the mapping families and their wild-type/ heterozygous siblings were 
pooled respectively, and used as PCR template for all 226 markers on the panel. Marker 
Z21636 on linkage group 4 were found to display different patterns between mutant pool 
and sibling pool in BSA, indicating that this marker is closely linked to the mutation 
sq181. Examination of individual embryos revealed that there were 10 recombinants out 
of the 28 mutant embryos examined, further demonstrating that sq181 locates on 
chromosome 4 and is closely linked to the SSLP marker Z21636 (Figure 4-5). 
4.2.2.2 Fine mapping and chromosomal walking on BAC contig 
Known SSLP markers near Z21636 in a high density genetic map established by 
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Figure 4-4 Principle of BSA. Mutant and sibling DNA pools are used as PCR template. 
Four kinds of chromosomes containing the mutation (WIK background and AB 
background, recombinants and non-recombinants) are in sibling DNA pool, while the 
majority of the mutant chromosomes are in AB background. Only the closely linked 
SSLP marker M produce different pattern between two pools: sibling pool shows both 
WIK and AB bands while mutant pool shows AB band and no or weak WIK band. A 




























Figure 4-5 Initial mapping of sq181. (A) BSA showed that the mutation was closely 
linked to the marker Z21636. The patterns of mutant and sibling pools were different 
using Z21636. The WIK band (red arrow) was weaker in mutant pool than in sibling 
pool (left panel). No difference was found between mutant and sibling pool using non-
linked marker Z3314 (right panel). (B) The linkage of the mutation and Z21636 was 
verified by checking 28 individual mutants. As expected, mutants showed only AB 
band (white horizontal arrow) except 10 recombinants (white vertical arrow) displayed 
both AB and WIK band. red arrow: WIK band; white horizontal arrow: AB band; 
white vertical arrow: recombinant. AB, AB grandparental heterozygote mutant fish; 
WIK, WIK grandparental fish; M1 and M2, two mutant pools from different 





















































Figure 4-6 Integrated genetic/physical map summarizing the map-based cloning 
of the sq181 mutant gene. Genetic markers are shown on the top with their 
corresponding number of recombinants shown below. The mutant gene was located 
between SNP24 and SNP41 spanning a 45 kb genomic DNA fragment contained in 
two BACs DEKY-66D18 and DEKY-28J4. ‘m’ in red: sq181 mutation locus. 
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polymorphism test on the mutant DNA pool and sibling DNA pool, and several markers, 
including Z7524, Z26623, Z11657 and Z7931, were found to display polymorphisms. 
Two SSLP markers, Z7524 and Z7931, were found to locate on different sides of the 
mutation, named as the north and south end, respectively. Z7524 and Z7931 were used to 
screen recombinants from a population of 3999 mutant embryos, 252 recombinants were 
identified using the north marker Z7524 and 353 recombinants with the south marker 
Z7931. Using a closer north marker Z26623 and a closer south marker Z11657, 93 
recombinants were detected on the north end, and 25 for the south end. A search in the 
Ensembl database (http://www.ensembl.org/Danio_rerio/index.html) and Genome 
Fingerprinting Project database (http://www.sanger.ac.uk/Projects/D_rerio/WebFPC/ 
zebrafish) placed both Z7524 and Z11657 onto the BAC contig367 (363 in the latest 
edition), which is composed of hundreds of overlapping BAC clones. Based on the BAC 
sequences in this contig, 79 new SSLP markers were designed manually or with the help 
of website: http://danio.mgh. harvard.edu/markers/ssr.html. The north marker SSLP 68 
(on DKEY-66D18) and the south marker SSLP 79 (on DKEY-210E13) narrowed the 
distance to the mutation by 5 and 7 recombinants respectively. Another marker SSLP 50 
was so close to the mutation that no recombinant was found out of 3999 mutant embryos 
examined. Since marker SSLP 50 locates on the overlapping region of two BACs 
(DKEY-66D18 and CH211-28J4), another 5 SSLP markers and 54 single nucleotide 
polymorphism (SNP) markers were designed based on the sequences of these two BACs. 
A SSLP marker, SSLP 81 (on CH211-28J4) detected 3 recombinants on the south end 
and two SNP markers, SNP24 (on DKEY-66D18) and SNP41 (on the overlapping region 
of DKEY-66D18 and CH211-28J4) were found to flank the marker SSLP 50 (0 
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recombinant) with 1 north and 2 south recombinants, respectively, and these two SNP 
markers defined a 45 kb genomic DNA fragment (Figure 4-6). Blast search against the 
zebrafish genome sequence in the Ensembl database showed that this 45 kb genomic 
fragment contains the first exon of the mypt1 gene. 
4.2.2.3 The sq181 mutation alters a conserved motif in Mypt1 
By sequencing the exon defined by the two closest markers, a nucleotide change from G 
to A was found, resulting in an amino acid substitution from Val to Met on the 36th 
amino acid of the myosin-binding subunit of myosin phosphatase (Mypt1) (Figure 4-7 A, 
B and C). Sequencing the remainder of the mypt1 gene revealed no other mutations. 
Mypt1 is a subunit of myosin phosphatase, an enzyme which dephoshorylates myosin 
regulatory light chain to relax myosin mediated contraction in smooth muscle and non-
muscle cells (Ito et al., 2004; Terrak et al., 2004). Myosin phosphatase is composed of 3 
subunits: a catalytic subunit of type 1 phosphatase PP1c; a targeting subunit, Mypt1; and 
a small subunit, M20, of unknown function. Mypt1 is highly conversed among different 
vertebrates (Figure 4-7 B and C) and it has a myosin binding domain on its C-terminus, 
and an RVxF (35-38th amino acid) motif followed by an ankyrin-array (39-299th amino 
acid) at its N-terminus which binds to PP1c (Figure 4-7 D)(Ito et al., 2004; Terrak et al., 
2004). The sq181 alters the RVxF motif and probably affects the binding affinity to PP1c. 
4.2.3 V36 to M36 substitution in Mypt1 causes the liverless phenotype in sq181  
To confirm that the gene identified is indeed mutated gene that is responsible for the 
mutant phenotype observed, segregation analysis and complementation test were carried 
out. The genomic DNA from 12 heterozygous and 15 wild-type adult fish, and 32 
homozygous embryos were isolated and DNA fragment containing the mutation was  
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Figure 4-7 The sq181 mutation alters a conserved motif in Mypt1 (A,B) Sequence 
trace (A) showing the G to A change (yellow shaded) in the mypt1 gene in the sq181 
mutant that results in a GTG codon to ATG codon change (underlined in blue) 
converting V36 to M in the conserved KV36xF motif in Mypt1 (underlined in green) (B). 
(C) Mypt1 is highly conversed among different vertebrates. Alignment of Mypt1 
peptides from zrbafish (AAT68110), human (O14974), mouse (Q9DBR7), rat (Q10728) 
and chicken (Q90624). Noted highly conserved N-terminus between different species. 
(D) A model showing the myosin phosphatase complex. The RVxF motif and following 




amplified via PCR and sequenced. The wild-type is expected to show G/G, heterozygous 
mutant G/A and homozygous mutant A/A. The results showed that the G to A change 
was found in all heterozygous and homozygous mutants (Figure 4-7 A), suggesting that 
the G to A change co-segregates with the mutant phenotype. To unequivocally prove that 
the G to A substitution in the mypt1 gene is responsible for the sq181 mutant phenotype, 
mRNA encoding wild-type or mutant Mypt1 was injected into one-cell-stage mutant 
embryos. At 3 dpf, 93% of the mutants injected with the wild-type mypt1 mRNA (42 out 
of 45 injected mutant embryos examined) had restored the expression of the liver specific 
gene lfabp (liver fatty acid binding protein) (Figure 4-8 A) whereas the G to A mutant 
mypt1 mRNA failed to rescue the mutant phenotype (0/15 mutant embryos examined, Fig. 
4-8 a). These results definitively prove that the V36 to M36 substitution in Mypt1 in 
mypt1sq181 causes the liverless phenotype. 
4.2.4 An insertion allele of sq181 also confers a liverless phenotype 
The hi2653 zebrafish line generated by Nancy Hopkins’ laboratory in a large-scale 
insertional mutagenesis project was found to have the viral vector inserted into the first 
intron of the mypt1 gene (Figure 4-8 B) but was not reported to exhibit liver defect 
previously (Amsterdam and Hopkins, 2004). We found that the hi2653 homozygotes, like 
the mypt1sq181 mutant, also displayed a liverless phenotype (Figure 4-8 C). Genetic 
complementation tests showed that sq181 and hi2653 are allelic (Figure 4-8 D), which 
suggests that mypt1 is the mutated gene responsible for the liverless phenotype in sq181;   
therefore these two alleles are designated as mypt1sq181 and mypt1hi2653, respectively.  
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4.2.5 Knockdown of mypt1 gene phenocopies the liverless phenotype in sq181 
In zebrafish morpholino-mediated gene knock-down is a commonly used approach to 
study gene function. A splicing-blocking mypt1 morpholino, mypt1-E1I1, was designed 
to block the splicing site at the boundary of exon1 and intron1, and was found to 
effectively perturb the normal splicing and resulted in an in frame deletion of 44 amino 
acids in Mypt1 (36th-79th) including parts of RVxF (35-38th amino acid) motif and 
ankyrin-array (39-299th amino acid) (Figure 4-8 F and G). As the RVxF motif and 
ankyrin-array are necessary for the binding of Mypt1 to PP1c, the aberrant Mypt1 in 
morphants is likely of null function. Indeed, the liverless phenotype in sq181 was 
phenocopied in morphants injected with mypt1-E1I1 (297 liverless and 26 with smaller 
liver out 323 morphants), providing an additional genetic evidence that the mutated 
mypt1 is responsible to the liverless phenotype in sq181 (Figure 4-8 E).  
4.3 Discussions 
The BSA method is routinely used for initial mapping as the first step in positional 
cloning of mutated genes in zebrafish. To construct our own initial mapping panel, 451 
SSLP markers from established panels were tested in our AB and WIK lines, and 226 
polymorphic markers were selected for the initial mapping which turned out to be 
effective in BSA. Fine mapping and chromosomal walking on BAC contig and 
subsequent DNA sequencing identified a G to A substitution in the mypt1 gene, which 
results in the V36 to M36 substitution in an RVxF motif in Mypt1. Co-segregation analysis, 
mypt1 morpholino knockdown experiment, finding of an additional allele of sq181 and 
mRNA rescue experiment all together provide unequivocal evidence to prove that the G 
to A mutation in sq181 is responsible for the liverless phenotype. 
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Figure 4-8 V36 to M36 substitution in Mypt1 causes the liverless phenotype in sq181  
(A) The liverless phenotype of the sq181 mutant (mu) was fully or partially rescued by 
the WT mypt1 mRNA but not the G to A mutant mRNA (mypt1m). black arrow: liver; 
(B) Diagram showing the viral vector insertion in the mypt1 gene in hi2653 zebrafish 
line obtained from Nancy Hopkins’ laboratory;  (C) hi2653 was liverless; (D) Genetic 
complementation test showing that hi2653 failed to complement the liverless phenotype 
of sq181 (sq181 x hi2653). Therefore, sq181 and hi2653 are allelic; (E) Injection of 
morpholino mypt1-E1I1 mimicked the sq181 phenotype; (F) the normal splicing was 
perturbed and an in-frame deleted mRNA was produced in morphants. The mypt1 new 
transcripts have a 132 nt-deletion (129-260) in Exon I 3’end; (G) showing the first 300 
amino acids of Mypt1, 44 amino acids (36-79, in red) was deleted in the new protein. 














Charpter 5 Mypt1-mediated spatial positioning of Bmp2-producing 
cells is essential for liver organogenesis 
5.1 Introductions 
General speaking, liver organogenesis begins with the establishment of a population of 
cells  gaining competent hepatic cell fate within the ventral foregut endoderm which is 
instructed by Foxa and Gata factors, then, mesodermal signals, including Fgfs, Bmps 
Wnt2bb and retinoic acid, induce the specification of hepatoblasts, and next, hepatoblasts 
migrate and proliferate to form a discrete liver bud, and finally hepatoblasts in the liver 
bud undergo rapid proliferation and differentiation to give rise to bile duct cells and 
functional hepatocytes (Allende et al., 1996; Wallace et al., 2001; Stafford and Prince, 
2002; Zaret, 2002; Duncan, 2003; Field et al., 2003; Mayer and Fishman, 2003; Chen et 
al., 2005; Holtzinger and Evans, 2005; Ober et al., 2006; Sadler et al., 2007; Shin et al., 
2007). During the liver budding stages in zebrafish, an autonomous asymmetric lateral 
plate mesoderm (LPM) migration, called LPM displacement, drives the bending of the 
anterior portion of the endodermal rod, a process termed as “gut looping” and this 
process places the liver bud on the left side of the body axis (Figure 5-1) (Horne-
Badovinac et al., 2003). However, the molecular consequence of such a cellular 
framework is still mysterious, especially regarding its possible significance for the liver 
bud growth during this period. 
We showed in the previous chapter that the mutation in sq181 is a G to A substitution and 
this mutation alters a conserved motif in Mypt1 that results in a liverless phenotype in the 
sq181 mutant. Mypt1 is one of the three components of myosin phosphatase, and the 
main function of the myosin phosphatase is to dephosphorylate phosphorylated myosin  
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Figure 5-1 LPM undergoes asymmetric migration during gut-looping. (A and B) 
Whole-mount in situ hybridization with the endodermal marker foxA3 reveals 
digestive tract morphology before (A) and immediately after (B) looping 
morphogenesis. The looping region (brackets) lies between the caudal border of the 
pharyngeal endoderm and the pancreatic islet. Dorsal views, anterior to the top. (C) 
Diagram of the looped gut at 30 hpf. Blue lines indicate position of sections. (D) Key 
for the diagrams in (E') to (G'). [(E) to (G)] Transverse sections through the endoderm 
and LPM. aPKCs (red) show weak expression in the endoderm but are highly 
expressed and apically localized in the LPM epithelium. Most cells are outlined with 
cortical actin (green) and endodermal cells have weak cytoplasmic green fluorescent 
protein (GFP). Dorsal to the top. (E) At 20 hpf the endodermal rod lies in the midline 
and both sides of the LPM are at the same dorsoventral level as the endodermal rod. 
(F) At 26 hpf, both sides of the LPM have migrated medially. The left LPM is dorsal 
to the endoderm and the right LPM is beginning to migrate ventrolaterally. Although 
the LPM is markedly asymmetric at this stage, the developing intestine is still in the 
midline. Asymmetry seen within the endoderm is due to leftward budding of the liver, 
which can be genetically uncoupled from gut looping. (G and H) At 30 hpf the 
migration is complete. The developing intestine has shifted to the left and the position 
of the left versus the right LPM is highly asymmetric. Adapted from Horne-Badovinac 
et al., 2003; Ober et al., 2003. 
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regulatory light chain (MRLC) to relax  contractile actomyosin filaments, a protein 
complex composing of actin and myosin II filaments activated by phosphorylation of 
myosin regulatory light chain by myosin light chain kinase (MLCK) in smooth muscle 
and non-muscle cells (Ito et al., 2004). Numerous reports have shown that, at the cellular 
level, Mypt1 regulates cell migration, adhesion and retraction through the myosin 
phosphatase (Egloff et al., 1997; Xia et al., 2005). At the developmental level, Mypt1 
mediates the protrusive activity of paraxial mesodermal cells to conduct convergent 
extension during gastrulation in zebrafish (Weiser et al., 2007)(personal communication 
with David Kimelman). The loss-of-function of Drosophila DMYPT caused disorganized 
cell sheet movement and cell shape change because of excessive nonmuscle myosin II 
activity that in turn caused the failure of dorsal closure during embryogenesis (Mizuno et 
al., 2002; Tan et al., 2003; Lee and Treisman, 2004). In C. elegans, loss-of-function of 
Mypt1 (mel-11) caused a shortened embryos because of excessive activity of actomyosin 
filaments (Wissmann et al., 1999; Piekny et al., 2003). Knock-out of Mypt1 leads to an 
early embryonic lethality before 7.5 dpc in mice (Okamoto et al., 2005). 
The most crucial question to be addressed in the study of mypt1sq181 is to link the liverless 
phenotype with the Mypt1 function. Since Mypt1 is involved in the cell migration which 
is important for the liver development, examination of cell movements in mypt1sq181 may 
help to reveal the mechanism of Mypt1 action in the liver development. Before 
investigating the underlying molecular mechanism in mypt1sq181, it is necessary to 
investigate the liver development in the mutant in detail, and the biochemical function of 
the mutant form Mypt1. 
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5.2 Results 
5.2.1 The mypt1sq181 mutation confers a liverless phenotype  
The mypt1sq181 mutant was identified from our genetic screen for zebrafish mutants that 
have disruptions in liver development using the liver-specific probe prox1 (Ober et al., 
2003). Whereas prox1 is strongly expressed in the embryonic liver at 72 hpf in the wild-
type (wt) zebrafish, there was no detectable prox1 signal at this site in mypt1sq181 mutants 
(Figure 5-2A). The liverless phenotype was confirmed by the observation that mypt1sq181 
also lacked expression of the liver specific gene lfabp (Figure 5-2B). Checking trypsin 
(exocrine pancreas) and insulin (islet) expression we found that while the mypt1sq181 
mutant exocrine pancreas was absent (~80%) or greatly reduced in size (~20%) (Figure 
5-2C), the islet was unaffected (Figure 5-2D). Interestingly, the shape and length of the 
mutant intestine was comparable to that observed in the wild-type when examined with 
the intestinal marker ifabp (intestine fatty acid binding protein), although partially 
reduced in size (Figure 5-2E). Finally, using the pan-endodermal marker foxa3 to 
simultaneously compare all endodermal organs between the mypt1sq181 mutant and wild-
type we further confirmed that the mypt1sq181 mutation confers a liverless phenotype 
(Figure 5-2F). These results demonstrate that the mypt1sq181 mutation primarily, but not 
exclusively, affects the development of the zebrafish liver. 
5.2.2 The mypt1sq181 mutation does not block hepatic competency  
The failure of the liver development in the mypt1sq181 mutant could be due to the inability 
of endodermal cells to become competent to develop as hepatic cells. To test this, we 
examined the expression of foxa1, foxa3 and gata6, three factors required for the 




























Figure 5-2 sq181 mutation confers a liverless phenotype (A and B) Lateral view 
using the liver-specific markers prox1 (A) and lfabp (B) showed that the mutant was 
liverless. (C and D) Dorsal view using a trypsin probe for the exocrine pancreas (C) 
and an insulin probe for the islet (D). (E and F) Doral view using an ifabp probe for 
the intestine (E) and a foxa3 probe for the entire digestive system (F).wild-type (wt) 
and mutant (mu) embryos at 3 dpf were harvested for whole mount in situ 
hybridization. In (A to F), black arrow: liver; red arrow: exocrine pancreas; black 
arrowhead: islet; blue arrow: intestine.
20% 80%
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no discernable difference between wild-type and mutant embryos was observed (Figure 
5-3A), demonstrating that the initial expression of these competency genes was not 
affected by the mypt1sq181 mutation. Previous reports have shown that at 30 hpf 
hepatoblasts under the first somite thicken to form a bulge from which the liver will 
develop (Ober et al., 2003; Ng et al., 2005; Wallace and Pack, 2003). We refer to this 
bulge as the liver primordium. At 30 hpf, the expression patterns of foxa1, foxa3 and 
gata6, including their expression in the liver primordium, were very similar in mutant 
and wild-type embryos except that the liver primodium appears to be positioned slightly 
posterior in the mutant embryos at this stage (Figure 5-3B). At 34 hpf, both the wild-type 
and the mypt1sq181 mutant continued to express foxa1, foxa3 and gata6 in the liver 
primordium. However, while the wild-type liver primordium formed a discrete bud at 34 
hpf, the shape and size of the liver primordium in the 34 hpf mutant was almost the same 
as that observed at 30 hpf (Figure 5-3). In addition, we observed that the liver 
primordium was positioned more posteriorly than normal in the mutant embryos (Figure 
5-3B). At 48 hpf, the mutant had little or no detectable expression of foxa1, foxa3 and 
gata6 in the liver primordium but their expression were clearly detectable in other parts 
of the digestive organs except for the pancreatic bud (Figure 5-3B). These results show 
that the mypt1sq181 mutants initiate the expression of the genes required for the endoderm 
to become competent to form hepatic precursors (Lee et al., 2005b). 
5.2.3 The mypt1sq181 mutant hepatoblasts are not maintained 
We next asked if the disrupted liver development in the mypt1sq181 mutant is due to the 
failure in the specification of hepatoblasts from competent hepatic endoderm cells. prox1 







Figure 5-3 sq181 mutation does not block hepatic competency. Wild-type (wt) and 
mutant (mu) embryos at 24 (A), 30, 34 and 48 hpf (B) were flat-mounted following in 
situ hybridization and shown in a dorsal view (liver primordium: black arrow; 
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Figure 5-4 sq181 mutation blocks liver bud formation but not hepatoblast 
specification. Wild-type (wt) and mutant (mu) embryos at 24 (A), 30, 34 and 48 hpf 
(B) were flat-mounted following in situ hybridization and shown in a dorsal view 
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determine if the mypt1sq181 mutant is capable of producing definitive hepatoblasts, we 
examined the expression of these genes. Both prox1 and hhex displayed similar 
expression patterns in the liver primordia of wild-type and mypt1sq181 embryos at 24 and 
30 hpf (Figure 5-4A and B), demonstrating that the mutant initially developed definitive 
hepatoblasts. After this time, however, the expression of these genes in wild-type and 
mutant embryos diverged. Whereas the expression of hhex and prox1 in wild-type 
embryos continued to increase at 34 and 48 hpf, forming a discrete bud on the left side of 
the embryo; in mypt1sq181 mutants the expression territory of these genes never increased 
beyond 30 hpf, but instead went decreasing (Figure 5-4B). Thus, while the mutants 
initially induce the hepatoblast fate, they are unable to sustain it. 
5.2.4 The mutant Mypt1 binds PP1c poorly and is functionally attenuated 
Before we investigate the mechanism how the mypt1sq181 mutation leads to the above liver 
development defects, the biochemical consequence caused by the mutation should be 
addressed. Structural analysis has shown that Mypt1 binds to PP1c using its N-terminus, 
which contains the KVxF motif, whereas it binds to myosin regulatory light chain at its 
C-terminus (Ito et al., 2004; Terrak et al., 2004). We asked if the KV36xF to KM36xF 
conversion would compromise the binding of Mypt1 to PP1c since the KVxF motif is 
crucial for this function. Molecular modeling based on the known structure of the chicken 
Mypt1-PP1c complex shows that all five possible conformations of Met in the M36-
Mypt1 mutant protein are involved in steric clashes with the pocket of PP1c that binds 
the KVxF motif (Egloff et al., 1997; Terrak et al., 2004), which is expected to disfavor 
high affinity binding of Mypt1 to PP1c (Figure 5-5A and 5B). To test this prediction, 
FLAG-tagged zebrafish and mouse wild-type and M36-mutant Mypt1-305 proteins were co-
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expressed with HA-tagged mouse PP1c in the COS-7 cells. Co-immunoprecipitation 
analysis showed that the wild-type Mypt11-305 exhibited strong binding to PP1c whereas 
the binding of M36-Mypt1 to PP1c was greatly reduced (Figure 5-5C and 5D).  
Myosin phosphatase  regulates myosin activity by dephosphorylating myosin regulatory 
light chain to relax contractile actomyosin filaments (Ito et al., 2004; Xia et al., 2005). 
Stress fibers, a similar protein complex as actomyosin filaments, are bundles of actin and 
myosin II that develop in the cultured cells in response to tension or growth factors, and 
high activities of myosin phosphatase results in the disassembly of stress fibers. 
Therefore, stress fibers assay is a widely used approach to determine the activities of 
myosin phosphatase by observing the dissociation of stress fibers in respond to certain 
condition to be tested (Ito et al., 2004; Xia et al., 2005). Because the binding of PP1c to 
Mypt1 is important for myosin phosphatase to exert its function, we predicted that the 
compromised binding of PP1c to M36 -Mypt1 would likely lead to attenuated disassembly 
of stress fibers in cultured cells (Xia et al., 2005). Indeed, while HeLa cells transfected 
with zebrafish wild-type Mypt11-305 lost almost all of their stress fibers (Figure 5-5E) 
(Yong et al., 2006), cells transfected with M36-Mypt11-305 maintained a similar level of 
stress fibers as that observed in untransfected cells (Figure 5-5E and 5F ), indicating that 
this mutant lost its function in regulating myosin activity. 
5.2.5 Knockdown of PP1c phenocopy mypt1sq181 
The mypt1sq181 mutation in Mypt1 compromised the binding of PP1c to Mypt1 and 
caused the attenuated function of myosin phosphatase, as a result, the mutant mypt1sq181 
had no liver at 72 hpf, suggesting that full function of myosin phosphatase is necessary to 
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Figure 5-5 The mypt1sq181 mutation compromises the binding of Mypt1 to PP1c. 
(A and B) Interactions of the KVxF motif (cyan) of Mypt1 with PP1c (gray) in the 
crystal structure of the chicken Mypt1-PP1c complex (A; PDB code: 1S70). Molecular 
modeling shows that all five possible conformations of methionine in KM36xF are 
involved in steric clashes with the KVxF-binding pocket of PP1c (B). For simplicity, 
only three conformations of M36 are shown in yellow, red and green, respectively (B).  
(C) FLAG-tagged zebrafish and mouse wild-type and M36-mutant Mypt11-305 were co-
expressed with HA-tagged mouse PP1c in COS-7 cells, respectively, and were co-
immunoprecipitated using an anti-FLAG antibody. PP1c was detected with an anti-HA 
antibody and Mypt1 with an antibody against the human Mypt1. Cells transfected with 
HA-PP1c alone were used as the negative control (-). w, wild-type Mypt11-305; m, M36-
Mypt11-305; zb, zebrafish; mus, mouse. (D) Quantitative analysis of the PP1c co-
immunoprecipitated by mutant Mypt1 relative to that by the wild-type Mypt1 as 
described in (C). zWT: zebrafish wild-type Mypt11-305; zMT: zebrafish M36-mutant 
Mypt11-305; mWT: mouse wild-type Mypt11-305; mMT: mouse M36-mutant Mypt11-305; 
—: negative control.(E) Immunofluorescence microscopy of HeLa cells transfected 
with FLAG-tagged zebrafish wild-type Mypt11-305 (Mypt1) or mutant M36-Mypt11-305 
(M36-Mypt1). Cells containing Mypt1 or M36-Mypt1 were detected with an anti-FLAG 
antibody (white arrow) (left panels). Stress fibers were stained with TRITC-labeled 
phalloidin (right panels). Note that cells lacking Mypt1 or M36-Mypt1 (marked with *) 
contained significantly higher amounts of stress fibers as did cells transfected with 
M36-Mypt11-305 (white arrow) (lower right panel). (F) Expression of wild-type Mypt1 
and mutant M36-Mypt1 in HeLa cells used for stress fiber assay in (E). An anti-FLAG 


























Figure 5-6 Knockdown of PP1c phenocopies mypt1sq181 (A) pp1c E2I2 morphants 
(pp1c-MO) displayed either a liverless or small liver phenotype (black arrow). PP1c 
morphants at 3 dpf were examined with an lfabp probe. (B) RT-PCR picture showing 
the new transcripts (arrow) generated by pp1c morpholino (C) DNA sequencing 
showed that the new transcript in pp1c-MO have a 337 bp insertion that originates 
from the entire intron 2 of the pp1c gene. The last 50 bases of exon 2 and the first 50 
bases of exon 3 of pp1c are shown in capital letters. The entire intron 2 is shown in 




myosin phosphatase activity in zebrafish embryos by knocking down of pp1c using a 
splicing blocking morpholino pp1cE2I2 (Figure 5-6B and 6C). Analysis of the liver using 
an lfabp probe showed that the pp1cE2I2 morphants resembled the mypt1sg181 mutant and 
were either liverless or had a small liver (100% penetration, out of 92 embryos examined, 
43 were liverless and 49 showed small liver) (Figure 5-6A). This observation argues that 
the cause of the liverless phenotype in the mypt1sq181 mutant is due to an attenuated 
function of myosin phosphatase. 
5.2.6 mypt1 is expressed in the liver primordium and surrounding lateral plate 
mesoderm 
The above biochemical assay showed that the mypt1sq181 mutation resulted in attenuated 
function of myosin phosphatase; we also provided genetic evidence showing that full 
function of myosin phosphatase is necessary to the liver development in zebrafish. 
However, it was unknown how the attenuated function of myosin phosphatase caused by 
mypt1sq181 mutation leads to a liverless phenotype in mypt1sq181 mutants at the 
developmental level. To address this question we first determined which tissues express 
mypt1 during the early stages of zebrafish development. Northern-blot revealed that 
mypt1 transcripts were expressed at similar levels from unfertilized eggs (maternal 
expression) to 5 day post-fertilization embryos (Figure 5-7A). Interestingly, mypt1 
transcripts were barely detectable in adult zebrafish liver (Figure 5-7A). Whole mount in 
situ hybridization showed that at 24 hpf mypt1 is mainly expressed in the head and 
somites (Figure 5-7B). At 28, 30 and 34 hpf, mypt1 transcripts are mainly enriched in the 
head region and also expressed along the foregut endoderm, which later become the 











Figure 5-7 mypt1 is expressed in the LPM and hepatoblasts (A) Northern blot 
showing mypt1 expression at the early stages of embryogenesis and in the adult liver. 
adl, adult liver; unf, unfertilized eggs. (B) Lateral and dorsal views of WISH embryos 
using a mypt1 probe on embryos at 24, 28, 30 and 34 hpf. fe, foregut endoderm; hd, 
head region; sm, somites. (C and D) Sectioning of WISH embryos (34 hpf) with the 
mypt1 single probe (C) or prox1 (red) and mypt1 (purple) double probe (D) shows that 
mypt1 is expressed in the liver primordium and LPM. Black arrow, liver primordium; 
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hybridized with mypt1 single probe (Figure 5-7C) or mypt1 and prox1 double probes 
(Figure 5-7D) showed that mypt1 was expressed in the neural tube, in the LPM 
surrounding the endoderm giving rise to digestive organs, and in the endoderm cells 
including hepatoblasts (compare Figure 5-7C and 7D).  
5.2.7 The mypt1sq181 mutation causes the liverless phenotype in a tissue non-
autonomous manner 
To determine if the Mypt1 expressed in the liver primordium is necessary to maintain the 
capability of hepatoblasts to differentiate into hepatocytes, we performed cell 
transplantation experiments to study the tissue autonomy of the liverless phenotype 
caused by the mypt1 mutation, and found that the mypt1sq181 mutant donor cells still retain 
the capability to become hepatocytes in wild-type recipients (observed in 5 out of 20 
cases) (Figure 5-8A-8C) whereas the wild-type mesoderm donor cells (achieved by 
injecting a morpholino specifically targeting the casanova gene, Stafford et. al., 2006), 
when dominating the mesoderm in the mypt1-MO morphant recipients, can partially 
rescue the liver development (small liver in 31 out of 65 transplant recipients verse 26 out 
323 morphants as control) (Figure 5-8D-8F and Figure 4-8E), suggesting that the 
mypt1sq181 mutation does not affect the cell fate determination but might alter a 
mesodermal signaling pathway(s) necessary for the liver development. 
5.2.8 The mypt1sq181 mutation causes abnormal bundling of actomyosin filaments 
and disorganization of LPM cells  
The non-autonomy of the mypt1sq181 mutation implicated that the essential role of 
mesoderm in the liver development. Because the mypt1-expressing lateral plate 




Figure 5-8 The mypt1sq181 mutation causes the liverless phenotype non-cell 
autonomously. (A-C) A confocal section of the liver in a WT embryo transplanted with 
mypt1sq181 donor cells at 72 hpf. The liver is stained with the lfabp probe (A) and the 
donor cells were labeled with fluorescein-dextran (B). (A) and (B) are superimposed in 
(C). (D-F) mypt1 morphants were transplanted with WT mesoderm cells (obtained from 
a casanova morphant labeled with biotin-dextran). At 72 hpf, the liver was stained with 
the lfabp probe (white arrow) (E) and WT donor cells were visualized using the biotin 
tag (F).  mypt1-MO morphant control stained with the lfabp probe (D). 
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LPM were the cause of liver phenotype in the mypt1sq181 mutant. Results from stress fiber 
assay showed Mypt1V36-M36 mutant protein lost its function in regulating myosin activity. 
We further examined the actin filaments in the mypt1sq181 mutant in the gut-GFP 
background and observed abnormal accumulation of actin filament bundles in the LPM 
and hepatoblasts in the mypt1sq181 mutant at 29hpf, which is in contrast to the smooth 
peripheral distribution of actin filaments in wild-type (Figure 5-9 A to F). Such 
disorganized actin assembly led to a disorganization of LPM cells and a compromised 
LPM movement (LPM displacement) in mutant embryos during the gut looping (Figure 
5-9 A to F). These results agreed with the well-documented function of Mypt1 in the 
regulation of cell migration (Egloff et al., 1997; Xia et al., 2005). 
Interestingly, we observed another cell movement defect in mutant embryos. Our initial 
results indicated that the liver primordium was positioned more posteriorly than normal 
in the mutant embryos (Figure 5-3 and Figure 5-4) at 34 hpf. To examine this more 
carefully, we examined the relative positions of the liver primordium with respect to the 
somites using three markers, insulin (islet), hhex (hepatoblasts) and the F59 antibody 
(somites) (Latimer et al., 2002). In the wild-type, the islet is normally located under the 
4th somite and the liver primordium, labeled by hhex, is consistently positioned under the 
first somite throughout the early stages of liver organogenesis (Figure 5-9G). In the 
mypt1sq181 mutant, the islet position was not obviously affected, and it remained under the 
fourth somite at 30 and 34 hpf (Figure 5-9G). In contrast, the liver primordium in the 
mutant was variably positioned under the 1st and 2nd somites at 30 hpf, and was 
positioned under the 2nd and 3rd somites at 34 hpf, resulting in a shorter distance from the 
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Figure 5-9 The mypt1sq181 mutation disrupts LPM organization and causes 
posterior shift of the liver primordium. (A,B) Cross-sections from wild-type (wt) 
and mutant (mu) zebrafish embryos in the gut GFP Tg(gutGFP)S584  background 
(green) stained with phalloidin (red). (C-F) High-magnification views of boxed 
regions in A (C,E) and B (D,F) showing abnormal aggregations of actin filaments 
(arrows) and cell organization in the mutant endoderm (C versus D) and LPM (E 
versus F) cells. Endoderm cells were GFP positive (green fluorescence). Abnormal 
bundles of actin filaments in the mutant are highlighted with white arrows head. (G) 
WISH using insulin (for islet, black arrowhead) and hhex (for liver, black arrow) 
probes, and F59 antibody (for somites, black lines) shows a posterior shift of the liver 
primordia in mutants (mu) compared to wild-type from 30 to 34 hpf.  
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Therefore, the mypt1sg181 mutation caused a posterior shift of the liver primordium, a 
possible second cause of the liver development defect in the mypt1sq181 mutant. 
5.2.9 Bmp2a rescues the liver development in mypt1sg181  
The results of chimera embryo assay suggest that the abnormal LPM organization 
contributes to the mutant phenotypes, and also suggest that some mesodermal inductive 
signals that are essential for the liver bud formation may be perturbed in their signaling in 
the mutant. If this is the case, we speculated that ectopically expressing this inductive 
signal would rescue the mutant phenotype since the inductive signal would be present in 
all cells of the embryo. We tested fgf8, wnt2bb, bmp2a, bmp2b and RA since these four 
classes of signaling factors have been implicated in liver development in different 
systems (Jung et al., 1999; Ober et al., 2006; Rossi et al., 2001; Stafford and Prince, 2002; 
Shin et al., 2007). We injected expression plasmids or mRNA for each of these factors 
into one-cell mypt1sq181 mutant embryos, or incubated the embryos in RA, and analyzed 
the embryos three days post-fertilization with the lfabp marker. Ectopic expression of 
wnt2bb (mRNA) and fgf8 (expression plasmid) or incubation with RA failed to rescue the 
liverless mutant phenotype (Table 5-1). Importantly, injection of bmp2a mRNA rescued 
liver development in 45% of the homozygous mypt1sq181 mutants (42/93 mutant embryos 
examined) even though these embryos had a severely ventralized phenotype caused by 
the ectopic Bmp2a (Figure 5-10A). Injection of bmp2b mRNA could also rescue the liver 
development but in a much lower ratio (14/66 mutant embryos examined) (Table 5-1), 
probably Bmp2a and Bmp2b are functionally redundant but Bmp2a is more potent in 
inducing liver development. The rescued liver development in the mutant by injection of 
bmp2a mRNA can be explained in two ways: ventralization caused by Bmp2a  
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Signaling molecules Rescued number/total number 
of mutant embryos examined 
wnt2bb mRNA (100ng/ul) injection 0/18 
bmp2a mRNA (1 ng/ul) injection 42/93 
bmp2b mRNA (2.5 ng/ul) injection 14/66 
psox17-bmp2a plasmid  injection (ng/ul): 
                          5  
                          10 





psox17-fgf8 plasmid injection (ng/ul) 
                          5 




RA incubation: 10-8 M 































Table 5-1 Summary of rescue of liver phenotype in mypt1sq181 by various signaling 
molecules 
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 overexpression may lead to rearrangement of the mesoderm in such a way that will 
reconnect the necessary mesodermal signal to the liver primordium. Failure of rescue of 
the liverless phenotype by Wnt2bb, Fgf8 and RA suggests that at least these mesoderm 
signals are not reconnected by ectopic Bmp2a if the hypothesis is correct. Alternatively, 
the ectopic Bmp2a itself can support the liver development. In the following I will 
provide evidence to show that Bmp signal is essential for liver development in zebrafish. 
5.2.10 Blocking Bmp signaling causes the liverless phenotype  
Our results suggested that alteration of the bmp2a signaling is at least one of the causes of 
the liverless phenotype in the mypt1sq181 mutant. To directly test this hypothesis, we 
blocked Bmp signaling using a transgenic zebrafish line expressing a dominant-negative 
form of Xenopus Bmp receptor type 1a (BmpR1a) fused to GFP, which is under the 
control of a heat-shock promoter (Figure 5-10B). This line allowed us to temporally 
block Bmp signaling during the stages we predicted that Bmp is important for liver 
development, and to avoid the defects caused by inhibiting Bmp signaling during earlier 
stages of development (Pyati et al., 2005; Pyati et al., 2006). In addition, in an outcross of 
heterozygous adults carrying the transgene, embryos containing the transgene can be 
readily separated from the control non-transgenic embryos after the heat shock based on 
GFP fluorescence. In embryos heat-shocked between 18 and 21 hpf the dominant-
negative BmpR1a-GFP fusion protein was maximally expressed within two hours, and 
remained at this level for at least another four hours (Figure 5-10C), suggesting that the 
blockage of Bmp signal may happen two hours later than the heat shock treatment  . As 
observed previously, heat shock treatment at either 18 or 21 hpf did not cause any overt 
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Figure 5-10 Bmp signaling is essential for liver organogenesis. (A) mypt1sq181 
mutant embryos 72 hrs after injection of bmp2a mRNA, stained with the lfabp probe. 
wt, WT; mu, mutant.(B) A method for attenuating Bmp signaling in transgenic 
zebrafish. Diagram of a wild-type cell receiving a Bmp signal (left) and a transgenic 
cell receiving a Bmp signal after heatshock (right). In a wild-type cell, the Bmp ligand 
binds to a Type I/Type II receptor complex, which then phosphorylates and activates a 
receptor SMAD (rSMAD), leading to target gene activation. After heatshock of the 
transgenic cell, the truncated Type I Bmp receptor containing GFP in place of the 
kinase domain displaces the endogenous Type I receptor, preventing the receptor 
complex from activating rSMADs. As a result, downstream target genes are not 
activated, and the cell is reduced in its capacity to respond to Bmp signals. KD, kinase 
domain; LB, ligand-binding domain; P, phosphate; TM, transmembrane domain (Pyati 
et al., 2005). (C) Immunoblot analyses of dominant-negative BmpR1a-GFP expression 
using an anti-GFP antibody after heatshock treatment. Total protein lysates were 
prepared from heatshocked embryos at different time intervals as indicated. (D-F) 
WISH using the lfabp (D), ifabp (E) and prox1 probes and F59 antibody (F) on 
heatshocked embryos. Embryos in (D and E) were heat shocked at 18-21 hpf and in 
(F) at 24 hpf. 
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indistinguishable (Figure 5-10D-10F) (Pyati et al., 2005). We then examined these 
embryos with the liver marker lfabp and the intestinal marker ifabp. Whereas the GFP– 
embryos had normal liver development, almost all of the heat shocked GFP+ embryos 
were either liverless or had a very small liver (Figure 5-10D), an observation also 
reported by Shin et al recently (Shin et al., 2007). In addition, in those embryos, which 
displayed the small liver after a heat shock at 24 hpf, the position of the liver with respect 
to the first somite was not obviously affected when examined with a prox1 probe at 48 
hpf (Figure 5-10E), demonstrating that liver primordium will not form normally if Bmp 
signaling is disrupted even when the primordium is correctly positioned within the 
embryo. In contrast to the effects on the liver, the size of the intestine was not obviously 
affected in the GFP+ heat shocked embryos (Figure 5-10F).                       
5.2.11 M36-Mypt1 disrupts the spatial coordination between the liver primordium 
and Bmp2a-producing cells 
Our rescue results suggested that the perturbed Bmp2a signaling is likely the cause of 
liver defects in mypt1sq181 mutants. To depict the alteration of Bmp2a signaling in 
mutants, we examined the expression pattern of bmp2a in wild-type and mutant embryos. 
At 24 hpf, bmp2a was expressed as two stripes symmetrically positioned on left and right 
side of the midline in wild-type and mutant embryos (Figure 5-11A and B). However, 
while the right stripe starts migrate leftward to join the left stripe in wild-type at 26 and 
28 hpf, this process failed in mutants (Figure 5-11C to 11F). Sections of 28 hpf embryos 
showed that bmp2a was specifically expressed in the LPM cells (Figure 5-11G to 11J). 
Thus, the dynamic expression pattern of bmp2a was coupled with the asymmetric 
migration of the lateral plate mesoderm (LPM displacement) during gut looping (Horne-
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Badovinac et al., 2003). The failure of migration of bmp2a stripes in mutants was caused 
by the compromised LPM movement discussed in the previous sections. At 30 and 34 hpf, 
the right stripe had moved across the midline so that both stripes were on the left side of 
the midline, and the two bmp2a stripes aligned along the dorsal-ventral axis on the left 
side of the embryo to form a V-shaped pocket sandwiched the liver primordium in wild-
type (Figure 5-11K, 11M, 11N, 11P and 11Q). In mutants the right bmp2a stripe failed to 
migrate across the midline to join the left stripe, and thus the bmp2a-pocket was not 
formed at 30 and 34 hpf due to impaired LPM displacement in the mutant (Figure 5-11L, 
11O, 11R and 11S). In addition, the peanut-shaped residual mutant liver primodium was 
positioned more ventrally (Figure 11P to 11S) and was separated from the bmp2a 
expressing cells by a gap of unknown nature that apparently prevented the close abutting 
of the bmp2a-producing cells and the liver primordium (Figure 5-11G to 11J and Figure 
11P to 11S). Comparison of sections from 28 and 34 hpf mutant embryo (Figure 11I and 
11R) revealed that the migration of the right bmp2a stripe in the right LPM was 
compromised rather than abolished.    
In addition to the defective movement of the LPM in mutants, previous results showed a 
posterior shift of the liver primordium. We questioned that whether the mesoderm 
surrounding the liver primordium was also moved posteriorly. Using somites as reference, 
bmp2a was expressed as stripes straddling first three somites in wild-type, and stripes 
were found to span on the second and third somite in mutants (Figure 11K and 11L), 
suggesting that the anterior part of LPM (bmp2a expressing) slightly moved posteriorly, 
like the situation of posterior shift of the liver primordium (Figure 5-9G). These results 
























Figure 5-11 The mypt1sq181 mutation alters the spatial alignment between the liver 
primordium and the two stripes of LPM expressing Bmp2a. (A-F, K-M and O) 
Dorsal views of WISH embryos using the bmp2a probe in wild-type (wt) and mutant 
(mu). Somites were stained with the F59 antibody (K and L, horizontal black lines). 
(M and O) Dorsal view of WISH embryos using prox1 (red stain of the liver 
primordium) and bmp2a (purple) shows that the liver primordium is sandwiched 
between the two bmp2a stripes in wild-type embryos, one above the primordium and 
one underneath (M). (N) Lateral view of two-color WISH wild-type embryos. In the 
mutant the right stripe failed to cross the midline to align with the left stripe to 
sandwich the liver primordium (O). (G-J) Sectioning of the bmp2a WISH embryos at 
28 hpf (G and I) and their corresponding DAPI staining (H and J). (P-S) Sectioning of 
the prox1 and bmp2a WISH embryos at 34 hpf (P and R) and their corresponding 
DAPI staining (Q and S). Green and yellow arrows mark the left and right stripes of 
LPM, respectively; black arrows mark the liver primordium; red arrows mark the fin 
buds (fb). The white dashed line circles the liver primordium and the black dashed line 
shows the midline (md).  
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posterior movement, though it is unknown if the movement of both tissues is 
synchronized.      
Taken together, we demonstrated bmp2a mRNA injection was sufficient to rescue the 
liver development in mypt1sq181 mutants, and Bmp signaling was necessary to support 
proper hepatic program. Further investigation revealed that the liver primordium failed to 
establish a proper spatial positioning with bmp2a-producing cells in LPM due to the 
impaired LPM displacement between 26 to 34 hpf in the mutant, which probably affected 
hepatoblasts to sense Bmp signaling, however, we questioned if such a defect could 
account for all phenotypes displayed in mypt1sq181 mutants: a small liver by 34 hpf and 
total loss of liver cells by 48 hpf. A Bmp signaling defective mutant lost-a-fin, (laf, also 
known as alk8) with a mutation in a type I Bmp receptor, shows a smaller liver at 26 hpf 
which disappears at 48 hpf, similar to that happened in the mypt1sq181 mutant. However, 
the initial liver development in lost-a-fin is supported by the maternal deposited laf 
mRNA (Shin et al., 2007). Interestingly, when the heat shock treatment was done at 24 
hpf (because the fusion protein will become abundant 2 hours after the heat shock, this 
treatment is to block Bmp signaling by 26 hpf, the stage when Bmp signaling was 
affected in the mypt1sq181 mutant), embryos harboring the transgene showed a smaller 
liver at 48 hpf (Figure 5-10F) (Shin et al., 2007), unlike the liverless phenotype observed 
in the mypt1sq181 mutant. The defective LPM displacement was also observed in the has 
and soul (has) mutant (Horne-Badovinac et al., 2003), however, the has mutant displayed 
bilateral small livers at 34 and 72 hpf instead of liverless phenotype as that for the 
mypt1sq181 mutant (Figure 5-12)(Horne-Badovinac et al., 2001). The above three pieces of 




























Figure 5-12 The has mutant gives rise to two smaller liver. Dorsal views of the 
WISH embryos of wild-type (wt) and has mutants using prox1 (left panel) and lfabp 
(right panel) as probes. Black arrows mark the liver primordium. 
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mutant, perturbs the proliferation of hepatoblats and results in a smaller liver by 34 hpf. 
These data also imply presence of another unidentified mechanism causing the liverless 
phenotype in the mypt1sq181 mutant; probably cell death resulted from the failure of 
maintaining hepatoblasts cell fates. To test this hypothesis, experiments were performed 
to check the proliferation and cell death in wild-type and mutants.     
5.2.12 Mutant hepatoblasts are impaired in proliferation  
We carried out immunostaining using an antibody against the phosphohistone-3 protein 
(P-H3) as a marker of proliferating cells. Examining sectioned embryos at 30 hpf we 
found that the mutant had approximately three-fold less P-H3 positive cells than wild-
type in the liver primordium region (10.6 cells in wild-type versus 3.5 cells in mutant, six 
sections per embryo examined; n= 5 wild-type and 6 mutant; Figure 5-13A and 13B) 
whilst in the same sections we found only a 1.4-fold decrease of P-H3 positive cells in 
the mutant neural tube compared to wild-type (61.8 cells in wild-type versus 45.5 cells in 
the mutant per embryo; six sections per embryo examined; n= 5 wild-type and 6 mutant; 
Figure 5-13A and 13B). Since there is no obvious size difference between the wild-type 
and mutant liver primordium at 30 hpf (Figure 5-4B), this result suggests the proliferation 
of hepatoblasts at 30 hpf in the mutant was severely impaired, leading to the reduced liver 
size at later stages. 
5.2.13 Mutant hepatoblasts undergo apoptosis to cause the liverless phenotype 
We examined the apoptotic activity via TUNEL assay in both the wild-type and mutant 
liver primordium region at 28, 30, 34 and 38 hpf. While no or rare apoptotic cell 
appearing in both wild-type and mutant in the liver primordium in embryos at 28 and 30 
hpf (Table 5-2), we consistently observed that the mutant hepatoblasts and part of the  
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Figure 5-13 Mutant hepatoblasts are impaired in proliferation. (A) Immunostaining 
using an anti-P-H3 antibody (pink) on sectioned wild-type (wt) and mutant (mu) 
embryos at 30 hpf. DAPI (blue) is used to mark nucleus. The white dashed line circles 
the liver primordium. (B) Quantitative analysis of the proliferating cells in (A). Six 
sections across the liver primordium per embryo are counted. 
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# At least three mutant and wild-type embryos were performed TUNEL assay. All 








Figure 5-14 Mutant hepatoblasts undergo cell apoptosis that leads to a liverless 
phenotype. TUNEL assay of cell apoptosis in wild-type (wt) (upper panel) and 
mypt1sq181 mutant (mu) (lower panel) embryos at 38 hpf. DAPI (blue) is used to mark 
the nucleus. The white dashed line circles the liver primordium. 
Table 5-2 Cell death in the mutant liver primordium 
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LPM cells adjacent to the liver primordium underwent active cell apoptosis whilst almost 
no apoptotic cells were observed in the same region in wild-type embryos at 38 hpf 
(Figure 5-14, Table 5-2). Therefore, our results indicate that an initial reduction in cell 
proliferation and ultimately programmed cell death leads to the liverless phenotype in 
mypt1sq181. 
5.3 Discussions 
5.3.1 V36 to M36 in Mypt1 confers the liverless phenotype 
Mypt1 binds to myosin by a myosin-binding domain at its C-terminus and to PP1c by an 
RVxF (35-38th amino acid) motif followed by an ankyrin-array (39-299th amino acid) at 
its N-terminus to dephosphorylate phosphorylated myosin regulatory light chain and 
relaxes the contractile activity of actomyosin filaments formed by smooth muscle/non-
muscle myosin II (Ito et al., 2004; Terrak et al., 2004). Mypt1 mediates convergent 
extension during gastrulation in zebrafish (Weiser et al., 2007)(personal communication 
with David Kimelman). Loss-of-function analysis of Drosophila DMYPT and C. elegans 
Mypt1 (mel-11) reveal roles of Mypt1 in the cell sheet movement, cell shape change and 
determine embryo body length (Weiser et al., 2007; Mizuno et al., 2002; Piekny et al., 
2003; Tan et al., 2003; Lee and Treisman, 2004; Xia et al., 2005). Here we report that, in 
zebrafish, a single amino acid substitution, namely V36 to M36, in the highly conserved 
KV36xF sequence in Mypt1 leads to a liverless phenotype in the myptsq181 mutant because 
this mutation compromises the binding of Mypt1 to PP1c, the first genetic evidence of 
the importance of RVxF motif in binding of Mypt1 to PP1c. In the mypt1sq181 mutant the 
endodermal genes necessary for liver competence are activated at normal levels, as are 
the two genes that mark the hepatoblast fate, hhex and prox1. Activation of these two 
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hepatoblast genes is under the control of Wnt2bb, Bmp and Fgf signaling (Ober et al., 
2006; Shin et al., 2007), demonstrating that the initial activation of the liver fate proceeds 
normally. However, after 30 hpf, when the liver bud starts to form, the expression of hhex 
and prox1 is gradually lost in the mutant, and the hepatoblasts fail to proliferate and 
eventually undergo apoptosis, resulting in the liverless phenotype. Although MYPT1 
functions at the early stage to regulate cell migration (Weiser et al., 2007)(personal 
communication with David Kimelman), the early development, such as gastrulation, in 
the myptsq181 mutant seems quite normal, it can be explained that abundant maternal 
mRNA deposit is sufficient to support early morphgenesis.   
5.3.2 The myptsq181 mutation causes defective LPM displacement 
The inability of mutant Mypt1 to dissociate stress fibers in cell culture implicates that 
such a mutation cause compromised function of myosin phosphatase. The in vivo data 
reveal that the mutation causes the abnormal accumulation of actin filament bundles in 
LPM cells and disorganization of LPM cells during gut looping. As a result, the LPM 
movement is compromised but not abolished. Horne-Badovinac et al found that the 
polarity of LPM cells was necessary to achieve the LPM displacement (Horne-Badovinac 
et al., 2003). Here we show the compromised function of myosin phosphatase in the 
myptsq181 mutant is also required for the LPM displacement.         
5.3.3 The defective LPM displacement leads to the failure of establishment a proper 
spatial positioning between Bmp2a producing cells and the liver primordium to 
support hepatoblasts proliferation 
Our studies show that mypt1 is expressed in the LPM and foregut endoderm, which is 
consistent with the observation that defective Mypt1 leads to aberrant morphogenesis of 
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both the LPM and the liver primordium. Normally, the right LPM crosses the midline and 
moves ventral to the liver primordium whereas the left LPM moves dorsal to the liver 
primordium, thus forming a V-shaped LPM pocket surrounding the liver primordium. In 
the mutant, the right LPM fails to cross the midline and thus the pocket fails to form. 
These alterations in the morphogenesis of the liver primordium and LPM alter the 
relative position of these two tissues. The mutant liver primordium also appeared to be 
closer to the midline. There are two possible explanations of this defect: 1) normal Mypt1 
activity within the liver primordium might be necessary for its leftward movement, or 2) 
the compromised LPM displacement fails to push the endoderm further to the left in the 
mutant. Our cell transplantation experiments showed that the myptsq181 mutation works in 
a non-cell autonomous manner. These results suggest the mesodermal signals are altered 
and fail to maintain the liver primordium in the mutant. Testing the four kinds of 
candidate signals that could be involved in liver maintenance, we found that ectopic 
expression of Bmp2a could completely rescue liver gene expression in the mutants. 
Moreover, inhibiting Bmp expression before the hepatoblasts specification caused the 
liverless phenotype (also recently reported by Shin et al., 2007). Of major importance is 
the observation that the LPM cells in the vicinity of the liver primordium express bmp2a 
and alterations in the relative position of the bmp2a-expressing LPM and the liver 
primordium in the mypt1sq181 mutant prevents the close apposition of the Bmp2a 
producing cells and the liver primordium by 30 hpf. Subsequently, the mutant 
hepatoblasts are impaired in proliferation and ultimately undergo apoptosis. Therefore, 
precise spatial positioning of Bmp2a cells with respect to the liver primordium is 
essential for the proliferation and survival of hepatoblasts, whereas in the mypt1sq181 
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mutant cell proliferation is retarded and cell apoptosis is activated which in the end leads 
to the liverless phenotype. These observations fit very well with studies in mouse and 
zebrafish, which demonstrate the importance of Bmp signaling in the liver development 
(Rossi et al., 2001; Shin et al., 2007). 
5.3.4 Bmp signaling is essential for the hepatoblasts specification and proliferation 
Previous two reports have shown the essential function of Bmp signaling in the 
hepatoblasts specification (Rossi et al., 2001; Shin et al., 2007); however, neither of these 
reports demonstrates how dynamic cell movement establishes a spatial relationship 
between Bmp-producing cells and the liver primordium to direct Bmp signaling during 
liver organogenesis. In other words, the establishment of the spatial interaction between 
Bmp-producing cell and the competent endoderm during a specific time window is not 
well studied. We first reveal a dynamic pattern of Bmp2a during the early liver 
development. Since Bmp2a is expressed as two stripes in the LPM, the presence of 
Bmp2a signaling is achieved by the LPM migration, when the hepatoblasts undergo 
specification and proliferation. By the time of hepatic specification at 22 to 24 hpf, two 
parallel stripes of Bmp2a are located on the each side of the middle line and not directly 
contacted with the competent endoderm. The proliferating hepatoblasts form a liver bud 
by 30 hpf, when the two Bmp2a stripes join together at the left side of axis to form a 
pocket to directly abutting the liver primordium. Interestingly, Wnt2bb, a signal 
necessary for the hepatic specification, is also expressed in LPM and display a similar 
dynamic pattern as Bmp2a (Ober et al., 2006). Another Bmp member, Bmp2b, is also 
found expressed in such a manner (gene expression database in zfin). The above results 
suggest that the LPM may serve as mesodemal signal source to supply signaling 
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molecules to promote the hepatic specification and proliferation by LPM displacement. 
Thus, during the hepatic specification, the low concentration of Wnt2bb and Bmp2 is 
provided to the competent endoderm. Although Bmp2 signals and/or other Bmps are 
involved in this process the mechanism is not determined yet. On the hand, during the 
liver bud formation, Bmp2a-producing LPM cells directly abut hepatoblasts to supply 
strong Bmp2a signal to support robust proliferation of hepatoblasts. Since the close 
contact between bpm2a-producing cells and hepatoblasts is achieved through LPM 
displacement, mutations perturbing this process will leads to decreased hepatoblasts 
proliferation. Both the compromised LPM displacement in the mypt1sq181 mutant and the 
abolished LPM displacement in the has mutant result in small liver due to the low 
proliferation rate in hepatoblasts, and the dual livers in the has mutant is probably a result 
from bilateral Wnt and Bmp signals in the early liver development. Moreover, blocking 
Bmp signal in this time window leads to small liver too. The above evidence suggests a 
dual role of Bmp in the early liver development: hepatoblast specification and 
proliferation.  
5.3.5 A posterior shift of the liver primordium also appears in the mypt1sq181 mutant  
It is interesting that a mutation in mypt1 has such subtle effects, apparently altering only 
the liver and exocrine pancreas, which was revealed using in situ hybridization markers. 
We believe that mypt1sq181 is a near-null mutation since we find the same phenotype in 
the insertional mutant mypt1hi2653, and with a splice-blocking morpholino that targets 
mypt1. We note that there is a large maternal contribution of mypt1, which would allow 
the embryo to undergo early morphogenesis without apparent defects. However, from 30 
hpf onwards the maternal wild-type Mypt1 can no longer sustain the normal development 
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due to either protein degradation or reduced protein amount in individual cells and thus 
excess contractile activity of myosin in the mypt1 mutant causes the posterior shifting of 
the liver bud with respect to the somites, in addition to the aforementioned LPM 
displacement defect. Interestingly, a similar posterior shift of the bmp2a expressing LMP 
cells was also observed, thus, the relative position between the liver primordium and 
Bmp2a producing cells along the anterior and posterior axis is not affected significantly. 
The consequence of such an aberrant tissue movement on the liver development is not 
investigated yet. We anticipate that other defects may be found in these embryos when 
they are examined with probes that reveal subtle alterations in the development of other 
embryonic structures. Interestingly, we observed a decrease in hhex expression in the 
mypt1sq181 mutant, coincident with a failure of the liver primordium to move properly. 
Hex homozygous mutants in mouse are impaired in normal endoderm movement, and 
they fail to initiate ventral pancreatic specification and lose hepatic differentiation (Bort 
et al., 2004; Bort et al., 2006). It would be interesting to determine if there is a direct link 
between the maintenance of hhex expression and the endoderm movement phenotype in 
the mypt1sq181 embryos. 
The results presented here allow us to expand our understanding of liver development in 
zebrafish. During gastrulation, RA establishes the correct anterior-posterior identity of 
the mesoderm and/or endoderm, which is necessary for liver induction to occur (Stafford 
and Prince, 2002). At approximately 22-24 hpf, Wnt2bb, Bmps and Fgfs signals activate 
the competent endodermal cells to initiate the hepatoblast fate (Ober et al., 2006; Shin et 
al., 2007). Under the influence of the Nodal factors, the right LPM begins to move across 
the midline, and then under the liver primordium (Horne-Badovinac et al., 2003). This 
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movement not only provides the force for the looping of the liver and gut (Horne-
Badovinac et al., 2003), but as we show here, it also brings bmp2a-expressing cells next 
to the liver primordium. The critical role of Mypt1, and by extending myosin contractility, 
therefore, is to carefully position the liver primordium relative to the source of Bmp in 
the LPM in order to maintain the hepatoblasts.   



















Chapter 6 General conclusion and future prospects 
The main purpose of this research is to explore molecular mechanism of the liver 
development in zebrafish.  
As a first step, a forward genetic screen was carried out to identify specific liver defective 
mutants. We developed a high-throughput RNA WISH method for our screen using a 
liver specific marker prox1 as a probe to visualize the embryonic liver at 3 dpf. After 
screening 524 mutagenized genomes, we obtained 71 putative mutants with abnormal 
liver organogenesis. 19 mutant lines showed specific liver defects and relatively normal 
morphology, and these mutants were starting materials to investigate the molecular 
mechanism underlying the liver development. Such a productive screen using a highly 
efficient high-throughput WISH method overcomes the difficulty of examining liver 
development met in the previous screens by observing this internal organ under 
dissecting microscope (Chen et al., 1996; Pack et al., 1996). 
Positional cloning was used to reveal molecular lesions in mutants. To construct our own 
initial mapping panel, total 451 simple SSLP markers from established panels were tested 
in our AB and WIK lines. 226 markers which showed polymorphism were selected to be 
used for initial mapping. Positional cloning identified a G to A substitution in the mypt1 
gene, which results in the V36 to M36 substitution in an RVxF motif in Mypt1 in a 
liverless mutant sq181. Several genetic approaches, including co-segregation analysis, 
mypt1 morpholino knockdown experiment, finding an additional allele of sq181 and 
mRNA rescue experiment, were used to confirm that the G to A mutation in sq181 is 
responsible for the liverless phenotype. We provide the first genetic data that Mypt1 
regulates the liver development in zebrafish. 
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Mypt1 is one of three components of myosin phosphatase and RVxF motif is crucial for 
Mypt1 binding to PP1c (Ito et al., 2004; Terrak et al., 2004). Biochemical assay showed 
that the V36 to M36 substitution in mutant attenuates the affinity of Mypt1 to PP1c and 
results in a compromised myosin phosphatase function indicated by stress fibers assay. 
This is the first genetic data to verify the conclusion drawn in protein structure study that 
the RVxF motif is essential for interaction between Mypt1 and PP1c (Egloff et al., 1997; 
Terrak et al., 2004). The consequence of the compromised myosin phosphatase function 
in the mypt1sq181 mutant is abnormal bundling of actin filaments in LPM cells which 
causes the disorganization of LPM cells around the hepatic endoderm. As a result, the 
asymmetrical migration of LPM occurred during this stage is perturbed in the mypt1sq181 
mutant, which leads to the failure of two stripes of Bmp2a-expressing cells in the LPM to 
align in a V-shaped pocket to directly abut the liver primordium. Our results showed that 
Bmp signaling is necessary for liver development, and overexpression of bmp2a was able 
to restore the liverless phenotype in mutants. These data indicate that the disrupted spatial 
position of Bmp2a producing cells with respect to the liver primordium leads to 
phenotypes in the mypt1sq181 mutant, a reduction of hepatoblast proliferation at first and 
final abortion of hepatoblasts by apoptosis that causes the liverless phenotype. Previous 
studies show that various mesodermal inductive signals are essential for liver 
organogenesis (Jung et al., 1999; Rossi et al., 2001; Stafford and Prince, 2002; Ober et al., 
2006; Shin et al., 2007). However, little is known about how these signals are presented 
spatially and temporally to and hepatic endoderm during morphogenesis. We found that 
Mypt1 mediates coordination between mesoderm and endoderm cell movements during 
liver budding stage to establish a direct contact between them such that the liver 
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primordium receives a mesodermal Bmp signal that is essential for liver formation in 
zebrafish. 
Although out of the scope of this study, some issues derived from this project are very 
interesting and worth putting effort in the further study. Our results suggest that a high 
concentration of Bmp is necessary for proliferation of hepatoblasts; however, more 
experiments are required to validate this theory. The dominant negative Bmp receptor 
transgenic line can be used as a model to temporally block Bmp signal to examine the 
effect of Bmp signaling on hepatoblast proliferation. Similar to the mypt1sq181 mutant, the 
correct spatial position of Bmp2a signal and the liver primordium in has mutant failed to 
be established due to the abolished asymmetrical migration of LPM, therefore, has 
mutant can serve as an attenuated Bmp2a signaling model to study this issue. Bmp 
signaling is necessary for the liver specification (Rossi et al., 2001; Shin et al., 2007). 
Bmp2a producing cells are away from the competent endoderm at this stage, it is 
interesting to determine if the Bmp2 signaling is required for the liver specification; if yes, 
it seems that a low concentration of Bmp2 is enough to support the liver specification, 
and it is very exciting to investigate if the model, low Bmp for differentiation while high 
Bmp for proliferation, is a common way for Bmp signals to regulate organogenesis. 
Bmp signaling is proven to be essential in the liver development; however, the upstream 
and downstream events are unknown. Nodal signal regulates the asymmetrical migration 
of LPM during liver budding stage and guides the spatial positioning of Bmp2a 
producing cells in LPM (Horne-Badovinac et al., 2003), a natural question is whether 
Nodal signal directly regulates Bmp2a expression or not. Bmp signaling is relayed by 
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Smad1/5/8 cascade to activate the downstream genes (Pyati et al., 2005), and it is 
unknown which are responsible for liver development. 
Besides Bmp2a, other signals are also expressed in LPM including Bmp2b and Wnt2bb 
(Ober et al., 2006)(gene expression database in zfin). It is interesting to investigate how 
these signals collaborate to regulate the liver organogenesis. 
In the mypt1sq181 mutant, the development of exocrine pancreas is affected. The study of 













































In Section 1.1 the liver structure and functions, most cited information is from internet, 
including http://www.britannica.com/eb/art-68633/Anterior-and-posterior-views-of-the-
liver?articleTypeId=1; http://www.moondragon.org/health/disorders/gallbladder.html and   
http://www.sacs.ucsf.edu/home/cooper/Anat118/GI-Glands/lvrpancsaliv.htm. 
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